Page last updated: 2024-08-17

adenosine monophosphate and 2019 Novel Coronavirus Disease

adenosine monophosphate has been researched along with 2019 Novel Coronavirus Disease in 569 studies

Research

Studies (569)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	569 (100.00)	2.80

Authors

Authors	Studies
Andres, M; Barbani, MT; Hirzel, C; Holbro, A; Ramette, A; Schenker, C; Suter-Riniker, F; Tritschler, T; Walti, LN; Zeerleder, SS	1
Brown, CE; Clement, FM; Congly, SE; Saxinger, L; Varughese, RA	1
Cherrington, NJ; Ekins, S; McGrath, ME; Miller, SR; Wright, SH; Zorn, KM	1
Brondeel, KC; Charipova, K; Cornett, EM; Erwin, A; Fox, CJ; Gress, KL; Kaye, AD; Kevil, CG; Knight, HE; Lerner, ZI; Urits, I; Urman, RD	1
Al-Sawalha, NA; Keewan, N; Slati, F; Taha, HR	1
Banerjee, A; Kanwar, M; Maiti, S	1
Anson, BJ; Ghosh, AK; Hattori, SI; Higashi-Kuwata, N; Lendy, EK; Mesecar, AD; Mitsuya, H; Raghavaiah, J; Shahabi, D; Yadav, M	1
Ader, F; Belhadi, D; Bouscambert-Duchamp, M; Burdet, C; Costagliola, D; Diallo, A; Greil, R; Guedj, J; Hites, M; Lê, MP; Mentré, F; Paiva, JA; Peiffer-Smadja, N; Peytavin, G; Poissy, J; Staub, T; Yazdanpanah, Y	1
Azzam, EI; Jadhav, AB; Wang, Y; Yu, J	1
Basler, CF; Davey, RA; Edwards, MR; El-Sayed, NS; Jureka, AS; Keiser, PT; Lohan, S; Parang, K; Tiwari, RK; Totonchy, J; Williams, CG	1
Almario-Hernandez, AF; Doerholt, K; Drysdale, SB; Gilmour, C; Heath, PT; Pereira, NMD	1
Kaka, AS; Linskens, EJ; MacDonald, R; Wilt, TJ	1
Bisimwa, HM; Ciesielska, EJ; Ciesielski, GL; Grier, C; Kim, S; Oliveira, MT; Rahman, MM; Young, CKJ; Young, MJ	1
Assis, LC; da Cunha, EFF; de Almeida La Porta, F; de Castro Ramalho, T; de Castro, AA; de Jesus, JPA; Kuca, K; Nepovimova, E	1
Bal, W; Balwierz, W; Bień, E; Chaber, R; Dembowska-Bagińska, B; Gryniewicz-Kwiatkowska, O; Irga-Jaworska, N; Kazanowska, B; Krawczuk-Rybak, M; Kruk, A; Książek, A; Matkowska-Kocjan, A; Matysiak, M; Mizia-Malarz, A; Młynarski, W; Ociepa, T; Peregud-Pogorzelski, J; Pierlejewski, F; Raciborska, A; Sawicka-Żukowska, M; Styczyński, J; Szczepański, T; Szmydki-Baran, A; Ussowicz, M; Wachowiak, J; Węcławek-Tompol, J; Zając-Spychała, O; Zakrzewska, Z; Zaucha-Prażmo, A	1
Ali, S; Desai, K; Ghosh, S; Harris, I; Kiptanui, Z	1
Allerton, C; Anderson, AS; Anson, BJ; Arenson, D; Aschenbrenner, L; Bakowski, MA; Beutler, N; Binder, J; Boras, B; Chatterjee, AK; Chen, E; Eng, H; Frieman, MB; García-Sastre, A; Hammond, H; Hammond, J; Haupt, RE; Hoffman, R; Jones, RM; Kadar, EP; Kania, R; Kimoto, E; Kirkpatrick, MG; Lanyon, L; Lendy, EK; Lillis, JR; Logue, J; Luthra, SA; Ma, C; Mason, SW; McGrath, ME; Mesecar, AD; Noell, S; O' Brien, MN; O'Connor, R; Obach, RS; Ogilvie, K; Owen, D; Pettersson, M; Reese, MR; Rogers, TF; Rosales, R; Rossulek, MI; Sathish, JG; Shirai, N; Steppan, C; Ticehurst, M; Updyke, LW; Wang, J; Weston, S; White, KM; Zhu, Y	1
Chen, J; Han, F; Liu, Y; Mo, M; Wang, C; Wu, J; Yang, Y	1
García-Vallecillos, C; Hidalgo-Tenorio, C; Sequera-Arquelladas, S	1
Ferrara, F; Vitiello, A	1
De Clercq, E	1
Arcimowicz, Ł; Jassem, E; Jassem, J; Marek-Trzonkowska, NM; Papak, I; Smiatacz, T; Zaucha, JM	1
Amri Male, P; Ezoji, K; Latifi, K; Mohammadnia-Afrozi, M; Sadeghi Haddad Zavareh, M; Seyfi, S	1
Dangerfield, T; Johnson, KA	1
Chanda, SK; Cheng, K; Martin-Sancho, L; Nair, NU; Pal, LR; Pu, Y; Riva, L; Ruppin, E; Sinha, S; Yin, X	1
Amini, M; Demirdas, S; Saify Nabiabad, H	1
Bjork, JA; Wallace, KB	1
Ahmed, SSU; Bappy, MNI; Chelliah, R; Elahi, F; Ghosh, A; Hasan, M; Hassan, MM; Hoque, SF; Mony, TJ; Muhit, S; Oh, DH; Park, SJ; Sajib, EH; Uddin, MB	1
AbdulKhaliq, I; Baxendale, H; Bermingham, W; Brown, LK; Brown, M; Buckland, M; Goodman, A; Hunter, M; Jarvis, H; Jenkins, M; Jolles, S; Karanam, S; Khan, S; Lowe, DM; Moran, E; Patel, A; Richter, A; Robbins, A; Savic, S; Shields, A; Simpson, T; Underwood, J	1
Hamada, S; Hirai, T; Imoto, E; Ito, I; Itohara, K; Kai, S; Katada, Y; Matsumura, K; Nakagawa, T; Ohtsuru, S; Sato, Y; Sukeishi, A; Tanabe, N; Terada, T; Yanagita, M; Yonezawa, A	1
Green, DJ; Imburgia, CE; Kelley, WE; Mcknite, AM; Reilly, CA; Rower, JE; Watt, KM	1
Kechris, K; Leach, SM; Showers, WM; Strong, M	1
Alavi, J; Arabsheybani, S; Haem, E; Jafarian, S; Jalali, SS; Malekhosseini, SA; Mardani, P; Mirzad Jahromi, K; Moeini, YS; Niknam, T; Salimi, M; Shafiekhani, M; Shahabinezhad, F; Shahriarirad, R; Tara, SA; Zare, Z	1
Alam, MJ; Alreshidi, M; Saeed, A; Saeed, M	1
Boglione, L; Borrè, S; Cantone, M; Di Pasquale, F; Domenicale, B; Esposito, M; Meli, G; Moglia, R; Poletti, F; Rostagno, R; Scianguetta, C	1
Blanco, R; Haider, N; Patel, RH; Pella, PM	1
Abolnezhadian, F; Alavi, SM; Ghafourian, M; Khodadadi, A; Mahmoudian-Sani, MR; Nashibi, R; Sharhani, A; Shohan, M	1
Anderson, C; Neil, GA; Perlin, DS; Raines, S; Ware, CF; Wilkins, HJ; Zafir-Lavie, I	1
Asantewaa, G; Ciesla, JH; Dewhurst, S; Harris, IS; Leach, J; Lutz, MM; Monaghan, M; Munger, J; Raymonda, MH; Schafer, XL; Smorodintsev-Schiller, LA; Takimoto, T	1
Babiker, AG; Baker, JV; Barkauskas, CE; Benfield, T; Bowdish, ME; Brown, SM; Cao, H; Chang, CC; Chang, W; Davey, VJ; Dewar, RL; Files, DC; Gardner, EM; Gelijns, AC; Gerry, NP; Ginde, AA; Goodman, AL; Gottlieb, RL; Grund, B; Harris, ES; Higgs, ES; Highbarger, H; Holland, TL; Jain, MK; Jensen, JU; Johansen, IS; Kan, VL; Klekotka, P; Knowlton, KU; Lane, HC; Leshnower, BG; Lundgren, JD; Markowitz, N; Matthay, MA; Murray, DD; Murray, TA; Natarajan, V; Neaton, JD; Paredes, R; Parmar, MKB; Phillips, AN; Polizzotto, MN; Reilly, C; Rupert, AW; Sandkovsky, U; Self, WH; Sharma, S; Shaw-Saliba, K; Sherman, BT; Teitelbaum, M; Thompson, BT; Wentworth, D; Østergaard, L	1
Baden, LR; Morrissey, S; Rubin, EJ	6
Abdelghany, M; Behenna-Renton, N; Brown, M; Brown, SM; Camus, G; Chen, S; Davies, S; Duff, F; Ginde, AA; Gottlieb, RL; Hidalgo, A; Hill, JA; Hyland, RH; Juneja, K; Katz, MJ; Marty, FM; Mera, J; Mittal, S; Nielsen, BU; Oguchi, G; Osinusi, A; Osiyemi, O; Paredes, R; Perez, G; Ryan, P; Sachdeva, Y; Schiffer, JT; Skarbinski, J; Vaca, CE; Webb, BJ	1
Ayodele, O; Bao, Y; Gondek, K; Jonsson Funk, M; Keenan, H; Ren, K; Signorovitch, J; Zhao, J; Zhu, J	1
Barba-Spaeth, G; Gibier, JB; Isnard, P; Mueller, F; Pierron, G; Pietropaoli, S; Rabant, M; Rameix-Welti, MA; Rensen, E; Simon-Loriere, E; Sommer, S; Souquere, S; Terzi, F; Weber, C; Zimmer, C	1
Béraud, G; Leleu, H; Timsit, JF	1
Barker, R; Bechman, K; Bernal, W; Dobson, RJB; Galloway, JB; Kraljevic, Z; Mann, K; Nagra, D; Norton, S; Patel, A; Periselneris, J; Rutherford, AI; Smith, LJ; Teo, JHT; Walder, D; Yates, M	1
Biancofiore, A; Copetti, M; De Cosmo, S; Di Viesti, MP; Labonia, M; Lombardi, R; Mirijello, A; Puteo, MA	1
Ali, K; Azher, T; Baqi, M; Binnie, A; Borgia, S; Carrier, FM; Cavayas, YA; Chagnon, N; Cheng, MP; Conly, J; Costiniuk, C; Daley, P; Daneman, N; Douglas, J; Downey, C; Duan, E; Duceppe, E; Durand, M; English, S; Farjou, G; Fera, E; Fontela, P; Fowler, R; Fralick, M; Geagea, A; Grant, J; Harrison, LB; Havey, T; Hoang, H; Kelly, LE; Keynan, Y; Khwaja, K; Klein, G; Klein, M; Kolan, C; Kronfli, N; Lamontagne, F; Lau, R; Lee, N; Lee, TC; Lim, R; Longo, S; Lostun, A; MacIntyre, E; Malhamé, I; Mangof, K; McGuinty, M; Mergler, S; Munan, MP; Murthy, S; O'Neil, C; Ovakim, D; Papenburg, J; Parhar, K; Parvathy, SN; Patel, C; Perez-Patrigeon, S; Pinto, R; Rajakumaran, S; Rishu, A; Roba-Oshin, M; Rushton, M; Saleem, M; Salvadori, M; Scherr, K; Schwartz, K; Semret, M; Silverman, M; Singh, A; Sligl, W; Smith, S; Somayaji, R; Tan, DHS; Tobin, S; Todd, M; Tran, TV; Tremblay, A; Tsang, J; Turgeon, A; Vakil, E; Weatherald, J; Yansouni, C; Zarychanski, R	1
Misra, A; Singh, A; Singh, AK; Singh, R	1
Kozlov, M	1
Abu Bakar, U; Gan, SH; Jaber, AAS; Jusnita, N; Lukas, S; Pratiwy, I; Ramatillah, DL; Syed Sulaiman, SA	1
Chaturvedi, N; Chauhan, P; Karthic, A; Kesarwani, V; Kushwaha, SK; Singh, RK; Yadav, BS; Yadav, PK	1
Zachariah, P	1
Chantelot, L; Chevret, S; De Castro, N; Delaugerre, C; Esnault, V; Gressens, SB; Hervier, B; Molina, JM; Sellier, P; Sene, D	1
Annie, F; Mandadi, S; Pulluru, H	1
Ledford, H	5
Alquézar-Arbé, A; Burillo-Putze, G; García-Lamberechts, EJ; González Del Castillo, J; Jacob, J; Jiménez, S; Llorens, P; Martín, A; Martín-Sánchez, FJ; Martínez-Nadal, G; Mebazaa, A; Mirò, Ò; Piñera, P; Sabaté, M	1
Arasawa, S; Hirayama, Y; Iwashima, D; Takahashi, KI; Uemasu, K; Yasuda, Y	1
Albrich, WC; Boggian, K; Dollenmaier, G; Flury, D; Gantenbein, P; Kern, L; Kohler, P; Rüfenacht, S	1
Chen, XW; Jin, X; Li, X; Liu, FL; Qin, JR; Sun, J; Wang, JH; Wu, ML; Yan, QH; Zhao, JC; Zheng, YT	1
Amarasinghe, N; Bruno, R; Colaneri, M; Gregorini, M; Meloni, F; Pelenghi, S; Pieri, TC; Rampino, T; Rezzonico, L; Ricciardi, A; Roda, S; Sambo, M; Segalini, E	1
Núñez, I; Soto-Mota, A; Valdés-Ferrer, SI	1
Diószegi, Á; Farkas, K; Hevessy, Z; Illés, Á; Magyari, F; Nagy, B; Nagy, G; Páyer, E; Pinczés, LI; Sik, M; Simon, Z; Ujfalusi, S	1
Agarwal, G; Burkholder, GA; Erdmann, NB; Goepfert, PA; Hauptfeld-Dolejsek, V; Houp, JA; Kew, CE; Killian, AC; Killian, JT; Kumar, V; Leal, SM; Levitan, EB; Locke, JE; Lund, FE; Nellore, A; Ong, SC; Orandi, BJ; Porrett, PM; Roman Soto, SA; Zumaquero, E	1
Goldfarb, IT; Herz-Roiphe, R; Kaimal, AJ; Kim, AY	1
Alexander, J; Arya, V; Belew, Y; Birnkrant, D; Chan-Tack, K; Earp, J; Hausman, E; Sampson, M; Struble, K; Yao, L	1
Lee, TC; McDonald, EG	1
Jackson, EK; Kessinger, CJ; Kitsios, GD; Lu, MY; Macatangay, BJC; McVerry, BJ; Morris, A; Schaefer, CM	1
Aiken, JM; Choi, S; Herbst, A; Hoang, AN; Kim, C; Martinez Moreno, D; McKenzie, D; Wanagat, J	1
Arora, V; Barton, R; Chakraborty, A; Chiniga, V; Diwan, A; Holkar, N; Holkar, P; Pandey, R; Pond, B; Tatake, J; Thakur, Y	1
Chang, J; Hintze, TD; Jones, J; Sellers, J	1
Aguilar, J; Blanco, S; Cargnelutti, DE; Colombo, MI; Gallego, S; Germanó, MJ; Giai, C; Konigheim, B; Mackern-Oberti, JP; Sanchez, MV; Spinsanti, L; Valdez, HA	1
Kalil, AC	1
Aldir, I; Campos, L; Carmo, E; Carmo, I; Carvalho, A; Coelho, L; Correia, J; Falcão, F; Farinha, H; Fonseca, C; Mansinho, K; Martins, AP; Mendes, D; Miranda, AC; Mirco, A; Póvoa, P; Soares, J; Solano, M; Viegas, E	1
Chaudhary, R; Kingsley, R; Kirchoff, R; Otto, A; Phelan, D; Rohlman, C	1
Medhi, B; Prabha, PK; Prakash, A	1
Al-Ghusn, AI; Bakheit, AH; Darwish, H; Darwish, IA	1
Alcaraz, A; Báguena, C; Bernal, E; Cano, A; Carter, P; García-Villalba, E; Hernández, MD; Martinez, M; Minguela, A; Muñoz, A; Nuñez, ML; Pons, E; Puche, G; Sancho, N; Tomás, C; Vicente, MR; Villalba, MC	1
Dai, L; Long, C; Romero, ME; Yu, J	1
Camus, G; Gale, M; Greninger, AL; Han, D; Hao, L; Hedskog, C; Huang, ML; Ireton, RC; Jerome, KR; Li, J; Perry, JK; Porter, DP; Rodriguez, L; Roychoudhury, P	1
Mehrotra, J; Sen, S; Singhal, T	1
Abdan, Z; Allahyari, H; Amini, K; Assar, S; Dastbaz, M; Kafi, H; Lotfi, R; Roghani, SA; Rostampour, R; Shahrokhvand, SZ; Taghadosi, M	1
Lu, H	1
Cao, R; Hu, Z; Liu, J; Shi, Z; Wang, M; Xiao, G; Xu, M; Yang, X; Zhang, L; Zhong, W	1
Cihlar, T; Cronin, J; de Wit, E; Feldmann, F; Feldmann, H; Jordan, R; Okumura, A; Scott, D; Thomas, T	1
Maxmen, A	1
Lu, X; Pan, B; Sun, P; Sun, W; Xu, C	1
Li, J; Qi, C; Shen, L; Wang, Y; Zhang, Q	1
Elfiky, AA	1
De Clercq, E; Li, G	1
Anderson, PO	1
Brouqui, P; Colson, P; Lagier, JC; Raoult, D; Rolain, JM	1
Chen, PL; Hsueh, PR; Huang, CT; Ko, WC; Lee, NY; Lee, PI; Rolain, JM	1
Dong, L; Gao, J; Hu, S	1
Martinez, MA	2
Du, B; Kang, HYJ; Li, XY; Qiu, HB; Sun, B; Tong, ZH; Wang, F; Wang, YS; Zhan, X	1
Hsueh, PR; Hsueh, SC; Ko, WC; Lai, CC; Liu, YH; Wang, CY; Wang, YH; Yen, MY	1
Duan, Y; Zhou, C; Zhu, HL	1
Carradori, S	1
Atluri, S; Hirsch, JA; Manchikanti, L	1
Cohen, J; Kupferschmidt, K	1
Dai, Y; Huang, S; Zhang, C; Zheng, F	1
Cohen, S; Corbett, R; Haczku, A; Hardin, K; Nguyen, MV; Pidcock, W; Sanville, B; Schivo, M; Sebat, C; Thompson, GR	1
Reina, J	1
Ceccarelli, F; Conti, F; Di Franco, M; Spinelli, FR	1
Chang, YL; Chen, MY; Lee, WS; Lu, CC	1
Chan, MCW; Chen, D; Cheung, PP; Choy, KT; Chu, DKW; Huang, X; Hui, KPY; Kaewpreedee, P; Peiris, M; Sia, SF; Wong, AY; Yen, HL	1
Agostini, ML; Baric, RS; Bluemling, GR; Brown, AJ; Chappell, JD; Denison, MR; Dinnon, KH; George, AS; Graham, RL; Harcourt, J; Hill, CS; Hughes, TM; Kolykhalov, AA; Leist, SR; Lu, X; Montgomery, SA; Natchus, MG; Painter, G; Pruijssers, AJ; Saindane, M; Schäfer, A; Sheahan, TP; Sims, AC; Stevens, LJ; Swanstrom, R; Tamin, A; Thornburg, NJ; Zhou, S	1
Barlow, A; Barlow, B; Claassen, CW; Heavner, JJ; Heavner, MS; Landolf, KM; Yeung, SYA	1
Ahmed, S; Asperges, E; Bernett, J; Brainard, DM; Cao, H; Castagna, A; Chelliah, D; Chen, D; Chihara, S; Childs, R; Chokkalingam, A; Cohen, SH; Cunningham, J; D'Arminio Monforte, A; Desai, P; DeZure, A; Diaz, G; Elboudwarej, E; Feldt, T; Flanigan, T; Gaggar, A; Green, G; Green, ML; Grein, J; Henne, I; Ismail, S; Kato, H; L'Her, E; Lapadula, G; Lescure, FX; Maeno, T; Majumder, S; Massari, M; Mera, R; Mora-Rillo, M; Mutoh, Y; Myers, RP; Nguyen, D; Nicastri, E; Oda, R; Ohmagari, N; Osinusi, AO; Quiros-Roldan, E; Redinski, J; Sellers, S; Shin, D; Studemeister, A; Tan, SK; Telep, L; Timbs, L; Verweij, E; Winterbourne, L; Yo, K; Zhao, Y; Zhong, L; Zoufaly, A	1
Bottega, A; da Rosa, TF; Foletto, VS; Hörner, A; Hörner, R; Serafin, MB	1
Belfer, JJ; Bondici, A; Dumkow, LE; Hillaker, E; Murad, H	1
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM	1
Arora, N; Banerjee, AK	1
Avery, RK; Boyarsky, BJ; Durand, CM; Garonzik-Wang, JM; Getsin, SN; Jackson, KR; Kernodle, AB; Massie, AB; Po-Yu Chiang, T; Segev, DL; Van Pilsum Rasmussen, SE; Werbel, WA	1
Alvarez, K; Canard, B; Decroly, E; Eydoux, C; Ferron, F; Guillemot, JC; Le, NT; Peersen, O; Selisko, B; Shannon, A	1
Şimşek Yavuz, S; Ünal, S	1
Costanzo, M; De Giglio, MAR; Roviello, GN	1
Lal, A; Mishra, AK; Sahu, KK	1
Bergan, S; Elens, L; Hesselink, DA; Langman, LJ; Lemaitre, F; Moes, DJAR; Molinaro, M; Venkataramanan, R	1
Gangadaran, P; Jogalekar, MP; Veerabathini, A	1
Hsueh, PR; Jean, SS; Lee, PI	1
Al-Saffar, F; Cruz, D; Fan, A; Gaynor, P; Hsu, JJ; Kamath, M; Nsair, A	1
Aryal, D; Beane, A; Dondorp, AM; Hayat, M; Schultz, MJ	1
Ge, J; Li, H; Liu, Z	1
Aronson, JK; Ferner, RE	1
Beard, T; Cowan, M; Manning, TJ; Thomas-Richardson, J	1
Aaron, JG; Arcasoy, S; Aversa, MM; Benvenuto, LJ; Brown, RS; Cohen, DJ; Dadhania, DM; Dove, LM; Dube, GK; Emond, JC; Farr, MA; Husain, SA; Kapur, S; Kodiyanplakkal, RP; Miko, BA; Mohan, S; Pereira, MR; Ratner, LE; Rosenblatt, RE; Samstein, B; Satlin, M; Small, CB; Tsapepas, DS; Uriel, N; Verna, EC; Walsh, TJ	1
Augustin, M; Hallek, M; Nitschmann, S	2
Alkindi, N; Mazer-Amirshahi, M; Mehta, N; Pourmand, A	1
Ahsan, W; Alhazmi, HA; Bratty, MA; Javed, S; Najmi, A	1
Ardura, M; Auletta, JJ; Dandoy, C; Hartley, D; Jaglowski, S; Lehmann, L	1
Kao, JH; Su, TH	1
Jeevaratnam, K	1
Dai, J; Huang, J; Jiang, H; Li, C; Li, R; Li, X; Liu, B; Ma, Q; Pan, W; Shi, Y; Wang, Z; Xie, Y; Yang, Z; Zhao, J; Zheng, K	1
Antonucci, M; Avataneo, V; Cusato, J; D'Avolio, A; de Nicolò, A; di Perri, G; Lamorde, M; Manca, A; Palermiti, A; Waitt, C; Walimbwa, S	1
Delang, L; Neyts, J	1
Ballout, RA; Bukrinsky, MI; Remaley, AT; Sviridov, D	1
Fang, Y; Meng, XM; Ni, WJ; Shen, AZ; Xu, T; Zhou, H	1
Cao, D; Li, C; Li, G; Li, Z; Sun, R; Wang, X	1
Kiessling, L; MacLaughlin, C; Sattin, S	1
Douedi, S; Miskoff, J	1
Coumou, J; de Vries, PJ	1
Gadebusch Bondio, M; Marloth, M	1
Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D	1
Yang, K	1
Baggett, MV; Rhee, EP; Shepard, JO; Sise, ME; Stevens, JS	1
Ferguson, J; Gumma, M; Kappagoda, S; Quintero, O; Rogers, A; Rosser, JI; Scott, J; Subramanian, A	1
Boucher, HW; Ison, MG; Wolfe, C	1
Aldrich, M; Cabana, MD; Chao, JY; Derespina, KR; Goldman, DL; Herold, BC; Medar, SS; Ushay, HM; Weingarten, J	1
Angeli, E; Antinori, S; Bonazzetti, C; Borghi, B; Castelli, A; Coen, M; Colombo, R; Corbellino, M; Cossu, MV; Galli, M; Giacomelli, A; Giorgi, R; Gismondo, MR; Gubertini, G; Magni, C; Meroni, L; Milazzo, L; Mileto, D; Oreni, L; Pagani, G; Pellicciotta, M; Rech, R; Ridolfo, AL; Rizzardini, G; Rusconi, S; Torre, A; Vimercati, S	1
Bonovas, S; Piovani, D	1
Fätkenheuer, G; Lundgren, J	1
Hoffmann, C	1
Lai, T; Wu, B; Wu, J	1
Brainard, D; Grein, J; Myers, RP	1
Berlin, DA; Gulick, RM; Martinez, FJ	1
Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R	1
Jia, X; Kai, G; Li, L; Nile, A; Nile, SH; Qiu, J	1
Stuebe, A	1
Carugati, M; Castaldo, G; Faccioli, P; Franzetti, M; Iemoli, E; Longoni, E; Molteni, C; Ormas, V; Pandolfo, A; Piconi, S; Pozzetti, U	1
Estella, Á; Garnacho-Montero, J	1
Norrie, JD	1
Cao, B; Cao, L; Cheng, Z; Ding, D; Du, G; Du, R; Fan, G; Fu, S; Gao, L; Gu, X; Guo, T; Hayden, FG; Horby, PW; Hu, Y; Jaki, T; Jiang, Y; Jin, Y; Li, H; Liu, B; Liu, Z; Lu, Q; Lu, Y; Luo, G; Mei, C; Qin, H; Ruan, S; Shang, L; Tang, X; Wan, Y; Wang, A; Wang, C; Wang, K; Wang, S; Wang, Y; Wu, F; Xu, J; Yang, C; Yang, J; Ye, X; Ye, Y; Yin, W; Zhang, D; Zhang, Y; Zhao, J; Zhou, F	1
Marto, N; Monteiro, EC	1
Aggarwal, G; Aggarwal, S; Bangalore, S; Henry, BM	1
Cattaneo, D; Clementi, E; Corbellino, M; Galli, M; Gervasoni, C; Riva, A	1
Ahmad, SI	1
Gottlieb, M; Hicks, C; Liang, SY; Long, B; Rosenberg, H	1
Bhattacharya, M; Chakraborty, C; Lee, SS; Saha, A; Sharma, AR; Sharma, G	1
Atmar, RL; Babiker, AG; Beigel, JH; Benfield, T; Bonnett, T; Burgess, TH; Chu, HY; Creech, CB; Dierberg, K; Dodd, LE; Fätkenheuer, G; Finberg, RW; Green, M; Hohmann, E; Hsieh, L; Kalil, AC; Kline, S; Kortepeter, MG; Lane, HC; Lopez de Castilla, D; Luetkemeyer, A; Lundgren, J; Lye, DC; Makowski, M; Mehta, AK; Nayak, S; Neaton, JD; Oh, MD; Ohmagari, N; Osinusi, A; Paredes, R; Patterson, TF; Pett, S; Ruiz-Palacios, GM; Short, WR; Sweeney, DA; Tapson, V; Tomashek, KM; Touloumi, G; Zingman, BS	1
Atzrodt, CL; Clements, TP; Maknojia, I; McCarthy, RDP; Oldfield, TM; Po, J; Stepp, HE; Ta, KTL	1
Dresser, LD; Jorgensen, SCJ; Kebriaei, R	1
Cao, B; Cheng, Z; Du, G; Du, R; Fan, G; Fu, S; Gao, L; Hayden, FG; Horby, PW; Hu, Y; Jaki, T; Jin, Y; Liu, W; Liu, Y; Lu, Q; Lu, Y; Luo, G; Ruan, S; Wang, C; Wang, K; Wang, Y; Zhang, D; Zhang, Y; Zhao, J; Zhou, F	1
Sun, D	1
Dolin, R; Hirsch, MS	1
Ahn, MY; Blair, C; Brainard, DM; Bruno, R; Cao, H; Chen, YS; Diaz, G; Gaggar, A; Galli, M; Goldman, JD; Hui, DS; Hyland, RH; Lye, DCB; Marks, KM; Marty, FM; Montejano, R; Mullane, KM; Muñoz, J; Nahass, RG; Osinusi, AO; SenGupta, D; Spinner, CD; Subramanian, A; Tashima, KT; Towner, WJ; Wei, X	1
Davies, M; Dhanda, S; Evans, A; Lane, S; Osborne, V; Roy, D; Shakir, S	1
Jain, S; Jolly, T; Mansuri, Z; Shah, B; Zafar, MK	1
Beh, DLL; Chew, N; Ngiam, JN; Poh, KK; Sia, CH	1
Beretta, P; Carnevale, S; Morbini, P	1
Gupta, P; Kumar, A; Narasimha Kumar, GV; Prajapati, S; Sharma, M	1
Bohula, EA; Lang, JP; Morrow, DA; Moura, FA; Siddiqi, HK; Wang, X	1
Campos, L; Gouveia, CC	1
Balevic, SJ; Benjamin, DK; Cohen-Wolkowiez, M; Gonzalez, D; Hornik, CD; Hornik, CP; Maharaj, AR; Smith, PB; Wu, H; Zimmerman, KO	1
Andreou, A; Filippou, D; Sipsas, N; Trantza, S; Tsiodras, S	1
Amore, A; Bimonte, S; Cascella, M; Celentano, E; Crispo, A; Cuomo, A	1
Gebrie, D; Getnet, D; Manyazewal, T	1
Islam, T; Nasir, M; Parveen, RA; Saha, SK; Selina, F; Talha, KA	1
Adamsick, ML; Bhattacharyya, RP; Bidell, MR; Elshaboury, RH; Gandhi, RG; Kim, AY; Nigwekar, S; Rhee, EP; Sise, ME	1
Benfiels, T; Jensen, TØ; Johansen, IS; Lundgren, J; Nielsen, H; Wiese, L; Østergaard, L	1
Anzick, S; Barbian, K; Bosio, CM; Cihlar, T; de Wit, E; Feldmann, F; Hanley, PW; Leighton, I; Lovaglio, J; Martens, C; Meade-White, K; Munster, VJ; Okumura, A; Pérez-Pérez, L; Porter, DP; Saturday, G; Schulz, J; Schwarz, B; Scott, DP; van Doremalen, N; Williamson, BN; Yinda, CK	1
Fumeaux, T	1
Brown, JC; Cordova, FC; Criner, GJ; Galli, JA; Mamary, AJ; Marchetti, N; Mulhall, PD; Myers, CN; Scott, JH; Sehgal, S; Shenoy, KV; Shigemura, N	1
Asudani, D; Bouland, D; Gupta, V; Kwak, K; Segar, S; Taplitz, R; Torriani, F	1
Chen, D; Dong, L; Pan, X; Peng, C; Yang, L	1
Di Perri, G	1
Yoo, JH	1
Bamford, A; Brierley, J; Frauenfelder, C; Perucca, G; Whittaker, E	1
Di Pasquale, G; Maggioni, AP	1
Abrams-Downey, A; Saabiye, J; Vidaurrazaga, M	1
Hui, N; Li, H; Liang, C; Liu, Y; Qiao, G; Shi, Z; Tang, Y; Tian, L; Xie, X; Zhang, D; Zhao, X	1
Ahn, BY; Choe, PG; Kang, CK; Kim, NJ; Oh, MD; Park, SW; Park, WB; Seo, JD; Song, SH	1
Chan, R; Kuo, CR; Lipworth, B	1
Besari, A; Lee, YY; Omar, SFS; Thalha, AMM	1
Magro, G	1
Alvarez, JC; Annane, D; Etting, I; Larabi, IA; Moine, P	1
Gafarova, AR; Gainullina, EN; Timerbulatov, SV; Timerbulatov, VM; Timerbulstov, MV	1
Angus, DC; White, DB	1
Kaltenboeck, A; Kesselheim, AS; Sarpatwari, A	1
Cooke, G; Costelloe, CE; Daunt, A; Hauck, K; Liew, F; Nayagam, S; Perez-Guzman, PN; Thursz, MR	1
Cao, H; Chng, E; German, P; Humeniuk, R; Ling, J; Mathias, A; Osinusi, A; Shen, G; Vu, A	1
Li, C; Ren, L; Wang, L	1
Brandt, N; Chou, J	1
Amenta, F; Nittari, G; Pallotta, G; Tayebati, SK	1
Agrati, C; Ascoli Bartoli, T; Avataneo, V; Capobianchi, MR; Caputi, P; Castilletti, C; D'Avolio, A; Forini, O; Ippolito, G; Lalle, E; Marchioni, L; Nicastri, E; Notari, S; Scorzolini, L; Tempestilli, M	1
Abraham, OC; John, R; Karthik, R; Manesh, A; Varghese, GM	1
Ali, A; Ali, SS; Babar, Z; Hamayun, F; Khan, A; Khan, AA; Khan, M; Saleem, S; Sardar, Z; Wei, DQ	1
Burwick, RM; Glucksman, L; Naqvi, M; Smithson, S; Zakowski, P	1
Bouadma, L; Deconinck, L; Dubert, M; Ghosn, J; Houhou-Fidouh, N; Isernia, V; Kramer, L; Le Hingrat, Q; Le Pluart, D; Lescure, FX; Patrier, J; Rioux, C; Visseaux, B; Wicky, PH; Yazdanpanah, Y	1
Ahluwalia, M; Givertz, MM; Mehra, MR	1
Azmy, V; Benson, J; Love, K; Steele, R	1
Chakraborty, A; Hosoki, K; Sur, S	1
Danta, CC	1
Agostinis, P; Carafoli, E; Li, X; Melino, G; Rabson, A; Shi, Y; Sun, E; Wang, Y	1
Cleland, E; Giovane, RA; Henderson, CE; Rezai, S	1
Gillenwater, S; Hadeh, A; Rahaghi, F	1
McMahon, JH; Peleg, AY; Udy, A	1
Kim, DH; McCaw, ZR; Wei, LJ	1
Olalla, J	1
Beigel, JH; Dodd, LE; Tomashek, KM	1
Ancliff, P; Badle, S; Bamford, A; Bartram, J; Brierley, J; Cheng, D; Dalton, C; Dexter, D; Dixon, G; Du Pré, P; Ghorashian, S; Grandjean, L; Mittal, P; O'Connor, D; Orf, K; Pavasovic, V; Rao, A; Rogosic, S; Samarasinghe, S; Vora, A	1
Abi Jaoude, J; El Alam, MB; Garcia Garcia, CJ; Kouzy, R; Ludmir, EB; Taniguchi, CM	1
Manteuffel, J; Patel, HK; Ramesh, M; Spadaccini, M; Thoguluva Chandrasekar, V; Venkatesalu, B	1
Allen, JM; Bakare, LS	1
Dizaye, K; Marouf, BH	1
Brun, P; Dubois, J; Dulière, V; Julien, T; Lina, B; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O; Traversier, A	1
Li, Z; Liu, Y; Wang, D	1
Donato, AA; Paladugu, S	1
Foo, R; Thum, T; Wang, Y	1
Acharya, Y; Sultan, S	1
Ajaz, SJ; Banday, AH; Shameem, SA	1
Azevedo, PCP; Azevedo, TCP; Barbosa, FT; Carvalho, ARVS; Cezarotti Filho, ML; Matos-Rocha, TJ; Ramos, FWDS; Silveira Filho, RN; Sousa-Rodrigues, CF	1
Arcobello, J; Bakouny, Z; Choueiri, TK; de Lima Lopes, G; Doroshow, DB; Egan, PC; Farmakiotis, D; Fecher, LA; Friese, CR; Galsky, MD; Goel, S; Grivas, P; Gupta, S; Halfdanarson, TR; Halmos, B; Hawley, JE; Hsu, CY; Khaki, AR; Kuderer, NM; Lee, BJ; Lemmon, CA; Lyman, GH; Mishra, S; Olszewski, AJ; Painter, CA; Panagiotou, OA; Pennell, NA; Peters, S; Puc, MM; Revankar, SG; Rini, BI; Rivera, DR; Rubinstein, SM; Schapira, L; Schmidt, A; Schwartz, GK; Shah, DP; Shah, SA; Shyr, Y; Thompson, MA; Warner, JL; Wu, JT; Xie, Z; Yeh, AC; Zhu, H	1
Helleberg, M; Kirk, O; Lane, C; Lebech, AM; Lundgren, J; Moestrup, KS; Niemann, CU	1
Albrecht, R; Benner, C; Burgstaller-Muehlbacher, S; Cao, J; Chan, JF; Chanda, SK; Chang, MW; Chapman, ME; Chatterjee, AK; Cheng, K; Choi, A; De Jesus, PD; Dejosez, M; García-Sastre, A; Glynne, RJ; Herbert, KM; Hull, MV; Johnson, JR; Lendy, EK; Liu, WC; Martin-Sancho, L; Martinez-Sobrido, L; Matsunaga, N; Mesecar, AD; Miorin, L; Nguyen, C; Nguyen, TH; Pache, L; Poon, VK; Pu, Y; Rathnasinghe, R; Riva, L; Rubanov, A; Ruppin, E; Schotsaert, M; Schultz, PG; Sit, KY; Su, AI; Sun, R; Teriete, P; White, KM; Yin, X; Yuan, S; Yuen, KY; Zwaka, TP	1
Bellutti-Enders, F; Hartmann, K; Jamiolkowski, D; Leuppi-Taegtmeyer, A; Manjaly Thomas, ZR; Scherer Hofmeier, K; Steveling-Klein, E	1
Carvalho Junior, RN; J C Neto, AM; Martins, AY; Reis, AF; S Costa, JF; Silva Arouche, TD	1
Durrieu, G; Montastruc, F; Thuriot, S	1
Abd Ellah, NH; E Batiha, G; Gad, SF; Hetta, HF; Muhammad, K	1
Andini, R; Bertolino, L; Corcione, A; De Rosa, R; Durante-Mangoni, E; Florio, LL; Galdo, M; Mele, F; Zampino, R	1
Knight, TE	1
Aly, B; Baron, DA; Blodget, E; Hashemi, A; Kouyoumjian, S; Musa, A; Pendi, K; Stevens, S; Warbasse, E; Yousif, J	1
Martín Mateos, RM; Téllez, L	1
Kääb, S; Kellnar, A; Stark, K; Stremmel, C; Weckbach, LT	1
Agarwal, A; Agoritsas, T; Azab, M; Bartoszko, JJ; Bravo, G; Brignardello-Petersen, R; Chu, DK; Couban, R; Devji, T; Escamilla, Z; Foroutan, F; Gao, Y; Ge, L; Ghadimi, M; Guyatt, GH; Han, MA; Heels-Ansdell, D; Honarmand, K; Hou, L; Ibrahim, Q; Izcovich, A; Khamis, A; Kum, E; Lam, B; Lamontagne, F; Loeb, M; Mansilla, C; Marcucci, M; Martinez, JPD; McLeod, SL; Miroshnychenko, A; Motaghi, S; Murthy, S; Mustafa, RA; Pardo-Hernandez, H; Qasim, A; Rada, G; Rizwan, Y; Saadat, P; Siemieniuk, RA; Switzer, C; Thabane, L; Tomlinson, G; Vandvik, PO; Vernooij, RW; Viteri-García, A; Wang, Y; Yao, L; Zeraatkar, D; Zhao, Y	1
Agarwal, A; Agoritsas, T; Appiah, JA; Bartoszko, J; Brignardello-Petersen, R; Ergan, B; Ge, L; Geduld, H; Gershengorn, HB; Guyatt, G; Huang, M; Kanda, S; Kawano-Dourado, L; Kurian, L; Kwizera, A; Lamontagne, F; Leo, YS; Manai, H; Murthy, S; Qadir, N; Rochwerg, B; Siemieniuk, R; Silvestre, MA; Vandvik, PO; Ye, Z; Zeng, L; Zeraatkar, D	1
Alam Riaz, T; Ali, ES; Calina, D; Cho, WC; Docea, AO; Khan, IN; Kudrat-E-Zahan, M; Martorell, M; Mishra, SK; Mubarak, MS; Nasiruddin, M; Rahman, MS; Sharifi-Rad, J; Torequl Islam, M	1
Saitz, R; Schwitzer, G	1
Bu, Z; Ge, J; He, X; Hua, R; Liu, R; Shan, D; Shuai, L; Sun, Z; Wang, C; Wang, J; Wang, X; Wen, Z; Zhang, X; Zhong, G	1
Baombe, JP	1
Egli, M; Jovanovic, D; Pallan, PS; Richert, C; Tremmel, P	1
Mendes, A	1
Li, N; Li, Y; Yu, X	1
Bickel, C; Heck, J; Jöckel, J; Krichevsky, B; Mettin, R; Stichtenoth, DO	1
Gan, W; Gu, J; Li, H; Li, Y; Lu, C; Luo, P; Miao, H; Tian, M; Wang, J; Wang, S; Wu, M; Yao, Y; Yuan, B; Zhao, D; Zhao, X	1
Aziz, N; Bianco, K; Blackburn, BG; El-Sayed, YY; Grant, P; Igbinosa, I; Kappagoda, S; Lyell, DJ; Miller, S; Nelson, J; Subramanian, A	1
Al-Yamani, MJ; Asdaq, SMB; Jomah, S	1
Ijaz, M; Khan, M; Kharaba, ZJ; Murtaza, G; Shamim, S	1
Bugiera, L; Grodd, M; Hazard, D; Kaier, K; Lambert, J; von Cube, M; Wolkewitz, M	1
Bigley, AN; Narindoshvili, T; Raushel, FM	1
Alvaro-Gracia, JM; Blanco, R; Carmona, L; Castrejón, I; Fernández Fernández, D; Fernandez-Nebro, A; Galindo, M; Gonzalez-Gay, MA; Lledó, A; Manrique-Arija, S; Martinez-Lopez, D; Mena Vázquez, N; Mera-Varela, A; Pablos, JL; Retuerto, M	1
Chua, KP; Conti, RM	1
Baysson, H; Beaune, G; Bing, F; Bonardel, C; Bonnerot, M; Chanzy, B; Combes, I; Cornut, L; Farines, M; Ludwig, M; Macheda, G; Vadot, W	1
Hadda, V; Misra, S; Nath, M; Vibha, D	1
Feldweg, A; Mullur, J; Wang, A	1
Farhadi, T; Hashemian, SM; Velayati, AA	1
Angus, DC; McCreary, EK	1
Ahn, MY; Arribas López, JR; Bernasconi, E; Bhagani, S; Blair, C; Brainard, DM; Cao, H; Castagna, A; Cattelan, AM; Chai, LYA; Chang, SC; Criner, GJ; Gaggar, A; Gottlieb, RL; Huhn, G; Hyland, RH; Le Turnier, P; Malhotra, P; Marty, FM; McPhail, MJ; Mullane, KM; Ogbuagu, O; Osinusi, AO; Roestenberg, M; Sanyal, AJ; SenGupta, D; Soriano Viladomiu, A; Spinner, CD; Tsang, OTY; Wang, H	1
Briasoulis, A; Kuno, T; Takagi, H; Yokoyama, Y	1
Barchiesi, F; Canovari, B; Mancini, M; Montalti, R; Pasquini, Z; Pimpini, D; Temperoni, C; Tempesta, M; Zallocco, N	1
Brun, P; Constant, S; Dubois, J; Dulière, V; Errazuriz-Cerda, E; Fouret, J; Gaymard, A; Julien, T; Lescure, FX; Lina, B; Padey, B; Pizzorno, A; Poissy, J; Rosa-Calatrava, M; Terrier, O; Traversier, A; Trouillet-Assant, S; Yazdanpanah, Y	1
Hirshberg, A; Levine, LD; McCoy, JA; Short, WR; Srinivas, SK	1
Bliton, MJ; Weber, E	1
Adewale, OB; Akanbi, MO; Bakare, OO; Fadaka, AO; Klein, A; Madiehe, AM; Meyer, M; Sibuyi, NRS	1
Burwick, RM; Dellapiana, G; Leggett, C; Naqvi, M; Tholemeier, L	1
Barfuss, P; Demirbag, S; Khan, KS; Le, TK; Ng, WL; Paris, C; Robson, F; Rocchi, P	1
Amézaga Menéndez, R; Catalán González, M; Díaz, E; Escapa, MG; Marcos Neira, P; Quintana Díaz, M; Serrano Lázaro, A; Suberviola, B; Vidal Cortés, P	1
Baker, JV; DeBruin, DA; Kesler, S; Kline, S; Leider, JP; Lim, S; Lynfield, R; Rizza, S; Sederstrom, N; Sharp, RR; Wolf, SM; Wu, J	1
Filipova, E; Pavlova, V; Uzunova, K; Vekov, T	1
Bhagani, S; Pollara, G; Richardson, C	1
Shih, WJ; Xie, T; Yao, C	1
Bunel, V; Descamps, D; Jaquet, P; Le Hingrat, Q; Lê, MP; Mal, H; Massias, L; Messika, J; Peytavin, G; Timsit, JF; Visseaux, B; Wicky, PH	1
Lamb, YN	1
Chen, J; Huo, X; Li, P; Wang, M; Wu, Z; Yuan, Q; Zhang, L; Zhang, W; Zhang, Z; Zou, Y	1
Kay, AW; Mandalakas, AM; Martinez, L; Ness, TE	1
Gonzales-Zamora, JA; Quiroz, T; Vega, AD	1
Green, RJ; Mustafa, F; Richards, GA; Sewlall, N	1
Makuch, R; Ochoa Chaar, CI	1
Dobrovolny, HM	1
Doggrell, SA	1
Gohh, R; Merhi, B	1
Chang, HT; Glaberson, WR; Leeman, R; Mahajan, N; Manalo, R	1
Hasslboeck, C; Kishioka, Y; Kweder, SL; Saint-Raymond, A; Sato, J; Teixeira, T	1
Arthur, CM; Clarke, S; Josephson, CD; Lough, C; MacDonald, H; Roback, JD; Rodriguez, Z; Shane, AL; Stowell, SR; Suthar, M; Verkerke, H; Wolf, M; Wrammert, J; Zimmerman, MG	1
Abzug, MJ; Aldrich, ML; Bio, L; Chiotos, K; Cross, SJ; Denison, MR; Dillman, NO; Downes, KJ; Dulek, DE; Goldman, DL; Grapentine, S; Groves, HE; Hayes, M; Hersh, AL; James, SH; Jones, SB; Kimberlin, DW; Lamb, GS; MacBrayne, CE; Nakamura, MM; Newland, JG; Oliveira, CR; Olivero, R; Orscheln, RC; Pinninti, SG; Rajapakse, NS; Ratner, AJ; Schwenk, HT; Soma, VL; Tamma, PD; Thorell, EA; Timberlake, K; Tribble, AC; Vora, SB; Waghmare, A; Wattier, RL; Wolf, J; Yarbrough, A; Young, J; Zachariah, P	1
Alom, S; Harky, A; Hewage, S; Hussain, N; Yoganathan, A	1
Shilatifard, A	1
Hansen, PR; Jürgens, G; Rasmussen, HB; Taboureau, O; Thomsen, R	1
Bos, LDJ; Brodie, D; Calfee, CS	1
Deng, M; Hu, Y; Jiang, L; Luo, X; Pan, L; Wang, M; Wu, T; Xia, Z; Yang, X; You, Y; Zuo, Z	1
Ader, F	1
Berger, M; Carraro, F; Fagioli, F; Grassitelli, S; Pessolano, R; Saglio, F; Scolfaro, C; Spadea, M; Vassallo, E	1
Gupta, SP	1
Alshaeri, HK; Natto, ZS	1
Bai, YX; Guo, Y; Ma, KW; Qiu, S; Sun, C; Wang, X; Xu, YH	1
Aslan, GS; Bojkova, D; Ciesek, S; Cinatl, J; Dendorfer, A; Dimmeler, S; Ermel, UH; Eschenhagen, T; Frangakis, AS; Günther, S; Hansen, A; Harter, PN; Klingel, K; Krishnan, J; Luxán, G; Milting, H; Pham, MD; Saleem, U; Shumliakivska, M; Tschöpe, C; Wagner, JUG; Zeiher, AM	1
Perišić, O	1
Abo, KM; Alysandratos, KD; Beermann, ML; Bosmann, M; Bullitt, E; Burks, EJ; Hawkins, F; Hinds, A; Huang, J; Hume, AJ; Kotton, DN; Lindstrom-Vautrin, J; Mühlberger, E; Olejnik, J; Saeed, M; Sharma, A; Simone-Roach, C; Suder, EL; Villacorta-Martin, C; Wang, R; Werder, RB; Wilson, AA	1
Ata, O; Inci, TG; Kocer, S; Mutlu, O; Sariyer, E; Turgut-Balik, D; Ugurel, E; Ugurel, OM	1
Emanuela, C; Francesco, L; Giorgia, G; Pasquale, N; Roberto, P; Sara, D	1
Calvez, V; Delagreverie, H; Fafi-Kremer, S; Garnier, M; Humbrecht, C; Jary, A; Lacombe, K; Leducq, V; Marcelin, AG; Martinot, M; Mékinian, A; Pacanowski, J; Pirenne, F; Tiberghien, P	1
Bunel, V; Descamps, D; Jaquet, P; Le Beller, C; Le Hingrat, Q; Lê, MP; Mal, H; Massias, L; Messika, J; Peytavin, G; Timsit, JF; Visseaux, B; Wicky, PH	1
Muller, FL; Yan, VC	1
Guan, W; Lan, W; Ou, J; Wu, J; Wu, X; Yan, Y; Zhang, J; Zhang, Q; Zhao, S	1
Abraham, RS; Ardura, MI; Gibbs, A; Guider, W; Honegger, JR; Hunt, WG; Jean, S; King, T; Kuehn, HS; Marshall, JM; Mejias, A; Mustillo, PJ; Peeples, M; Ramilo, O; Rosenzweig, SD; Rueda, CM; Shimamura, M; Stewart, C; Wang, H	1
Dzhafer, N; Papathanasiou, JV	1
Glaus, MJ; Von Ruden, S	1
Adimora, AA; Cole, SR; Edwards, JK	1
Cui, JJ; Guo, CX; Ouyang, QY; Wang, LY; Yin, JY; Zhan, Y	1
Cao, B; Gu, X; Wang, C; Wang, Y; Xu, J	1
Gómez-Moreno, G	1
Alcobendas, R; Álvarez-Rojas, E; de la Serna, O; Laplaza-González, M; Murias, S; Quintana-Ortega, C; Remesal, A; Ruiz de Valbuena, M; Udaondo, C	1
Chien, M; Jockusch, S; Ju, J; Kalachikov, S; Kumar, S; Li, X; Morozova, I; Russo, JJ; Tao, C	1
Goldust, M; Sandhu, S; Schwartz, RA; Sharma, A; Szepietowski, JC	1
Ferguson, MR; Hernandez, RE; Ma, J; Noda, S; Romberg, EK	1
Baroutjian, A; Boneva, D; Elkbuli, A; McKenney, M; Sanchez, C	1
Chang, L; Hu, WJ; Liu, J; Shen, JS; Tan, B; Wang, X; Xie, YC; Yang, Y	1
Fätkenheuer, G; Malin, JJ; Priesner, V; Rybniker, J; Suárez, I	1
Gupta, J; Gupta, S; Kaushik, A	1
Chang, HL; Chang, PY; Chen, YH; Hsueh, PR; Tsai, CC; Wei, YJ; Yang, CJ	1
Ahmed, S; Bai, Q; Benzhanova, A; Han, G; Khan, S; Nabi, G; Rashid, F; Shereen, MA; Siddique, R; Xue, M	1
Cantini, F; Foti, R; Goletti, D; Najafi Fard, S; Niccoli, L; Petrone, L	1
Garg, NK; Knapp, RR; Okada, T; Sarpong, R; Tona, V	1
Adams, M; Baang, JH; Bachman, MA; Lauring, AS; Manthei, DM; Martin, ET; Mirabelli, C; Smith, C; Valesano, AL; Washer, L; Wobus, CE	1
Ban, K; Choi, SW; Go, YY; Jung, E; Kim, SJ; Lee, J; Lee, JH; Moon, SH; Park, HJ; Park, SJ; Park, SM; Park, YG; Shin, JS	1
Cardozo-Ojeda, EF; Goyal, A; Schiffer, JT	1
Ali, K; Mallah, H; Maveddat, A; Nugent, K; Rao, S; Sherali, S	1
Pathania, S; Rawal, RK; Singh, PK	1
Hussain, W; Kousar, K; Majeed, A; Rasool, N; Yasmin, F	1
Addo, MM; Gil-Ibanez, I; Haag, F; Heide, J; Hennigs, A; Hiller, J; Huber, S; Jasper, D; Jordan, S; Lütgehetmann, M; Malsy, J; Peine, S; Rosien, U; Schmiedel, S; Schulze Zur Wiesch, J; Stein, A; Veletzky, L	1
Aldeyab, M; Hasan, SS; Kow, CS	1
Chou, JT; Hana, D; Kaczmarek, M; Khalaf, K; Mackiewicz, A; Papp, N	1
Chatterjee, S	1
Dimopoulos, MA; Fotiou, D; Gavriatopoulou, M; Kastritis, E; Korompoki, E; Migkou, M; Ntanasis-Stathopoulos, I; Psaltopoulou, T; Terpos, E; Tzanninis, IG	1
Farley, TM; Sabers, AJ; Williams, AL	1
Ashurst, J; Caine, K; Dietrich, T; Lee, S; Santarelli, A; Schritter, S	1
Alabed, SJ; Dahabiyeh, LA; Daoud, S	1
Niburski, K; Niburski, O	1
Delorme-Axford, E; Klionsky, DJ	1
Entezari-Maleki, T; Khiali, S; Rezagholizadeh, A	1
Vaidyanathan, G	1
Goldstein, RH; Walensky, RP	1
McLaughlin, M	1
Gund, TM; Jung, LS; Narayan, M	1
Barth, TFE; Conzelmann, C; Groß, R; Heller, S; Kleger, A; Koepke, L; Krüger, J; Müller, JA; Münch, J; Schütz, D; Seufferlein, T; Sparrer, KMJ; Stenger, S; Weil, T	1
Eilenberger, J; Fischer, M; Haas, N; Hauck, F; Hermann, M; Huebner, J; Jakob, A; Kappler, M; Kim-Hellmuth, S; Klein, C; Ley-Zaporozhan, J; von Both, U	1
Arbustini, E; Bergomi, P; Bozzini, S; Cavagna, L; Colombo, R; Corsico, AG; Cova, E; D'Amato, M; Di Toro, A; Fossali, T; Frangipane, V; Lettieri, S; Lilleri, D; Meloni, F; Mojoli, F; Morosini, M; Ottolina, D; Pandolfi, L; Percivalle, E; Saracino, L; Tomaselli, S; Urtis, M	1
Farbod, A; Mahmoudi, H; Mozafarihashjin, M; Neishabouri, A; Nili, A; Tavakolpour, S	1
Cheng, Y; Daemen, LL; Kolesnikov, AI; Mamontov, E; Ramirez-Cuesta, AJ; Ryder, MR; Stone, MB	1
Bebell, LM; Brigl, M; Matias, WR; Vaidya, A	1
Amato, AA; Manzano, GS; Woods, JK	1
Chen, S; Song, W; Yi, Z; Yuan, Z; Zhang, Y	1
Boguniewicz, J; DeVine, MN; Haynes, AS; MacBrayne, CE; Maxwell, S	1
Bilal, M; Eichenauer, DA; El Tabei, L; Fuhr, U; Hagmann, H; Kinzig, M; Malin, JJ; Rybniker, J; Scherf-Clavel, O; Simonis, A; Sörgel, F	1
Mishra, SK; Tripathi, T	1
Bruchfeld, A	1
Abdool Karim, Q; Abi Hanna, P; Ader, F; Al-Bader, AM; Alejandria, MM; Alhasawi, A; Allum, E; Alotaibi, A; Alvarez-Moreno, CA; Appadoo, S; Asiri, A; Aukrust, P; Barratt-Due, A; Bellani, S; Branca, M; Cappel-Porter, HBC; Cerrato, N; Chow, TS; Como, N; Eustace, J; García, PJ; Godbole, S; Gotuzzo, E; Griskevicius, L; Hamra, R; Hassan, M; Hassany, M; Henao-Restrepo, AM; Hernández García, C; Hutton, D; Irmansyah, I; Jancoriene, L; Kieny, MP; Kirwan, J; Kumar, S; Lennon, P; Lopardo, G; Lydon, P; Magrini, N; Maguire, T; Malekzadeh, R; Manevska, S; Manuel, O; McGinty, S; Medina, MT; Mesa Rubio, ML; Miranda-Montoya, MC; Murthy, S; Nel, J; Nunes, EP; Pan, H; Perola, M; Peto, R; Portolés, A; Preziosi, MP; Rasmin, MR; Raza, A; Reddy, KS; Rees, H; Reges, PPS; Rogers, CA; Roses Periago, M; Røttingen, JA; Salami, K; Salvadori, MI; Sathiyamoorthy, V; Sinani, N; Sterne, JAC; Stevanovikj, M; Swaminathan, S; Tacconelli, E; Tikkinen, KAO; Trelle, S; Zaid, H	1
Moirangthem, DS; Surbala, L	1
Akbar, SMF; Al Mahtab, M; Islam, F; Khan, MSI; Matsuda, S; Nabeka, H; Shimokawa, T	1
Chen, CH; Liu, HY; Pan, MY	1
Albreem, MA; Alomari, OA; Alsharif, MH; Alsharif, YH; Hossain, MS; Jahid, A; Solyman, AAA; Yahya, K	1
Chang, L; Hu, W; Ke, C; Liu, J; Shen, J; Tan, B; Xie, Y	1
Hale, CM; Hennrikus, EF; Mun, F	1
De, N; Gao, W; Mondal, S; Pal, A	1
Hanafin, PO; Hickey, AJ; Jermain, B; Kabanov, AV; Kashuba, AD; Rao, GG; Sheahan, TP	1
Ambrosino, I; Barbagelata, E; Ciarambino, T; Corbi, G; Moretti, AM; Politi, C	1
Cheung, WL; Cowart, MC; Gomez, MR; Gutierrez, LD; Hopwood, AJ; Jordan-Villegas, A; Laham, FR; McMahan, MJ; Vega-Montalvo, W	1
Ahuja, N; Amin, AN; Arguinchona, H; Beigel, JH; Billings, J; Bonnett, T; Branche, AR; Burgess, TH; Cantos, VD; Cardoso, A; Cohen, SH; Davey, RT; de Bono, S; Dempsey, W; Deye, GA; Dodd, LE; El Sahly, HM; Elie, MC; Engemann, JJ; Erdmann, N; Ferreira, J; Finberg, RW; Frank, M; Ghazaryan, V; Green, M; Hsieh, L; Iovine, NM; Jackson, PEH; Jain, MK; Kalil, AC; Kim, ES; Kline, S; Ko, ER; Larson, L; Luetkemeyer, AF; Lye, DC; Makowski, M; Marconi, VC; Mehta, AK; Mularski, RA; Nayak, SU; Nielsen, H; Oh, MD; Patterson, TF; Paules, CI; Ponce, PO; Proschan, M; Regalado Pineda, J; Rouphael, NG; Ruiz-Palacios, GM; Saklawi, Y; Sandkovsky, U; Sweeney, DA; Taiwo, B; Tan, SY; Tapson, V; Taylor, BS; Tomashek, KM; Watanabe, M; Wolfe, CR	1
Lexchin, J	1
Govil, A; Luckett, K; Miller-Handley, H	1
Chen, J; Chen, X; Feng, J; He, J; Li, L; Lin, Y; Pei, R; Rong, Z; Sun, H; Wen, K; Xiao, S; Xiong, J; Yang, X; Zhang, Y; Zhou, H	1
Haddad, F; Herth, FJF; Sakoulas, G	1
Agdamag, ACC; Alexy, T; Charpentier, V; Chowdhury, M; Edmiston, JB; Francis, GS; Fraser, M; Maharaj, VR	1
Akther, HD; Bergamaschi, L; Bloor, S; Bradley, JR; Buckland, MS; Ceron-Gutierrez, L; Coulter, TI; Devlin, L; Doffinger, R; Estcourt, L; Fhogartaigh, CN; Galloway, JB; Goodfellow, IG; Grigoriadou, S; Hackstein, CP; Hamilton, WL; Harvala, H; Hunter, M; Kiani-Alikhan, S; Klenerman, P; Lear, SE; Lehner, PJ; Loman, N; Lyons, PA; Mann, T; Matheson, NJ; Meredith, L; Mescia, F; Morgan, BP; Nelson, P; Ogbe, A; Ouwehand, WH; Periselneris, J; Provine, NM; Quick, J; Roberts, DJ; Screaton, N; Smielewska, A; Smith, KGC; Stockton, J; Thaventhiran, JED; Toonen, EJM; Török, ME; Turner, L; Vaghela, D; Vieira, VA; Wilkinson, IB; Yakovleva, A; Zelek, WM	1
Durvasula, R; Durvasula, SR; Kunamneni, A; Maciorowski, D; Ogaugwu, C	1
de Boer, MGJ; Gieling, EM; Sinha, BNM; van der Linden, PD; Vollaard, AM	1
Back, D; Boyle, A; Burger, D; Davidson, K; El-Sherif, O; Gibbons, S; Khoo, S; Marra, F; Marzolini, C; Siccardi, M; Smolders, EJ; Sommerville, AJ	1
Kumar, D; Trivedi, N; Verma, A	1
Bellera, CL; Comini, M; Gantner, ME; Gavernet, L; Llanos, M; Rodriguez, S; Talevi, A	1
Babiker, AG; Baker, JV; Barkauskas, CE; Benfield, T; Bowdish, ME; Brown, SM; Cao, H; Chang, CC; Davey, VJ; Dewar, RL; Files, DC; Gardner, EM; Gelijns, AC; Ginde, AA; Goodman, A; Gottlieb, RL; Grund, B; Harris, ES; Higgs, ES; Holland, TL; Jain, MK; Jensen, JU; Johansen, IS; Kan, VL; Klekotka, P; Knowlton, KU; Lane, HC; Leshnower, BG; Lundgren, JD; Markowitz, N; Matthay, MA; Murray, DD; Murray, TA; Neaton, JD; Paredes, R; Parmar, MKB; Phillips, AN; Polizzotto, MN; Reilly, C; Sandkovsky, U; Self, WH; Sharma, S; Teitelbaum, M; Thompson, BT; Wentworth, D; Østergaard, L	1
Jahanbani, A; Shao, Z; Sheikholeslami, SM	1
Camprubí, D; García-Vidal, C; Gaya, A; Marcos, MA; Martí-Soler, H; Mosquera, MDM; Muñoz, J; Oliver, A; Santos, M; Soriano, A	1
Acuña, MP; Rada, G; Solá, I; Verdugo-Paiva, F	1
Clement, KC; Isani, M; Kihlstrom, M; McLean, SE; Phillips, MR; Schwartz, SP; Smith, MM; Smith, RL; Walker, TC	1
An, MH; Hwang, TH; Kim, MS; Kim, WJ	1
Cho, S; Lin, HXJ; Meyyur Aravamudan, V; Molton, JS; Palraj, R; Sanda, HY; Venkatachalam, I	1
Pashaei, Y	1
Trkulja, V	1
Hanseus, K; Heying, R; Michel-Behnke, I; Milanesi, O; Sendzikaite, S	1
da Silva, S; Martinková, I; Petroušová, L; Rožnovský, L	1
Al-Abdouh, A; Antar, AAR; Barbarawi, M; Bizanti, A; Fashanu, OE; Jabri, A; Khan, SU; Kumar, A; Michos, ED; Zhao, D	1
Printz, C	1
Wen, S; Xu, X; Yadav, AK; Yu, L	1
Alarcón de la Lastra-Romero, C; Alegre-Del Rey, EJ; Gil-Sierra, MD; Sánchez-Hidalgo, M	1
Cheng, J; Gao, L; Liu, H; Pan, X; Wang, L; Wu, D; Yan, Z; Yao, X; Zhang, Y; Zhu, Q	1
Arumugaswami, V; Chen, X; Cui, Q; Garcia, G; Shi, Y; Sun, G; Tian, E; Wang, C; Wang, J; Zhang, M	1
Devi, S; Kar, N; Mohakud, S; Muthuvel, D	1
Aldir, I; Campos, L; Carmo, E; Carmo, I; Carvalho, A; Cavaco, P; Correia, J; Falcão, F; Falcao, M; Farinha, H; Fonseca, C; Mansinho, K; Mendes, D; Mirco, A; Pais Martins, A; Povoa, P; Rijo, J; Soares, J; Solano, M; Viegas, E	1
Anton-Vazquez, V; Clivillé, R	1
Dehghan, H; Fazlzadeh, A; Haddad, F; Kheirabadi, D; Mousavi-Roknabadi, RS; Rezaeisadrabadi, M	1
French, CT; Jaramillo, SA; Jones, AN; Keim, P; Knudsen, S; Martz, M; Ng, KR; Nottingham, R; Nunnally, HE; Raniere, MO; Sahl, JW; Settles, EW; Stone, NE; Vazquez, AJ; Versluis, LM; Wagner, DM; Zarn, KE	1
Billings, JL; Bold, TD; Gress, AR; Kline, S; Langlois, RA; Libby, SD; Matchett, WE; Menachery, VD; Noren, B; Ronayne, CE; Thiede, JM	1
Altınel, F; Aydın, AD; Erdoğmuş, H; Son, ÇD	1
Cicka, D; Sukhatme, VP	1
Avilés, P; Batra, J; Bouhaddou, M; Coughlan, L; Dejosez, M; Fabius, JM; García-Sastre, A; Guillén, MJ; Jangra, S; Kehrer, T; Krogan, NJ; Losada, A; Martinez-Romero, C; Miorin, L; Moreno, E; Obernier, K; Rathnasinghe, R; Rojc, A; Rosales, R; Schotsaert, M; Shokat, KM; Uccellini, MB; Vignuzzi, M; White, KM; Yildiz, S; Zwaka, T	1
Abdool Karim, SS; Baden, LR; Morrissey, S; Rubin, EJ	1
Abou-Sleymane, G; Al Faraj, A; Badro, DA; Daou, F; Khanafer, N; Tobaiqy, M	1
Kameoka, M; Kotaki, T; Shi, PY; Xie, X	1
Bold, TD; Daniel, J; Fiege, JK; Hunter, RC; Langlois, RA; Matchett, WE; Menachery, VD; Montanari, NR; Moore, PJ; Nanda, HA; Shen, SS; Stanley, E; Thiede, JM; Thielen, BK	1
Mylonakis, E; Zhang, R	1
Cai, JP; Cao, J; Chan, CC; Chan, JF; Chu, H; Jin, DY; Ong, CP; Poon, VK; Tang, K; Yang, D; Ye, ZW; Yu, CY; Yuan, S; Yuen, KY; Zhang, AJ	1
Palekar, S; Patel, K; Patki, M; Reznik, S	1
Brophy, JM; Butler-Laporte, G; Cheng, MP; Harrison, LB; Lee, TC; McDonald, EG	1
Agarwal, R; Bhalla, A; Chakrabarti, A; Garg, D; Kaur, H; Muthu, V; Puri, GD; Ramachandran, R; Sehgal, IS	1
Barcenas-Morales, G; Blane, E; Bradley, JR; Briggs, JAG; Ceron-Gutierrez, L; Chandra, A; Collier, DA; Datir, RP; Doffinger, R; Ferreira, IATM; Gayed, S; Gkrania-Klotsas, E; Goldstein, RA; Goodfellow, IG; Gouliouris, T; Gupta, RK; Hosmillo, M; Illingworth, CJR; Jahun, A; Kemp, SA; Leigh, KE; Lumb, IU; McCoy, LE; Mlcochova, P; Modis, Y; Pollock, DD; Rees-Spear, C; Roberts, DJ; Sharrocks, K; Skittrall, JP; Smielewska, A; Smith, C; Smith, KGC; Temperton, N; van Gils, MJ	1
Betschel, SD; Iaboni, A; Wong, N	1
Brügel, M; Habler, K; Liebchen, U; Paal, M; Scharf, C; Schönermarck, U; Teupser, D; Vogeser, M	1
Berkman, SA; Tapson, VF	1
Cihlar, T; Li, J; Martin, R; Mo, H; Parvangada, A; Perry, J; Porter, D; Svarovskaia, E	1
Danduga, RCSR; James, RA; Kandaswamy, DK; Raj, CTD; Rajasabapathy, R	1
Al Duhailib, Z; Alhazzani, W; Alshahrani, M; Alshamsi, F; Antonelli, M; Arabi, YM; Arrington, A; Bala, M; Belley-Cote, E; Bridges, E; Burry, L; Cecconi, M; Chertow, DS; Citerio, G; Coopersmith, CM; Crowther, M; Derde, L; Du, B; Dzierba, A; Evans, L; Fan, E; Greco, M; Hammond, N; Hayden, FG; Kaplan, LJ; Kesecioglu, J; Kleinpell, R; Koh, Y; Levy, MM; Lewis, K; Loeb, M; Machado, F; Mammen, MJ; Martin, GS; McGeer, A; Memish, ZA; Mermel, L; Møller, MH; Nainan Myatra, S; Ng Gong, M; Oczkowski, S; Ostermann, M; Prescott, HC; Rhodes, A; Szczeklik, W; Wunsch, H; Zarychanski, R	1
An, T; Jang, Y; Jung, E; Kim, K; Kim, M; Kim, UI; Lee, MK; Shin, JS	1
Alem, F; Bakovic, A; Bhalla, N; Chang, TL; Harness, JA; Narayanan, A; Risner, K; Weston, WK	1
Mahfouz, R; Maktabi, MAN; Younis, NK; Zareef, RO	1
Khazir, J; Maqbool, T; Mir, BA	1
Wilson, KC	1
Blanc, P; Esperti, S; Gabbuti, A; Mecocci, L; Pallotto, C; Suardi, LR	1
Li, CC; Li, J; Liu, HH; Wang, J; Yin, XD	1
Boshier, FAT; Breuer, J; Carter, SJ; Cortina-Borja, M; Gastine, S; Hung, IFN; Kloprogge, F; Lonsdale, DO; Pang, J; Standing, JF	1
Eleftheria, K; Eleni, M; Evangelia, M; Evangelos, B; Ioannis, K; Vana, S; Vasilios, V; Vissaria, S	1
Bansal, S; Bysani, S; Kalpakam, H; Mehta, RM	1
Guo, J; Li, W; Szendrey, M; Yang, T; Zhang, S	1
Agüero, D; Alonso-Navarro, R; Ambrosioni, J; Bodro, M; Cardozo, C; Castro, P; Chumbita, M; Cózar-Llistó, A; Dueñas, G; García, F; Garcia-Pouton, N; Garcia-Vidal, C; Grafia, N; Hernandez-Meneses, M; Jordan, C; Lopera, C; Martínez, JA; Meira, F; Mensa, J; Morata, L; Puerta-Alcalde, P; Rico, V; Sanjuan, G; Segui, F; Soriano, A	1
Barone, A; Incorvaia, C; Meschi, T; Nouvenne, A; Peveri, S; Pucciarini, F; Ridolo, E	1
Milano, G	1
Amato, L; Cruciani, F; Davoli, M; De Crescenzo, F; Mitrova, Z; Saulle, R; Vecchi, S	1
Cheung, PP; Gao, X; Huang, X; Jia, X; Li, Y; Wang, X; Yen, HL; Yuan, C; Zhang, D; Zhang, L	1
Barot, E; Bentzer, P; Bu, F; Feinberg, J; Gluud, C; Holgersson, J; Jakobsen, JC; Juul, S; Jørgensen, CK; Klingenberg, S; Nielsen, EE; Nielsen, N; Siddiqui, F; Thabane, L; Veroniki, AA	1
Bansal, D; Ding, H; Farag, EABA; Hadi, HA; Islam, MM; Sultan, AA; Triggle, CR	1
Alotaibi, NH; Bokharee, N; Khan, YH; Khokhar, A; Mallhi, TH; Rasheed, M	1
Aldakeel, FM; Ali, A; Alqahtani, MS; Bhat, EA; Khan, J; Mateen, A; Sajjad, N; Syed, R	1
Gullón, P; Lara, MÁ; Obispo, B; Rogado, J; Serrano, G	1
Bae, S; Baek, JH; Chang, HH; Cheon, S; Choe, PG; Choi, H; Chung, JW; Eom, JS; Heo, EY; Heo, JY; Joo, EJ; Kang, SJ; Kang, YM; Kim, BN; Kim, DY; Kim, JY; Kim, SE; Kim, SH; Ko, JH; Lee, BY; Lee, E; Park, JW; Park, Y; Peck, KR; Ra, SH; Shi, HJ; Sohn, Y	1
Alexander, GC; Bandeen-Roche, K; Bollinger, R; Garibaldi, BT; Gupta, A; Robinson, ML; Wang, K; Wang, MC; Xu, Y; Zeger, SL	1
Ijaz, M; Jalil, BA; Khan, AM; Ledbetter, TG	1
Attar, F; Bai, Q; Bloukh, SH; Falahati, M; Khan, RH; Khan, S; Nabi, F; Sharifi, M	1
Baruchel, A; Bertrand, Y; Boissel, N; Brethon, B; Ducassou, S; Gandemer, V; Halfon-Domenech, C; Leblanc, T; Leverger, G; Michel, G; Petit, A; Ray-Lunven, AF; Rohrlich, PS; Rouger-Gaudichon, J; Schneider, P; Sirvent, N; Strullu, M	1
Contreras, AG; Flores-García, NC; García-Juárez, I; Hoyo, I; Márquez-Guillén, E; Páez-Zayas, VM; Pérez-González, B; Rodríguez-Aguilar, EF; Thomas-Lora, FC; Visag-Castillo, V	1
Hastings, R; Jha, R; Kumar, P; Quek, E; Tahir, H	1
Olotu, FA; Omolabi, KF; Soliman, MES	1
Ahmed, T; Ballout, JA; Kolodziej, AR	1
Arbel, Y; Banai, A; Banai, S; Borohovitz, A; Furie, N; Gal-Oz, A; Ghantous, E; Granot, Y; Hochstadt, A; Ingbir, M; Lichter, Y; Lupu, L; Merdler, I; Sapir, O; Szekely, Y; Taieb, P; Topilsky, Y	1
Fujii, H; Goda, S; Hiraoka, N; Matsumoto, Y; Matsuyama, A; Omura, A; Ono, S; Shiotsu, S; Suga, Y; Sugitani, M; Takumi, C; Tanaka, S; Tsuji, T; Yuba, T	1
Copaescu, A; Drewett, G; Gordon, CL; Holmes, NE; James, F; Mouhtouris, E; Smibert, OC; Trubiano, JA; Vogrin, S	1
Morris, AM; Wu, PE	1
DuBrock, HM; Peters, BJ; Rabinstein, AA	1
Kalligeros, M; Mylona, EK; Mylonakis, E; Shehadeh, F; Tsikala Vafea, M; Zhang, R	1
Bandi, S; Katre, M; Lawman, KB; Nichani, S; Robinson, S; Saikia, B; Tang, J	1
Dolgin, E	1
Cai, D; Chen, D; Jiang, S; Jiang, Y; Si, L; Wu, J	1
Foguenne, J; Gothot, A; Keutgens, A; Nizet, A; Tassin, F	1
Kami, M; Murayama, A; Ozaki, A; Tanimoto, T; Ueda, M	1
Ahmed, M; Begum, SM; Islam, B; Islam, Z	1
Aldrich, ML; Bamford, A; Bonfanti, P; Brainard, DM; Camacho-Gonzalez, A; Cao, H; Carter, CC; Chokkalingam, AP; Das, M; Desai, P; DeZure, A; Goldman, DL; Hagmann, SHF; Katsarolis, I; Lapadula, G; Lee, P; Marshall, N; Méndez-Echevarría, A; Naik, S; Osinusi, A; Pikora, C; Telep, L; Zhao, Y	1
Campbell, EA; Cao, X; Chait, BT; Chen, J; Choi, YJ; Darst, SA; Eng, ET; Hernandez, C; Landick, R; Llewellyn, E; Malone, B; Olinares, PDB; Shaw, DE; Wang, Q	1
Gadzińska, J; Kloc, M; Kubiak, JZ; Kuchar, E; Matysiak, M; Wanke-Rytt, M	1
Bodin, R; Dale, M; Diflo, T; John, D; Latifi, R; Nishida, S; Nog, R; Partiula, B; Seyedsaadat, SM; Sogawa, H; Veillette, G; Wolf, DC	1
Demiri, I; Dimkovski, A; Dimovski, A; Filipce, V; Grozdanova, A; Panovska-Stavridis, I; Ridova, N; Ristevska, T; Stevanovic, M; Stojanoska, T; Stojanovska, S	1
Cen, S; Guo, F; Guo, S; Li, Q; Li, X; Liang, C; Lin, R; Liu, Z; Ma, L; Wang, J; Yi, D; Zhang, Y; Zhao, J	1
Arumugaswami, V; Beil, S; de Aja, JS; Garcia, G; Garcia-de-Alba, C; Gomperts, B; Kim, CF; Kolls, JK; Konda, B; Koziol, C; Mulay, A; Pessina, P; Pociask, DA; Purkayastha, A; Sen, C; Stripp, BR; Villalba, JM; Yao, C	1
Baden, R; Best, JH; Brawley, OW; Jariwala-Parikh, K; Kaplan-Lewis, E; Kong, AM; Loveless, J; Miller, KS; Mohan, SV; Zazzali, JL	1
Amini, H; Azhdari Tehrani, H; Haji Aghajani, M; Moradi, O; Pourheidar, E; Rabiei, MM; Sistanizad, M	1
Bhatia, S; Borkhardt, A; Kather, JN; Kronberg, RM; Lang, KS; Lang, PA; Müller, L; Ostermann, PN; Pandyra, AA; Schaal, H; Stachura, P; Werner, J	1
Anedda, L; Bianchini, L; Cuzzolin, L; Fanos, V; Finco, G; Marcialis, MA	1
Dellavalle, RP; Presley, CL; Pulsipher, KJ; Szeto, MD; Waller, JD	1
Arquiette, J; Galang, K; Liang, E; Mai, Y; Padilla, R; Singh, G	1
Antoniadi, M; Koletsi, P; Koltsida, G; Koukou, D; Mermiri, D; Michos, A; Noni, M; Spoulou, V	1
Kumar, R; Mahendra, M; Mahesh, PA; Nuchin, A; Shreedhar, S	1
Kutsuna, S	1
Bhuvanesh, N; Nandini Asha, R; Ravindran Durai Nayagam, B	1
Afridi, M; Akhtar, H; Akhtar, S; Ali, S; Khader, YS; Khalid, S	1
Abeles, SR; Jia, S; Kwon, J; Mehta, SR; Nan, B; Watanabe, JH	1
Bayrakci, B; Cengiz, AB; Gülhan, B; Gürlevik, SL; Kesici, S; Kurt Sukur, ED; Oygar, PD; Ozen, S; Ozsurekci, Y; Topaloglu, R	1
Chandra, PP; Jain, S; Potschka, H; Tripathi, M; Vohora, D	1
Abe, T; Maekawa, M; Mano, N; Sato, T; Yamaguchi, H	1
Goudarzi, R; Mehrolhassani, MH; Tasavon Gholamhoseini, M; Yazdi-Feyzabadi, V	1
Dölken, L; Spinner, CD; Stich, A	1
Steger, F; Timmermann, C; Voit, K	1
Bonner, E; Kreil, A; Leixner, G; Viveiros, A; Voill-Glaninger, A; Zadnikar, R	1
Bierwirth, C; Dickmanns, A; Dobbelstein, M; Freund, J; Gerber, S; Görlich, D; Groß, U; Klemke, L; Lugert, R; Manzini, V; Meister, TL; Nikolova, V; Pfaender, S; Salinas, G; Schlösser, D; Sitte, M; Stegmann, KM; Wollnik, B	1
Anderson, EJ; Edara, VV; Grubbs, G; Khurana, S; Lapp, SA; Patel, PA; Pauly, MG; Piantadosi, A; Rostad, CA; Sabnis, HS; Stokes, CL; Suthar, MS	1
Deb, S; Reeves, AA	1
Abdel-Rahman, MS; Algammal, AM; El-Saber Batiha, G; Elkady, AA; Farghaly, HSM; Hetta, HF; Koneru, G; Mabrok, M; Muhammad, K; Munawar, N; Ramadan, H; Waheed, Y	1
Biancalana, E; Chiriacò, M; Mechelli, S; Mengozzi, A; Sciarrone, P; Solini, A; Taddei, S	1
Baram, M; Chang, AM; Coppock, D; Henwood, P; Hess, B; Kubey, A; Li, M; Summer, R; Zurlo, J	1
Elfiky, AA; Elshemey, WM; Ibrahim, IM; Ibrahim, MN; Mahran, HA; Sonousi, A	1
Admane, P; Deshpande, M; Deshpande, N; Mardikar, H; Mardikar, M	1
Albani, S; Attena, E; De Rosa, A; Fiorentino, G; Maraolo, AE; Mollica, M; Parrella, R; Pisapia, R; Russo, V; Severino, S	1
Layton, AT; Sadria, M	1
Abubaker, J; Al-Mulla, F; Mohammad, A; Wei, DQ	1
Cipriani, L; Forner, G; Furlan, A; Gherlinzoni, F; Rigoli, R; Scotton, P; Vian, E	1
Aballi, S; Andersen, JT; Aukrust, P; Barratt-Due, A; Berg, Å; Blomberg, B; Dahl, TB; Dalgard, O; Dudman, S; Dyrhol-Riise, AM; Eiken, R; Ernst, G; Finbråten, AK; Fladeby, C; Hannula, R; Haugli, M; Heggelund, L; Hoel, H; Hoff, DAL; Holten, AR; Johannessen, A; Kåsine, T; Kildal, AB; Kittang, BR; Le, LAK; Lund-Johansen, F; Mathiessen, A; Mielnik, P; Müller, F; Nezvalova-Henriksen, K; Olsen, IC; Olsen, RB; Skåra, KH; Skei, NV; Skudal, H; Steffensen, A; Tholin, B; Thoresen, L; Tonby, K; Tran, T; Trøseid, M; Tveita, A; Ystrøm, CM	1
Kundu, S; Sarkar, D	1
Chan, YH; Chee, RS; Ding, Y; Fong, SW; Goh, YS; Kalimuddin, S; Leo, YS; Lye, DC; Ng, LFP; Renia, L; Tambyah, PA; Tan, SY; Young, BE	1
Alexander, B; Beck, BF; Crothers, K; Kobayashi, T; Lund, BC; Miller, DR; Ohl, ME; Richardson Miell, K; Vaughan Sarrazin, MS	1
Argentieri, G; Bernasconi, E; Gianella, P; Grazioli-Gauthier, L; Vanini, G	1
de Vries, YA; Field, SM; Hoek, JM; Linde, M; Muradchanian, J; Pittelkow, MM; van Ravenzwaaij, D	1
Negahdaripour, M	1
Busnadiego, I; Caflisch, A; Fernbach, S; Glas, I; Hale, BG; Hunziker, A; Marrafino, F; Moroz-Omori, EV; Pohl, MO; Stertz, S; Wiedmer, L	1
Aboumrad, M; Huizenga, H; Neupane, N; Riblet, N; Shiner, B; Young-Xu, Y	1
Kamath, A; Singh, A	1
Kassab, H; Manickam, R; Mechineni, A	1
Ejima, K; Fujita, Y; Iwami, S; Iwanami, S; Kim, KS; Kuba, K; Miyazaki, T; Oda, T	1
Ansems, K; Benstoem, C; Dahms, K; Fichtner, F; Grundeis, F; Metzendorf, MI; Mikolajewska, A; Piechotta, V; Stegemann, M; Thieme, V	1
Dey, M; Singh, RK	1
Abdullah, N; Anderson, EJ; Anglin, O; Barney, G; Bennett, NM; Billing, L; Bye, E; Chatelain, R; Como-Sabetti, K; Eisenberg, N; Felsen, CB; Fry, AM; Garg, S; Hall, A; Havers, FP; Herlihy, R; Hill, M; Kawasaki, B; Kim, L; Kim, S; Kirley, PD; Maslar, A; Milucky, J; Monroe, ML; Muse, A; O'Halloran, A; Openo, KP; Patel, K; Pham, H; Reeg, L; Reingold, A; Ryan, PA; Schaffner, W; Shiltz, J; Shrum Davis, S; Sutton, M; Talbot, HK; Taylor, C; Teno, K; Weigel, A; Whitaker, M; Wortham, J; Yousey-Hindes, K	1
Bartolini, D; Cruciani, G; Galli, F; Gioiello, A; Pistilli, A; Rende, M; Stabile, AM; Vacca, C	1
Bednar, P; Herout, V; Hrabovsky, S; Husa, P; Kabut, T; Kral, Z; Lengerova, M; Mayer, J; Pacasova, R; Prochazkova, J; Ruzek, D; Weinbergerova, B; Zdrazilova-Dubska, L	1
Afifi, N; Althani, A; Angelini, F; Caceci, T; Cenciarelli, C; Marei, HE; Pozzoli, G	1
Alexander, GC; An, H; Andersen, KM; Bates, B; Bennett, TD; Chute, CG; Garibaldi, BT; Joseph, C; Kocis, PT; Madhira, V; Mansour, O; Mehta, HB; Moffitt, R; Rashidi, ES; Setoguchi, S	1
An, A; Kapadia, S; Marks, K; Stoeckle, K; Witting, B	1
Awano, N; Fujimoto, K; Inomata, M; Ito, Y; Izumo, T; Kuse, N; Matsumoto, H; Muto, Y; Saiki, A; Sakamoto, K; Takada, K; Tone, M	1
Alders, N; Bamford, A; Best, T; Boshier, FAT; Breuer, J; Bynoe, PD; Dalton, C; de Silva, TI; Frauenfelder, C; Goldstein, RA; Grandjean, L; Grunewald, S; Hatcher, J; Köeglmeier, J; Myerson, P; Pang, J; Parker, M; Penner, J; Roy, S; Williams, R	1
Berk, H; Demir Önder, K; Öztoprak, N; Seremet Keskin, A; Seyman, D	1
Abdo, I; Abouelnaga, S; Al-Halfawy, A; El-Ansary, MG; Elhaddad, A; Elmeniawy, S; Hammad, M; Hassan, R; Khamis, N; Madeny, Y; Mansour, T; Shalaby, L; Sherief, N; Sidhom, I; Soliman, S; Zaki, I	1
Ammon, HPT; Caliebe, RH; Scior, T	1
Ceccarelli, G; Celani, L; d'Ettorre, G; Lombardi, F; Mancone, M; Marazzato, M; Mastroianni, CM; Piccirilli, A; Pugliese, F; Trinchieri, V	1
Assy, N; Azoulay, D; Basheer, M; Laskar, O; Rechnitzer, H; Saad, E; Schuster, O; Zisman-Rozen, S	1

Reviews

165 review(s) available for adenosine monophosphate and 2019 Novel Coronavirus Disease

Article	Year
Biology of COVID-19 and related viruses: Epidemiology, signs, symptoms, diagnosis, and treatment. Best practice & research. Clinical anaesthesiology, 2021, Volume: 35, Issue:3 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Animals; Antiviral Agents; Coronavirus; Cough; COVID-19; Diabetes Mellitus; Fatigue; Fever; Heart Diseases; Humans; Positive-Pressure Respiration; Prognosis; Pulmonary Disease, Chronic Obstructive; SARS-CoV-2; Treatment Outcome	2021
Remdesivir: A Closer Look at Its Effect in COVID-19 Pandemic. Pharmacology, 2021, Volume: 106, Issue:9-10 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2	2021
COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation. Cells, 2021, 08-27, Volume: 10, Issue:9 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Humans; Pandemics; Radiation, Ionizing; Radiotherapy; SARS-CoV-2; X-Ray Therapy	2021
Current treatment strategies for COVID‑19 (Review). Molecular medicine reports, 2021, Volume: 24, Issue:6 Topics: Adenosine Monophosphate; Alanine; Animals; Antimalarials; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Serotherapy; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Immunization, Passive; SARS-CoV-2	2021
Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection. Naunyn-Schmiedeberg's archives of pharmacology, 2022, Volume: 395, Issue:1 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Azetidines; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Disease Management; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Humans; Purines; Pyrazoles; Sulfonamides	2022
Remdesivir: Quo vadis? Biochemical pharmacology, 2021, Volume: 193 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Protein Structure, Tertiary; SARS-CoV-2	2021
Mechanisms of inhibition of viral RNA replication by nucleotide analogs. The Enzymes, 2021, Volume: 49 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Hepatitis C, Chronic; Humans; Kinetics; Nucleotides; RNA, Viral; SARS-CoV-2	2021
Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets. Molecular systems biology, 2021, Volume: 17, Issue:11 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Caco-2 Cells; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Datasets as Topic; Drug Development; Drug Repositioning; Host-Pathogen Interactions; Humans; Metabolic Networks and Pathways; Pandemics; RNA, Small Interfering; SARS-CoV-2; Sequence Analysis, RNA; Vero Cells	2021
Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp). Molecules (Basel, Switzerland), 2022, Jan-26, Volume: 27, Issue:3 Topics: Adenosine Monophosphate; Alanine; Amides; Catalytic Domain; Computational Biology; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Pyrazines; Pyrimidines; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Triazoles; Virus Replication	2022
COVID-19 in Children. Infectious disease clinics of North America, 2022, Volume: 36, Issue:1 Topics: Adenosine Monophosphate; Adolescent; Alanine; Child; COVID-19; Glucocorticoids; Hospitalization; Humans; Immunoglobulins, Intravenous; Systemic Inflammatory Response Syndrome	2022
Remdesivir. Profiles of drug substances, excipients, and related methodology, 2023, Volume: 48 Topics: Adenosine Monophosphate; COVID-19; COVID-19 Drug Treatment; Humans; SARS-CoV-2	2023
Understanding of COVID-19 based on current evidence. Journal of medical virology, 2020, Volume: 92, Issue:6 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Animals; Antiviral Agents; Betacoronavirus; China; Chiroptera; Communicable Disease Control; Coronavirus Infections; COVID-19; Disease Management; Humans; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Survival Analysis	2020
Clinical trial analysis of 2019-nCoV therapy registered in China. Journal of medical virology, 2020, Volume: 92, Issue:6 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Disease Management; Disease Outbreaks; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Pyrazines; SARS-CoV-2	2020
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Immunization, Passive; Interferon-beta; Lopinavir; Mice, Transgenic; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus	2020
[Pharmacotherapeutics for the new coronavirus pneumonia]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2020, Mar-12, Volume: 43, Issue:3 Topics: Adenosine; Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antiviral Agents; China; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Humans; Lopinavir; Pneumonia, Viral; Retrospective Studies; Ribonucleotides; Ritonavir	2020
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2020, Volume: 53, Issue:3 Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Alanine; Asymptomatic Infections; Betacoronavirus; China; Chloroquine; Comorbidity; Coronavirus Infections; COVID-19; Humans; Infection Control; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Young Adult	2020
Controversial treatments: An updated understanding of the coronavirus disease 2019. Journal of medical virology, 2020, Volume: 92, Issue:9 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Liver, Artificial; Ribavirin	2020
[Remdesivir, the antiviral hope against SARS-CoV-2]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2020, Volume: 33, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Potential therapeutic agents against COVID-19: What we know so far. Journal of the Chinese Medical Association : JCMA, 2020, Volume: 83, Issue:6 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Hydroxychloroquine; Interferon-alpha; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019. Pharmacotherapy, 2020, Volume: 40, Issue:5 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunomodulation; Interferon-alpha; Lopinavir; Nelfinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ribavirin; Ritonavir; SARS-CoV-2; Sulfonamides; Thiazoles	2020
Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International journal of antimicrobial agents, 2020, Volume: 55, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin	2020
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 2020, May-12, Volume: 323, Issue:18 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment	2020
Antiviral treatment of COVID-19 Turkish journal of medical sciences, 2020, 04-21, Volume: 50, Issue:SI-1 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles	2020
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions. Therapeutic drug monitoring, 2020, Volume: 42, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Interactions; Drug Monitoring; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Pandemics; Pneumonia, Viral; Protease Inhibitors; SARS-CoV-2; Transplant Recipients	2020
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions. Experimental biology and medicine (Maywood, N.J.), 2020, Volume: 245, Issue:11 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; China; Communicable Disease Control; Coronavirus Infections; COVID-19; Genome, Viral; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; SARS-CoV-2; Serine Proteinase Inhibitors; Severe acute respiratory syndrome-related coronavirus	2020
Treatment options for COVID-19: The reality and challenges. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2020, Volume: 53, Issue:3 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Teicoplanin	2020
Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Continuous Positive Airway Pressure; Coronavirus Infections; COVID-19; Developing Countries; Disease Management; Humans; Hydroxychloroquine; Lopinavir; Lung; Oxygen; Pandemics; Pneumonia, Viral; Respiration, Artificial; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed	2020
Scientific research progress of COVID-19/SARS-CoV-2 in the first five months. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:12 Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Testing; COVID-19 Vaccines; Disease Progression; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Immunization, Passive; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pyrazines; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus; Viral Vaccines	2020
[Remdesivir for patients with severe COVID-19]. Der Internist, 2020, Volume: 61, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Severity of Illness Index	2020
Pharmacotherapy in COVID-19; A narrative review for emergency providers. The American journal of emergency medicine, 2020, Volume: 38, Issue:7 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Hydroxychloroquine; Interleukin-6; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; SARS-CoV-2	2020
Treatment of SARS-CoV-2: How far have we reached? Drug discoveries & therapeutics, 2020, May-06, Volume: 14, Issue:2 Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferon-alpha; Interferon-beta; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2	2020
Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2020, Volume: 26, Issue:7 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Bone Marrow Transplantation; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Testing; Drug Combinations; Education, Distance; Hematopoietic Stem Cell Transplantation; Humans; Hydroxychloroquine; Immunization, Passive; Infection Control; Information Dissemination; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Real-Time Polymerase Chain Reaction; Ritonavir; SARS-CoV-2; Severity of Illness Index; Tissue Donors	2020
Medical treatment options for COVID-19. European heart journal. Acute cardiovascular care, 2020, Volume: 9, Issue:3 Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Recombinant Proteins; RNA, Viral; SARS-CoV-2	2020
Potential therapeutic targets and promising drugs for combating SARS-CoV-2. British journal of pharmacology, 2020, Volume: 177, Issue:14 Topics: Adenosine Monophosphate; Alanine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Basigin; Benzamidines; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Esters; Gabexate; Genome, Viral; Guanidines; Humans; Immunization, Passive; Immunosuppressive Agents; Medicine, Chinese Traditional; Nucleic Acid Synthesis Inhibitors; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protease Inhibitors; RNA-Dependent RNA Polymerase; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Viral Vaccines; Virus Internalization; Virus Replication	2020
Rapid review for the anti-coronavirus effect of remdesivir. Drug discoveries & therapeutics, 2020, Volume: 14, Issue:2 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus	2020
Severe Covid-19. The New England journal of medicine, 2020, Dec-17, Volume: 383, Issue:25 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Brain; COVID-19; COVID-19 Testing; Dexamethasone; Dyspnea; Humans; Lung; Male; Middle Aged; Patient Acuity; Radiography, Thoracic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Tomography, X-Ray Computed	2020
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine & growth factor reviews, 2020, Volume: 53 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Drug Therapy, Combination; Humans; Inflammation; Interferons; Oligonucleotides; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines	2020
Medicines for the Treatment Of COVID-19: Awaiting the Evidence. Acta medica portuguesa, 2020, Jul-01, Volume: 33, Issue:7-8 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Investigational; Global Health; Humans; Hydroxychloroquine; Lopinavir; Off-Label Use; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019. The American journal of cardiology, 2020, 08-01, Volume: 128 Topics: Adenosine Monophosphate; Alanine; Anti-Infective Agents; Azithromycin; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
Just the facts: What drugs are safe and effective for COVID-19? CJEM, 2020, Volume: 22, Issue:5 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antiviral Agents; Coronavirus Infections; COVID-19; Drug Therapy; Humans; Male; Middle Aged; Needs Assessment; Pandemics; Patient Safety; Pneumonia, Viral; Risk Assessment; Severe Acute Respiratory Syndrome; Severity of Illness Index; Steroids; Treatment Outcome	2020
A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. The FEBS journal, 2020, Volume: 287, Issue:17 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Drug Combinations; Humans; Hydroxychloroquine; Interferon beta-1a; Lopinavir; Middle East Respiratory Syndrome Coronavirus; Pandemics; Respiration, Artificial; Ritonavir; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Severity of Illness Index	2020
Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19. Pharmacotherapy, 2020, Volume: 40, Issue:7 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment. Drug safety, 2020, Volume: 43, Issue:7 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Risk Assessment; SARS-CoV-2; Treatment Outcome	2020
Educational case series of electrocardiographs during the COVID-19 pandemic and the implications for therapy. Singapore medical journal, 2020, Volume: 61, Issue:8 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronavirus Infections; COVID-19; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Pandemics; Pneumonia, Viral; Sampling Studies; Severe Acute Respiratory Syndrome; Singapore; Treatment Outcome	2020
A current review of COVID-19 for the cardiovascular specialist. American heart journal, 2020, Volume: 226 Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Biomarkers; Cardiovascular Diseases; Chloroquine; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Hypoxia; Pandemics; Plasma; Pneumonia, Viral; Receptor, Angiotensin, Type 2; Risk Factors; SARS-CoV-2; Takotsubo Cardiomyopathy; Virus Internalization	2020
Coronavirus Disease 2019: Clinical Review. Acta medica portuguesa, 2020, Jul-01, Volume: 33, Issue:7-8 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Blood Coagulation Disorders; China; Chiroptera; Chloroquine; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Infectious Disease Incubation Period; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Prognosis; Pyrazines; Radiography, Thoracic; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Symptom Assessment	2020
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2. In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl Topics: Acetylcysteine; Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Autophagy; Betacoronavirus; Colchicine; Copper; Coronavirus Infections; COVID-19; Cytidine; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxylamines; Inflammation; Nitric Oxide; Pandemics; Pneumonia, Viral; Prodrugs; Ribonucleosides; SARS-CoV-2; Virus Internalization; Virus Replication	2020
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome	2020
Use of Remdesivir in the Management of COVID-19: A Systematic Review on Current Evidences. Mymensingh medical journal : MMJ, 2020, Volume: 29, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2	2020
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19. Journal of the American Society of Nephrology : JASN, 2020, Volume: 31, Issue:7 Topics: Acute Kidney Injury; Adenosine Monophosphate; Alanine; Antiviral Agents; Cause of Death; Comorbidity; Coronavirus Infections; COVID-19; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Massachusetts; Pandemics; Pneumonia, Viral; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Rate	2020
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China. Virus research, 2020, Volume: 286 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Indoles; Interferons; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis	2020
Infant With SARS-CoV-2 Infection Causing Severe Lung Disease Treated With Remdesivir. Pediatrics, 2020, Volume: 146, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Infant; Infant, Premature; Intensive Care Units; Intubation, Intratracheal; Pandemics; Patient Discharge; Pneumonia, Viral; Radiography, Thoracic; Respiration, Artificial; Severe Acute Respiratory Syndrome; Treatment Outcome	2020
[COVID-19 trials: surfing between expectations and illusions, looking forward to evidence]. Giornale italiano di cardiologia (2006), 2020, Volume: 21, Issue:7 Topics: Adenosine Monophosphate; Alanine; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Italy; Male; Pandemics; Pneumonia, Viral; Prevalence; Randomized Controlled Trials as Topic; Risk Assessment	2020
Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials. European urology focus, 2020, Sep-15, Volume: 6, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Pandemics; Pneumonia, Viral; Receptors, Interleukin-6; SARS-CoV-2	2020
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir. European journal of medicinal chemistry, 2020, Sep-01, Volume: 201 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Emerging pharmacotherapy for COVID-19. The journal of the Royal College of Physicians of Edinburgh, 2020, Volume: 50, Issue:2 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Enzyme Inhibitors; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? The journal of the Royal College of Physicians of Edinburgh, 2020, Volume: 50, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking. Virus research, 2020, Volume: 286 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Anticoagulants; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Drug Combinations; Heparin; Humans; Hydroxychloroquine; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ritonavir; SARS-CoV-2; Sulfonamides	2020
[Drug treatment of coronavirus disease COVID-19: evidence exists?] Khirurgiia, 2020, Issue:6 Topics: Adenosine Monophosphate; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tissue Plasminogen Activator	2020
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection. Virus research, 2020, Volume: 286 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Teicoplanin	2020
Current pharmacological treatments for SARS-COV-2: A narrative review. European journal of pharmacology, 2020, Sep-05, Volume: 882 Topics: Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Immunity, Innate; Inflammation Mediators; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
Clinical management of COVID-19. The Indian journal of medical research, 2020, Volume: 151, Issue:5 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Airway Management; Alanine; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Critical Illness; Humans; Hydroxychloroquine; Immunization, Passive; Pandemics; Patient Acuity; Pneumonia, Viral; SARS-CoV-2; Shock; Specimen Handling; Symptom Assessment; Vulnerable Populations	2020
Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective. The Journal of allergy and clinical immunology, 2020, Volume: 146, Issue:2 Topics: Adenosine Monophosphate; Age Factors; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Asthma; Betacoronavirus; Clinical Laboratory Techniques; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Repositioning; Humans; Masks; Pandemics; Peptidyl-Dipeptidase A; Physical Distancing; Pneumonia, Viral; Prevalence; Quarantine; Receptors, Virus; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus	2020
Clinical Trials of Repurposed Antivirals for SARS-CoV-2. Antimicrobial agents and chemotherapy, 2020, 08-20, Volume: 64, Issue:9 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Treatment Outcome	2020
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection. ACS chemical neuroscience, 2020, 08-05, Volume: 11, Issue:15 Topics: Adenosine Monophosphate; Alanine; Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Blood-Brain Barrier; Brain; Central Nervous System Agents; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Humans; Methylprednisolone; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
Is hydroxychloroquine beneficial for COVID-19 patients? Cell death & disease, 2020, 07-08, Volume: 11, Issue:7 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Risk; SARS-CoV-2	2020
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review. Reviews in medical virology, 2020, Volume: 30, Issue:5 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Combinations; Drug Repositioning; Esters; Gabexate; Gene Expression Regulation; Guanidines; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2020
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. JAMA network open, 2020, 07-01, Volume: 3, Issue:7 Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Biological Products; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Non-Randomized Controlled Trials as Topic; Pandemics; Pneumonia, Viral; Protease Inhibitors; Protein-Tyrosine Kinases; Randomized Controlled Trials as Topic; Respiration, Artificial; SARS-CoV-2; Viral Load	2020
Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection. Journal of medical virology, 2021, Volume: 93, Issue:2 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Serotherapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Male; Middle Aged; Odds Ratio; Ritonavir; SARS-CoV-2; Survival Analysis; Treatment Outcome	2021
Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies. Drug discoveries & therapeutics, 2020, Volume: 14, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics. Journal of infection and public health, 2020, Volume: 13, Issue:10 Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antimalarials; Antiviral Agents; Betacoronavirus; Biomedical Research; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Drug Development; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2	2020
Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned. Vascular, 2021, Volume: 29, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Azithromycin; Cardiovascular Diseases; Chemically-Induced Disorders; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; SARS-CoV-2	2021
Use of remdesivir for patients with Covid-19: a review article. Revista da Associacao Medica Brasileira (1992), 2020, Volume: 66, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities. The Journal of allergy and clinical immunology, 2020, Volume: 146, Issue:4 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Hypersensitivity; Humans; Immunity, Innate; Immunologic Factors; Indoles; Infliximab; Interleukin 1 Receptor Antagonist Protein; Nitriles; Pandemics; Pneumonia, Viral; Pyrazines; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index	2020
Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine (London, England), 2020, Volume: 15, Issue:21 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Drug Repositioning; Host Microbial Interactions; Humans; Nanomedicine; Nanotechnology; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vaccines, Synthetic; Viral Vaccines	2020
Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019: A Clinical Overview and Primer. Biopreservation and biobanking, 2020, Volume: 18, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; SARS-CoV-2	2020
Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature. The western journal of emergency medicine, 2020, May-20, Volume: 21, Issue:4 Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
COVID-19 and liver disease: An update. Gastroenterologia y hepatologia, 2020, Volume: 43, Issue:8 Topics: Adenosine Monophosphate; Age Factors; Alanine; Antiviral Agents; Betacoronavirus; Bile Ducts; Chemical and Drug Induced Liver Injury; Chronic Disease; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Susceptibility; Gastroenterology; Health Resources; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Liver; Liver Diseases; Liver Function Tests; Liver Transplantation; Obesity; Pandemics; Pneumonia, Viral; Resource Allocation; Risk Factors; SARS-CoV-2	2020
Drug treatments for covid-19: living systematic review and network meta-analysis BMJ (Clinical research ed.), 2020, 07-30, Volume: 370 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Centers for Disease Control and Prevention, U.S.; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Databases, Factual; Drug Combinations; Evidence-Based Medicine; Glucocorticoids; Humans; Hydroxychloroquine; Lopinavir; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiration, Artificial; Ritonavir; SARS-CoV-2; Severity of Illness Index; Standard of Care; Treatment Outcome; United States	2020
A Perspective on Emerging Therapeutic Interventions for COVID-19. Frontiers in public health, 2020, Volume: 8 Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; COVID-19; Humans; Hydroxychloroquine; Public Health; Vaccines; Virus Replication	2020
Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature. European journal of clinical pharmacology, 2021, Volume: 77, Issue:1 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Eruptions; Exanthema; Humans; Male	2021
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:12 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Biomarkers; Child; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Drug Combinations; Early Diagnosis; Fever; Humans; Hydroxychloroquine; Interferon-alpha; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Ribavirin; Ritonavir; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed	2020
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review. Journal of infection and public health, 2020, Volume: 13, Issue:9 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2	2020
Potential strategies for combating COVID-19. Archives of virology, 2020, Volume: 165, Issue:11 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Indoles; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Severity of Illness Index; Viral Vaccines	2020
Efficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis. European journal of clinical investigation, 2020, Volume: 50, Issue:11 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Europe; Female; Humans; Lopinavir; Male; Pandemics; Pneumonia, Viral; Prognosis; Ritonavir; Survival Analysis; Treatment Outcome	2020
A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19. Drug design, development and therapy, 2020, Volume: 14 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Virus Replication	2020
Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials. Virus research, 2020, 10-15, Volume: 288 Topics: Adenosine Monophosphate; Alanine; Antimetabolites; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Drug Administration Schedule; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Treatment Outcome	2020
Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2. The Journal of international medical research, 2020, Volume: 48, Issue:8 Topics: Adenosine Monophosphate; Age Factors; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Communicable Disease Control; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Incidence; Pandemics; Personal Protective Equipment; Physical Distancing; Pneumonia, Viral; Quarantine; SARS-CoV-2; Severity of Illness Index; Survival Analysis	2020
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting. Molecular cell, 2020, 09-03, Volume: 79, Issue:5 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytidine; Genome, Viral; Humans; Hydroxylamines; Molecular Targeted Therapy; Mutation; Pandemics; Pneumonia, Viral; Pyrazines; Ribonucleosides; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Transcription, Genetic; Viral Nonstructural Proteins; Virus Replication	2020
[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)]. Medicina intensiva, 2021, Volume: 45, Issue:2 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Disease Progression; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunomodulation; Interferon-beta; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Nitriles; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Ritonavir; SARS-CoV-2	2021
Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic. Mayo Clinic proceedings, 2020, Volume: 95, Issue:9 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drugs, Investigational; Health Care Rationing; Humans; Minnesota; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States; United States Food and Drug Administration	2020
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 131 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
Remdesivir: First Approval. Drugs, 2020, Volume: 80, Issue:13 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Development; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems. Expert review of clinical pharmacology, 2020, Volume: 13, Issue:10 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Emergency Medical Services; European Union; Humans; Japan; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States	2020
The effect of antivirals on COVID-19: a systematic review. Expert review of anti-infective therapy, 2021, Volume: 19, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Ritonavir; Treatment Outcome	2021
Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis. BMJ supportive & palliative care, 2021, Volume: 11, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antirheumatic Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Indoles; Lopinavir; Medicine, Chinese Traditional; Ritonavir; SARS-CoV-2; Treatment Outcome	2021
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2. Current topics in medicinal chemistry, 2020, Volume: 20, Issue:26 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Gene Expression; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Immunization, Passive; Ivermectin; Models, Molecular; Niclosamide; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Interaction Domains and Motifs; Protein Structure, Secondary; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Vaccines	2020
A contemporary look at COVID-19 medications: available and potentially effective drugs. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Imatinib Mesylate; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
Advances in SARS-CoV-2: a systematic review. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Immunization, Passive; Immunotherapy; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2	2020
Current treatment of COVID-19 in renal patients: hope or hype? Internal and emergency medicine, 2020, Volume: 15, Issue:8 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Drug Combinations; Humans; Kidney; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ritonavir	2020
COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine. Virologica Sinica, 2020, Volume: 35, Issue:6 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antibodies, Viral; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Repositioning; Humans; Immunization, Passive; Medicine, Chinese Traditional; Pandemics; Pyrazines; SARS-CoV-2; World Health Organization	2020
Remdesivir-COVID-19: drug interactions in dentistry. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:18 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Dentistry; Drug Interactions; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Systemic Medications of Dermatological Importance in COVID-19. Journal of drugs in dermatology : JDD, 2020, Sep-01, Volume: 19, Issue:9 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Biological Products; Coronavirus Infections; COVID-19; Dermatologic Agents; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Pandemics; Pneumonia, Viral; Prognosis; Risk Assessment; Severe Acute Respiratory Syndrome	2020
SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence. The American journal of emergency medicine, 2020, Volume: 38, Issue:11 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Combinations; Evidence-Based Medicine; Humans; Hydroxychloroquine; Interferon beta-1b; Lopinavir; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; Systematic Reviews as Topic	2020
Remdesivir against COVID-19 and Other Viral Diseases. Clinical microbiology reviews, 2020, 12-16, Volume: 34, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Compassionate Use Trials; Coronavirus Infections; COVID-19; Drug Administration Schedule; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Patient Safety; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Survival Analysis; Treatment Outcome	2020
Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; China; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2	2021
Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic. Human vaccines & immunotherapeutics, 2021, 04-03, Volume: 17, Issue:4 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Chiroptera; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Humans; Lopinavir; Ritonavir; SARS-CoV-2; Virus Attachment; Virus Internalization	2021
Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review. Drugs, 2020, Volume: 80, Issue:18 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Biological Products; COVID-19; COVID-19 Drug Treatment; Cytokines; Dexamethasone; Drug Therapy, Combination; Humans; Inflammation Mediators; Intensive Care Units; Pandemics; Retrospective Studies; SARS-CoV-2	2020
Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2). The international journal of occupational and environmental medicine, 2020, Volume: 11, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Humans; Immunization, Passive; Lung; Pandemics; Pneumonia, Viral; Positive-Pressure Respiration; Respiratory Distress Syndrome; SARS-CoV-2; United States	2020
Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials. Journal of medical virology, 2021, Volume: 93, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Randomized Controlled Trials as Topic	2021
SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment. Frontiers in immunology, 2020, Volume: 11 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal; Antibodies, Viral; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Reservoirs; Drug Repositioning; Humans; Immunoenzyme Techniques; Immunotherapy; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Serologic Tests; Spike Glycoprotein, Coronavirus	2020
Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment. Drug research, 2021, Volume: 71, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Approval; Humans; RNA, Viral; SARS-CoV-2; Treatment Outcome; United States; United States Food and Drug Administration	2021
Emerging treatment strategies for COVID-19 infection. Clinical and experimental medicine, 2021, Volume: 21, Issue:2 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Humans; Hydroxychloroquine; Immunization, Passive; Palliative Care; Pyrazines; SARS-CoV-2; Treatment Outcome	2021
Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection. BMJ case reports, 2020, Oct-31, Volume: 13, Issue:10 Topics: Adenosine Monophosphate; Aged, 80 and over; Alanine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Emergency Service, Hospital; Humans; Length of Stay; Liver Diseases; Liver Function Tests; Male; Pandemics; Patient Discharge; Pneumonia, Viral; Respiratory Insufficiency; Severity of Illness Index; Treatment Outcome	2020
A comprehensive review on sarilumab in COVID-19. Expert opinion on biological therapy, 2021, Volume: 21, Issue:5 Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Pandemics; SARS-CoV-2	2021
Remdesivir: A beacon of hope from Ebola virus disease to COVID-19. Reviews in medical virology, 2020, Volume: 30, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; SARS-CoV-2; Treatment Outcome; Virus Replication	2020
One year update on the COVID-19 pandemic: Where are we now? Acta tropica, 2021, Volume: 214 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Drug Combinations; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Indoles; Ivermectin; Lopinavir; Mutation; Pandemics; Phytotherapy; Plant Extracts; Pyrazines; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tinospora; Viral Zoonoses	2021
The COVID-19 pandemic: consequences for nephrology. Nature reviews. Nephrology, 2021, Volume: 17, Issue:2 Topics: Acute Kidney Injury; Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Glucocorticoids; Humans; Kidney Failure, Chronic; Kidney Transplantation; Nephrology; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; SARS-CoV-2; Severity of Illness Index	2021
Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance. Current drug targets, 2021, Volume: 22, Issue:12 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Clinical Trials as Topic; Compassionate Use Trials; COVID-19; COVID-19 Drug Treatment; Humans; SARS-CoV-2	2021
Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:22 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Artificial Intelligence; Ascorbic Acid; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Deep Learning; Drug Combinations; Drug Development; Drug Repositioning; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lopinavir; Machine Learning; Ribavirin; Ritonavir; Vitamins	2020
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function. Advances in chronic kidney disease, 2020, Volume: 27, Issue:5 Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Creatinine; Cytidine; Dexamethasone; Drug Combinations; Drug Interactions; Humans; Hydroxychloroquine; Hydroxylamines; Immunization, Passive; Interferons; Janus Kinase Inhibitors; Lopinavir; Pyrazines; Renal Elimination; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ribavirin; Ritonavir; SARS-CoV-2	2020
Update on COVID-19 Myocarditis. Medicina (Kaunas, Lithuania), 2020, Dec-09, Volume: 56, Issue:12 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Immunization, Passive; Myocarditis; SARS-CoV-2; Steroids	2020
Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak. SLAS discovery : advancing life sciences R & D, 2021, Volume: 26, Issue:3 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Dexamethasone; Humans; Immunization, Passive; Pyrazines; SARS-CoV-2; Viral Proteins	2021
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment. Drugs in R&D, 2021, Volume: 21, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Dose-Response Relationship, Drug; Drug Repositioning; Humans; Hydroxychloroquine; Kidney Diseases; Liver Diseases	2021
Possible treatment and strategies for COVID-19: review and assessment. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:23 Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiparasitic Agents; Antiviral Agents; Cannabinoids; Chloroquine; Complement Inactivating Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Pyrazines; Ritonavir; SARS-CoV-2; Teicoplanin; Tetracyclines; Thiazoles	2020
Can drug repurposing strategies be the solution to the COVID-19 crisis? Expert opinion on drug discovery, 2021, Volume: 16, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Drug Therapy, Combination; Humans	2021
Remdesivir for the treatment of COVID-19: a living systematic review. Medwave, 2020, Dec-09, Volume: 20, Issue:11 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Randomized Controlled Trials as Topic; Respiration, Artificial; Treatment Outcome	2020
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis. PLoS medicine, 2020, Volume: 17, Issue:12 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Critical Illness; Hospitalization; Humans; Hydroxychloroquine; Immunization, Passive; Network Meta-Analysis; Observational Studies as Topic; Randomized Controlled Trials as Topic	2020
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence. Infection, 2021, Volume: 49, Issue:3 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; SARS-CoV-2; Time Factors; Treatment Outcome	2021
Analytical methods for the determination of remdesivir as a promising antiviral candidate drug for the COVID-19 pandemic. Drug discoveries & therapeutics, 2021, Jan-23, Volume: 14, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Monitoring; Humans; Predictive Value of Tests; Treatment Outcome	2021
Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials. Contemporary clinical trials, 2021, Volume: 101 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome	2021
Timing of remdesivir for COVID-19. The Medical letter on drugs and therapeutics, 2020, 10-19, Volume: 62, Issue:1609 Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Recovery of Function; Time Factors	2020
Antiviral treatment in COVID-19: which is the most promising?-a narrative review. Annals of palliative medicine, 2021, Volume: 10, Issue:1 Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles	2021
A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic. Journal of medical virology, 2021, Volume: 93, Issue:5 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Databases, Factual; Humans; Hydroxychloroquine; Immunoglobulins; Lopinavir; Pandemics; Pyrazines; Respiration, Artificial; Ritonavir; SARS-CoV-2	2021
The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19. International journal of environmental research and public health, 2021, 01-22, Volume: 18, Issue:3 Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Pandemics; Pyrazines	2021
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature. Mycopathologia, 2021, Volume: 186, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Diabetes Complications; Glucocorticoids; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mucormycosis; Rhizopus; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome	2021
COVID-19 and Its Implications for Thrombosis and Anticoagulation. Seminars in respiratory and critical care medicine, 2021, Volume: 42, Issue:2 Topics: Adenosine Monophosphate; Alanine; Ambulatory Care; Antibodies, Antiphospholipid; Antibodies, Monoclonal, Humanized; Anticoagulants; Antirheumatic Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dose-Response Relationship, Drug; Drug Combinations; Duration of Therapy; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Ritonavir; SARS-CoV-2; Thrombolytic Therapy; Thrombophilia; Thrombosis; Venous Thromboembolism	2021
COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review. Archives of microbiology, 2021, Volume: 203, Issue:5 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Serotherapy; Dexamethasone; Drug Repositioning; Evolution, Molecular; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Phylogeny; Prospective Studies; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2	2021
The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment. Genetic testing and molecular biomarkers, 2021, Volume: 25, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Evolution, Molecular; Global Burden of Disease; Humans; Hydroxychloroquine; Mutation; Off-Label Use; Pandemics; RNA, Viral; SARS-CoV-2; Severity of Illness Index	2021
A Review on Remdesivir: A Broad-spectrum Antiviral Molecule for Possible COVID-19 Treatment. Mini reviews in medicinal chemistry, 2021, Volume: 21, Issue:17 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Randomized Controlled Trials as Topic; SARS-CoV-2	2021
Coronavirus disease 2019 management. Current opinion in pulmonary medicine, 2021, 05-01, Volume: 27, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Serotherapy; Dexamethasone; Humans; Immunization, Passive; Immunologic Factors; Patient Selection; Respiration, Artificial; SARS-CoV-2	2021
COVID-19 illness and autoimmune diseases: recent insights. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2021, Volume: 70, Issue:4 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Arthritis, Rheumatoid; Autoimmune Diseases; Azetidines; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dendritic Cells; Humans; Immune System; Immunity, Innate; Immunization, Passive; Inflammatory Bowel Diseases; Killer Cells, Natural; Lupus Erythematosus, Systemic; Monocytes; Multiple Sclerosis; Purines; Pyrazoles; Sulfonamides	2021
Systematic Review and Patient-Level Meta-Analysis of SARS-CoV-2 Viral Dynamics to Model Response to Antiviral Therapies. Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:2 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Interferons; Male; Middle Aged; Proportional Hazards Models; SARS-CoV-2; Viral Load; Virus Shedding	2021
[The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.] Recenti progressi in medicina, 2021, Volume: 112, Issue:3 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Lopinavir; Mesenchymal Stem Cell Transplantation; Pandemics; Pyrazines; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Treatment Outcome; Uncertainty	2021
Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PloS one, 2021, Volume: 16, Issue:3 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bromhexine; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Expectorants; Humans; Immunoglobulins, Intravenous; Respiration, Artificial; SARS-CoV-2; Treatment Outcome	2021
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. Frontiers in immunology, 2021, Volume: 12 Topics: Adenosine Monophosphate; Aged; Alanine; Anti-Inflammatory Agents; Antigenic Variation; Antiviral Agents; Asymptomatic Diseases; Child; COVID-19; COVID-19 Vaccines; Dexamethasone; Humans; Immunity; Pandemics; SARS-CoV-2	2021
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials. Expert review of anti-infective therapy, 2021, Volume: 19, Issue:10 Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Chloroquine; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Intensive Care Units; Length of Stay; Lopinavir; Methylprednisolone; Observational Studies as Topic; Patient Admission; Pyrazines; Ritonavir; SARS-CoV-2; Survival Rate	2021
SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis - An updated review. International immunopharmacology, 2021, Volume: 95 Topics: Adenosine Monophosphate; Alanine; Animals; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Genome, Viral; Humans; Receptors, Coronavirus; SARS-CoV-2; Virus Attachment	2021
A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase. International journal of biological macromolecules, 2021, Jun-30, Volume: 181 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Computational Biology; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Models, Molecular; Nucleosides; RNA-Dependent RNA Polymerase; SARS-CoV-2	2021
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE). Bulletin du cancer, 2021, Volume: 108, Issue:5 Topics: Adenosine Monophosphate; Adolescent; Adrenal Cortex Hormones; Alanine; Antiviral Agents; Cancer Care Facilities; Child; Consolidation Chemotherapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Vaccines; Drug Interactions; France; Humans; Induction Chemotherapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Assessment; Societies, Medical	2021
Hepatic transplant during SARS-CoV-2 (COVID-19) pandemic. A literature review. Cirugia y cirujanos, 2021, Volume: 89, Issue:2 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Blood Component Transfusion; COVID-19; COVID-19 Serotherapy; Graft Rejection; Humans; Hydroxychloroquine; Immunization, Passive; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Pandemics; Waiting Lists; Withholding Treatment	2021
Treatment of COVID-19: a review of current and prospective pharmacotherapies. British journal of hospital medicine (London, England : 2005), 2021, Mar-02, Volume: 82, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azetidines; Colchicine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dexamethasone; Glucocorticoids; Humans; Immunization, Passive; Immunologic Factors; Ivermectin; Janus Kinase Inhibitors; Platelet Aggregation Inhibitors; Purines; Pyrazoles; SARS-CoV-2; Sulfonamides	2021
Mortality in mechanically ventilated patients with COVID-19: a systematic review. Expert review of medical devices, 2021, Volume: 18, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; COVID-19; Humans; Respiration, Artificial; SARS-CoV-2; Treatment Outcome	2021
Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature. Skeletal muscle, 2021, 04-21, Volume: 11, Issue:1 Topics: Adenosine Monophosphate; Adult; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; COVID-19; Creatine Kinase; Critical Illness; Dexamethasone; Electromyography; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Intensive Care Units; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Muscle, Skeletal; Muscular Diseases; Neural Conduction; Pulmonary Embolism; Quadriplegia; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Staphylococcal Infections; Ventilator Weaning	2021
Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021). Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2021, Apr-23, Volume: 42, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Chloroquine; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dexamethasone; Drug Combinations; Glucocorticoids; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Lopinavir; Ritonavir; SARS-CoV-2	2021
What if COVID-19 affects the child: which weapons and how to use them. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:8 Topics: Adenosine Monophosphate; Adolescent; Age Factors; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Carrier State; Child; Child, Preschool; Chloroquine; Continuous Renal Replacement Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Oseltamivir; Receptors, Cell Surface; Respiration, Artificial; Ribavirin; Ritonavir; SARS-CoV-2; Severity of Illness Index; Thrombosis	2021
[COVID-19: From a clinician's perspective.] Uirusu, 2020, Volume: 70, Issue:1 Topics: Adenosine Monophosphate; Alanine; COVID-19; Disease Progression; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Polymerase Chain Reaction; Risk Factors; SARS-CoV-2; Sputum; Time Factors	2020
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications. Epilepsy research, 2021, Volume: 174 Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inducers; Dexamethasone; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Epilepsy; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Ivermectin; Lopinavir; Pyrazines; Ritonavir; SARS-CoV-2	2021
Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2021, Volume: 24 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Hypoalbuminemia; Hypokalemia; Randomized Controlled Trials as Topic; Treatment Outcome	2021
Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:10 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SARS-CoV-2; Vitamin D	2021
Synthetic Attempts Towards Eminent Anti-viral Candidates of SARS-CoV. Mini reviews in medicinal chemistry, 2022, Volume: 22, Issue:2 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Lopinavir; Pyrazines; SARS-CoV-2	2022
Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness. Expert opinion on drug safety, 2021, Volume: 20, Issue:11 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; SARS-CoV-2; Treatment Outcome; Virus Replication	2021
Remdesivir for the treatment of COVID-19. The Cochrane database of systematic reviews, 2021, 08-05, Volume: 8 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Bias; Cause of Death; Confidence Intervals; COVID-19; COVID-19 Drug Treatment; Disease Progression; Humans; Middle Aged; Oxygen; Randomized Controlled Trials as Topic; Respiration, Artificial; SARS-CoV-2; Ventilator Weaning	2021
Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19. Pharmacology, 2021, Volume: 106, Issue:9-10 Topics: Acetates; Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Receptors, Leukotriene; Sulfides	2021
Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches. Molecular biology reports, 2021, Volume: 48, Issue:9 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Genetic Structures; Humans; Pandemics; SARS-CoV-2; Vaccination	2021

Trials

25 trial(s) available for adenosine monophosphate and 2019 Novel Coronavirus Disease

Article	Year
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. The Lancet. Infectious diseases, 2022, Volume: 22, Issue:2 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Europe; Extracorporeal Membrane Oxygenation; Female; Hospitalization; Humans; Male; Middle Aged; Oxygen; Respiration, Artificial; Standard of Care	2022
The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial. European journal of pharmacology, 2022, Jan-05, Volume: 914 Topics: Adenosine Monophosphate; Alanine; Amides; Antioxidants; Antiviral Agents; Biomarkers; COVID-19; COVID-19 Drug Treatment; Drug Monitoring; Female; Hemoglobins; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Patient Discharge; Pyrazines; Quercetin; Respiratory Rate	2022
Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome. The Journal of clinical investigation, 2022, 02-01, Volume: 132, Issue:3 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Alanine; Antibodies, Monoclonal; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Disease-Free Survival; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate; Tumor Necrosis Factor Ligand Superfamily Member 14	2022
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial. Annals of internal medicine, 2022, Volume: 175, Issue:2 Topics: Adenosine Monophosphate; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antigens, Viral; Antiviral Agents; Biomarkers; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Medical Futility; Middle Aged; RNA, Viral; SARS-CoV-2; Treatment Failure	2022
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. The New England journal of medicine, 2022, 01-27, Volume: 386, Issue:4 Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Antiviral Agents; Comorbidity; COVID-19; COVID-19 Drug Treatment; Disease Progression; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Outpatients; SARS-CoV-2; Time-to-Treatment; Viral Load	2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2022, 02-22, Volume: 194, Issue:7 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Canada; Comorbidity; COVID-19; COVID-19 Drug Treatment; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Pandemics; Respiration, Artificial; SARS-CoV-2	2022
An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19. Diabetes & metabolic syndrome, 2022, Volume: 16, Issue:2 Topics: Adenosine Monophosphate; Aged; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Double-Blind Method; Drug Approval; Drug Combinations; Female; Hospitalization; Humans; Hydroxylamines; Lactams; Leucine; Male; Middle Aged; Nitriles; Proline; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome	2022
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Lancet (London, England), 2022, 02-05, Volume: 399, Issue:10324 Topics: Adenosine Monophosphate; Alanine; Antibodies, Neutralizing; Antiviral Agents; COVID-19; COVID-19 Vaccines; Double-Blind Method; Female; Hospitalization; Humans; Inpatients; Internationality; Male; Middle Aged; Treatment Outcome; Vaccines, Inactivated	2022
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series. Infection, 2022, Volume: 50, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Immunization, Passive; Recurrence; SARS-CoV-2; Treatment Outcome	2022
Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score. Pulmonary pharmacology & therapeutics, 2023, Volume: 78 Topics: Adenosine Monophosphate; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Oxygen; Retrospective Studies; SARS-CoV-2	2023
Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1). The Journal of infectious diseases, 2023, 11-02, Volume: 228, Issue:9 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Child; COVID-19; COVID-19 Drug Treatment; Humans; SARS-CoV-2	2023
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status. Pharmacological research, 2020, Volume: 158 Topics: Acute Kidney Injury; Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transaminases; Treatment Outcome	2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet (London, England), 2020, 05-16, Volume: 395, Issue:10236 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Negative Results; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir for the Treatment of Covid-19 - Final Report. The New England journal of medicine, 2020, 11-05, Volume: 383, Issue:19 Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Extracorporeal Membrane Oxygenation; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Time Factors; Young Adult	2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials, 2020, May-24, Volume: 21, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; China; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Equivalence Trials as Topic; Female; Humans; Infusions, Intravenous; Male; Multicenter Studies as Topic; Pandemics; Patient Safety; Pneumonia, Viral; Risk Assessment; Risk Factors; SARS-CoV-2; Severity of Illness Index; Time Factors; Treatment Outcome	2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. The New England journal of medicine, 2020, 11-05, Volume: 383, Issue:19 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects. Clinical and translational science, 2020, Volume: 13, Issue:5 Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Alanine; Antiviral Agents; Area Under Curve; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Healthy Volunteers; Humans; Japan; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Young Adult	2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA, 2020, 09-15, Volume: 324, Issue:11 Topics: Adenosine Monophosphate; Administration, Intravenous; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Odds Ratio; Pandemics; Patient Acuity; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. BMJ open, 2020, 09-21, Volume: 10, Issue:9 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Early Warning Score; Extracorporeal Membrane Oxygenation; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interferon beta-1a; Length of Stay; Lopinavir; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; Ritonavir; SARS-CoV-2; Standard of Care; Treatment Outcome	2020
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. The New England journal of medicine, 2021, 02-11, Volume: 384, Issue:6 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Intention to Treat Analysis; Interferon beta-1a; Kaplan-Meier Estimate; Length of Stay; Lopinavir; Male; Middle Aged; Respiration, Artificial; Treatment Failure	2021
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. The New England journal of medicine, 2021, 03-04, Volume: 384, Issue:9 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Azetidines; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Oxygen Inhalation Therapy; Purines; Pyrazoles; Respiration, Artificial; Sulfonamides; Treatment Outcome	2021
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. The New England journal of medicine, 2021, 03-11, Volume: 384, Issue:10 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Hospitalization; Humans; Intention to Treat Analysis; Male; Middle Aged; Treatment Failure	2021
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe? Pediatric nephrology (Berlin, Germany), 2021, Volume: 36, Issue:11 Topics: Acute Kidney Injury; Adenosine Monophosphate; Adolescent; Alanine; Amides; Child; COVID-19; COVID-19 Drug Treatment; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Male; Pyrazines; Renal Elimination; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Treatment Outcome	2021
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial. Annals of internal medicine, 2021, Volume: 174, Issue:9 Topics: Adenosine Monophosphate; Alanine; Antibodies, Viral; Antiviral Agents; Biomarkers; Cause of Death; COVID-19; COVID-19 Drug Treatment; Female; Hospital Mortality; Humans; Hydroxychloroquine; Inflammation; Male; Middle Aged; Norway; Oropharynx; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Standard of Care; Treatment Outcome; Viral Load	2021
Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients. Hematological oncology, 2021, Volume: 39, Issue:5 Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Czech Republic; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Immunization, Passive; Male; Middle Aged; Prognosis; Retrospective Studies; SARS-CoV-2	2021

Other Studies

379 other study(ies) available for adenosine monophosphate and 2019 Novel Coronavirus Disease

Article	Year
Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response. British journal of haematology, 2022, Volume: 196, Issue:3 Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Immunization, Passive; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; SARS-CoV-2	2022
Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis. Scientific reports, 2021, 09-07, Volume: 11, Issue:1 Topics: Adenosine Monophosphate; Alanine; Clinical Decision-Making; Computer Simulation; Cost-Benefit Analysis; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Health Care Costs; Health Care Rationing; Humans; Intensive Care Units; Middle Aged; Oxygen; Quality-Adjusted Life Years; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; United States	2021
Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites. Molecular pharmacology, 2021, Volume: 100, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytidine; Dose-Response Relationship, Drug; Drug Interactions; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; HeLa Cells; Humans; Protein Binding; SARS-CoV-2	2021
Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir. Drug research, 2021, Volume: 71, Issue:8 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Biflavonoids; Catalytic Domain; Catechin; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Drug Design; Enzyme Inhibitors; Gallic Acid; Molecular Docking Simulation; Protein Conformation; SARS-CoV-2; Structure-Activity Relationship	2021
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies. Journal of medicinal chemistry, 2021, 10-14, Volume: 64, Issue:19 Topics: Adenosine Monophosphate; Alanine; Animals; Binding Sites; Chlorocebus aethiops; Coronavirus 3C Proteases; COVID-19; Crystallography, X-Ray; Humans; Indoles; Molecular Dynamics Simulation; Protease Inhibitors; Pyridines; SARS-CoV-2; Structure-Activity Relationship; Vero Cells	2021
Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus. European journal of medicinal chemistry, 2021, Dec-15, Volume: 226 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Ebolavirus; Fatty Acids; Humans; SARS-CoV-2	2021
SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia. The Pediatric infectious disease journal, 2021, 12-01, Volume: 40, Issue:12 Topics: Adenosine Monophosphate; Adolescent; Agammaglobulinemia; Alanine; Antibodies, Viral; Antiviral Agents; Biomarkers; Bronchoalveolar Lavage Fluid; COVID-19; COVID-19 Drug Treatment; Fever; Genetic Diseases, X-Linked; Humans; Inflammation; Male; Pneumonia, Viral; SARS-CoV-2	2021
Update Alert 2: Remdesivir for Adults With COVID-19. Annals of internal medicine, 2021, Volume: 174, Issue:12 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Humans; SARS-CoV-2; Viral Load	2021
Remdesivir triphosphate blocks DNA synthesis and increases exonucleolysis by the replicative mitochondrial DNA polymerase, Pol γ. Mitochondrion, 2021, Volume: 61 Topics: Adenosine Monophosphate; Alanine; Cells, Cultured; COVID-19; COVID-19 Drug Treatment; DNA Polymerase gamma; DNA Replication; DNA, Mitochondrial; Fibroblasts; Humans; SARS-CoV-2	2021
Effect of drug metabolism in the treatment of SARS-CoV-2 from an entirely computational perspective. Scientific reports, 2021, 10-07, Volume: 11, Issue:1 Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Design; Drug Discovery; Humans; Metabolic Networks and Pathways; Molecular Docking Simulation; Nitro Compounds; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Thiazoles	2021
COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study. Journal of hematology & oncology, 2021, 10-11, Volume: 14, Issue:1 Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Child; Child, Preschool; COVID-19; COVID-19 Serotherapy; Disease Management; Female; Hematologic Neoplasms; Humans; Immunization, Passive; Infant; Male; Poland; SARS-CoV-2	2021
Unmet need for COVID-19 therapies in community settings. The Lancet. Infectious diseases, 2021, Volume: 21, Issue:11 Topics: Adenosine Monophosphate; Alanine; Ambulatory Care; Antibodies, Monoclonal; Antiviral Agents; Community Health Services; COVID-19; COVID-19 Vaccines; Cytidine; Drug Combinations; Health Services Needs and Demand; Humans; Hydroxylamines; Socioeconomic Factors; Treatment Outcome; Viral Load	2021
Transparency, health equity, and strategies in state-based protocols for remdesivir allocation and use. PloS one, 2021, Volume: 16, Issue:10 Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; Health Equity; Humans; Information Dissemination; Internet; Pandemics; SARS-CoV-2; United States	2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19. Nature communications, 2021, 10-18, Volume: 12, Issue:1 Topics: Adenosine Monophosphate; Alanine; Animals; Chlorocebus aethiops; Coronavirus 229E, Human; Coronavirus 3C Proteases; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Design; Drug Synergism; Drug Therapy, Combination; HeLa Cells; Humans; Indoles; Infusions, Intravenous; Leucine; Mice; Pyrrolidinones; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Vero Cells	2021
Real-world outcomes of COVID-19 treatment with remdesivir in a Spanish hospital. Medicine, 2021, Sep-17, Volume: 100, Issue:37 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Hospitalization; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Spain; Statistics, Nonparametric	2021
Successful Treatment of Persistent SARS-CoV-2 Infection in a B-Cell Depleted Patient with Activated Cytotoxic T and NK Cells: A Case Report. International journal of molecular sciences, 2021, Oct-10, Volume: 22, Issue:20 Topics: Adenosine Monophosphate; Aged; Alanine; Antibodies, Monoclonal, Humanized; B-Lymphocytes; COVID-19; COVID-19 Serotherapy; Humans; Immunization, Passive; Killer Cells, Natural; SARS-CoV-2; T-Lymphocytes, Cytotoxic	2021
Comparing the outcomes of treatment with INF-β 1-a (interferon beta-1a) and IFN-β 1-b (interferon beta-1b) among COVID-19 inpatients. International immunopharmacology, 2021, Volume: 101, Issue:Pt B Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Atazanavir Sulfate; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Female; Humans; Immunization, Passive; Inpatients; Intensive Care Units; Interferon beta-1a; Interferon beta-1b; Male; Middle Aged; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Treatment Outcome	2021
Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study. Chemical biology & drug design, 2022, Volume: 99, Issue:2 Topics: Adenosine Monophosphate; Administration, Inhalation; Adult; Alanine; Antiviral Agents; Aptamers, Nucleotide; Cell Line; COVID-19; COVID-19 Drug Treatment; Humans; Liposomes; Lung; Male; Nanoparticles; Protein Domains; Recombinant Proteins; RNA Interference; RNA, Small Interfering; SARS-CoV-2; SELEX Aptamer Technique; Severity of Illness Index; Spike Glycoprotein, Coronavirus; Viral Load	2022
Remdesivir; molecular and functional measures of mitochondrial safety. Toxicology and applied pharmacology, 2021, 12-15, Volume: 433 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; DNA-Directed RNA Polymerases; DNA, Mitochondrial; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Mitochondria; RNA, Messenger	2021
Genomic diversity and molecular dynamics interaction on mutational variances among RB domains of SARS-CoV-2 interplay drug inactivation. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2022, Volume: 97 Topics: Adenosine Monophosphate; Alanine; Amino Acid Substitution; Antiviral Agents; Bangladesh; Binding Sites; China; COVID-19; COVID-19 Drug Treatment; Evolution, Molecular; Gene Expression; Genome, Viral; Humans; Likelihood Functions; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Netherlands; Phylogeny; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; United States	2022
Treatment of chronic or relapsing COVID-19 in immunodeficiency. The Journal of allergy and clinical immunology, 2022, Volume: 149, Issue:2 Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Antibodies, Monoclonal; Antiviral Agents; B-Lymphocytes; Chronic Disease; COVID-19; COVID-19 Serotherapy; Female; Humans; Immunization, Passive; Immunologic Deficiency Syndromes; Lymphocyte Count; Male; Middle Aged; Recombinant Fusion Proteins; Recurrence; SARS-CoV-2; Treatment Failure	2022
Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction. CPT: pharmacometrics & systems pharmacology, 2022, Volume: 11, Issue:1 Topics: Adenosine; Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Body Surface Area; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Extracorporeal Membrane Oxygenation; Female; Glomerular Filtration Rate; Humans; Japan; Kidney Diseases; Male; Middle Aged; Monte Carlo Method; Precision Medicine; Retrospective Studies	2022
Remdesivir and GS-441524 Extraction by Ex Vivo Extracorporeal Life Support Circuits. ASAIO journal (American Society for Artificial Internal Organs : 1992), 2022, 09-01, Volume: 68, Issue:9 Topics: Adenosine; Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; Extracorporeal Membrane Oxygenation; Humans; Renal Replacement Therapy	2022
Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2022, Volume: 97 Topics: Adenosine Monophosphate; Africa; Alanine; Amino Acid Substitution; Angiotensin-Converting Enzyme 2; Antiviral Agents; Asia; Binding Sites; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Databases, Factual; Epidemiological Monitoring; Europe; Evolution, Molecular; Furin; Gene Expression; Genome, Viral; Humans; Molecular Docking Simulation; Mutation; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; SARS-CoV-2; Spike Glycoprotein, Coronavirus; United States; Viral Nonstructural Proteins	2022
Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand? Virology journal, 2021, 11-22, Volume: 18, Issue:1 Topics: Adenosine Monophosphate; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Testing; Female; Humans; Immunologic Factors; Iran; Length of Stay; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Transplant Recipients	2021
Computational hunting of natural active compounds as an alternative for Remdesivir to target RNA-dependent polymerase. Cellular and molecular biology (Noisy-le-Grand, France), 2021, Jan-31, Volume: 67, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Biological Products; Catalytic Domain; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Curcumin; Databases, Protein; Drug Discovery; Drug Evaluation, Preclinical; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Phytochemicals; Protein Binding; SARS-CoV-2; Silybin	2021
Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM : monthly journal of the Association of Physicians, 2022, Jan-09, Volume: 114, Issue:12 Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Incidence; Intensive Care Units; Post-Acute COVID-19 Syndrome; Prospective Studies; Risk Factors; SARS-CoV-2	2022
Case Report: Severe SARS-CoV-2 Infection Treated with Remdesivir in a Patient with ESRD. Infectious disorders drug targets, 2022, Volume: 22, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Kidney Failure, Chronic; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2	2022
Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro. Virology, 2022, Volume: 566 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Benzoquinones; Cell Line; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Discovery; Drug Synergism; High-Throughput Screening Assays; Humans; Lactams, Macrocyclic; Lapatinib; Naphthalenes; Phenylurea Compounds; Pyrazoles; RNA, Viral; SARS-CoV-2; Vero Cells; Virus Replication	2022
Audio Interview: A Potential New Agent to Treat Covid-19. The New England journal of medicine, 2021, Dec-23, Volume: 385, Issue:26 Topics: Adenosine Monophosphate; Administration, Oral; Alanine; Anti-Inflammatory Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytidine; Evolution, Molecular; Hospitalization; Humans; Hydroxylamines; Mutagenesis; Risk Assessment; SARS-CoV-2; Time-to-Treatment; Vaccine Efficacy; Viral Load; Virus Replication	2021
Real-world treatment patterns and clinical outcomes for inpatients with COVID-19 in the US from September 2020 to February 2021. PloS one, 2021, Volume: 16, Issue:12 Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Comorbidity; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Obesity; Patient Discharge; Retrospective Studies; RNA, Viral; SARS-CoV-2; Treatment Outcome; United States; Young Adult	2021
Audio Interview: Covid-19 Vaccination and the Omicron Variant. The New England journal of medicine, 2021, Dec-30, Volume: 385, Issue:27 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiviral Agents; COVID-19; COVID-19 Vaccines; Disease Transmission, Infectious; Drug Approval; Hospitalization; Humans; Immunogenicity, Vaccine; SARS-CoV-2; Time Factors; Time-to-Treatment; Vaccine Efficacy	2021
Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH. Life science alliance, 2022, Volume: 5, Issue:4 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Caco-2 Cells; Cell Line, Tumor; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Humans; In Situ Hybridization; In Situ Hybridization, Fluorescence; Microscopy, Electron; Reproducibility of Results; RNA, Viral; SARS-CoV-2; Sensitivity and Specificity; Vero Cells; Virus Release; Virus Replication	2022
Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact. PloS one, 2022, Volume: 17, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Bed Occupancy; COVID-19; COVID-19 Drug Treatment; Dexamethasone; France; Hospitalization; Humans; Intensive Care Units; Length of Stay; Models, Statistical; SARS-CoV-2	2022
Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort. PloS one, 2022, Volume: 17, Issue:1 Topics: Adenosine Monophosphate; Aged; Alanine; Cohort Studies; Comorbidity; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Female; Hospital Mortality; Hospitalization; Humans; Inpatients; London; Male; Middle Aged; Pandemics; Patient Discharge; Proportional Hazards Models	2022
Remdesivir significantly reduces SARS-CoV-2 viral load on nasopharyngeal swabs in hospitalized patients with COVID-19: A retrospective case-control study. Journal of medical virology, 2022, Volume: 94, Issue:5 Topics: Adenosine Monophosphate; Alanine; Case-Control Studies; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Humans; Nasopharynx; Retrospective Studies; SARS-CoV-2; Viral Load	2022
Why scientists are racing to develop more COVID antivirals. Nature, 2022, Volume: 601, Issue:7894 Topics: Adenosine Monophosphate; Administration, Oral; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Drug Approval; Drug Combinations; Drug Development; Drug Resistance, Viral; Drug Therapy, Combination; Hospitalization; Humans; Hydroxylamines; Lactams; Leucine; Medication Adherence; Molecular Targeted Therapy; Mutagenesis; Nitriles; Proline; Public-Private Sector Partnerships; Research Personnel; Ritonavir; SARS-CoV-2	2022
Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination. PloS one, 2022, Volume: 17, Issue:1 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Comorbidity; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Female; Hospitals, Private; Humans; Immunization, Passive; Indonesia; Male; Middle Aged; Vaccination; Vitamins	2022
Treatment of COVID-19 in high-risk outpatients. The Medical letter on drugs and therapeutics, 2022, Feb-07, Volume: 64, Issue:1643 Topics: Adenosine Monophosphate; Alanine; Ambulatory Care; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytidine; Drug Combinations; Humans; Hydroxylamines; Lactams; Leucine; Nitriles; Outpatients; Proline; Ritonavir; Treatment Outcome	2022
Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study. PloS one, 2022, Volume: 17, Issue:2 Topics: Adenosine Monophosphate; Aged; Alanine; Anti-Inflammatory Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; SARS-CoV-2; Survival Rate	2022
Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients. PloS one, 2022, Volume: 17, Issue:2 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Aged; Alanine; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Incidence; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Proportional Hazards Models; Pseudomonas Infections; Respiration, Artificial; SARS-CoV-2; Staphylococcal Infections; Treatment Outcome	2022
Hundreds of COVID trials could provide a deluge of new drugs. Nature, 2022, Volume: 603, Issue:7899 Topics: Adenosine Monophosphate; Administration, Oral; Alanine; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Depsipeptides; Dexamethasone; Drug Combinations; Drug Repositioning; Drug Synergism; Esters; Guanidines; Hospitalization; Host-Pathogen Interactions; Humans; Hydroxylamines; Internationality; Lactams; Leucine; Mice; National Institutes of Health (U.S.); Nitriles; Peptide Elongation Factor 1; Peptides, Cyclic; Proline; Protease Inhibitors; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Serine Endopeptidases; Sodium-Glucose Transporter 2 Inhibitors; United States; Virus Replication	2022
A case-control, multicentre study of consecutive patients with COVID-19 and acute (myo)pericarditis: incidence, risk factors, clinical characteristics and outcomes. Emergency medicine journal : EMJ, 2022, Volume: 39, Issue:5 Topics: Adenosine Monophosphate; Biomarkers; Case-Control Studies; COVID-19; Humans; Incidence; Natriuretic Peptide, Brain; Peptide Fragments; Pericarditis; Risk Factors	2022
Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study. Respiratory medicine and research, 2022, Volume: 81 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Azetidines; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Humans; Purines; Pyrazoles; Retrospective Studies; SARS-CoV-2; Sulfonamides	2022
Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice. Zoological research, 2022, May-18, Volume: 43, Issue:3 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Endothelial Cells; Histamine Antagonists; Inflammation; Lung Injury; Mice; Rodent Diseases; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2022
Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 121 Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; Humans; Organ Transplantation; Retrospective Studies; SARS-CoV-2; Transplant Recipients	2022
Hospitalization as an outcome in ambulatory COVID-19 trials-not applicable in every setting. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022, Volume: 28, Issue:9 Topics: Adenosine Monophosphate; Antiviral Agents; COVID-19; Hospitalization; Humans; SARS-CoV-2	2022
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies. Annals of hematology, 2022, Volume: 101, Issue:10 Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Hematologic Neoplasms; Humans; Immunization, Passive; Lymphopenia; Oxygen; SARS-CoV-2	2022
COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19. Transplant international : official journal of the European Society for Organ Transplantation, 2022, Volume: 35 Topics: Adenosine Monophosphate; Alanine; Antibodies; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Graft Rejection; HLA Antigens; Humans; Kidney Transplantation; Pandemics; SARS-CoV-2; Transplant Recipients; Vaccination	2022
Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge. The Journal of hospital infection, 2022, Volume: 129 Topics: Adenosine Monophosphate; COVID-19; COVID-19 Drug Treatment; Female; Humans; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious	2022
Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program. Journal of clinical pharmacology, 2023, Volume: 63, Issue:2 Topics: Adenosine Monophosphate; Adolescent; Adult; Alanine; Antiviral Agents; Child; COVID-19; COVID-19 Drug Treatment; Humans; Infant; Infant, Newborn; SARS-CoV-2	2023
Remdesivir for the treatment of COVID-19: author's response. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:1 Topics: Adenosine Monophosphate; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; SARS-CoV-2	2023
Suppressed renoprotective purines in COVID-19 patients with acute kidney injury. Scientific reports, 2022, 10-17, Volume: 12, Issue:1 Topics: Acute Kidney Injury; Adenosine; Adenosine Monophosphate; Animals; COVID-19; Guanosine; Guanosine Monophosphate; Inosine; Purines	2022
Remdesivir does not affect mitochondrial DNA copy number or deletion mutation frequency in aged male rats: A short report. PloS one, 2022, Volume: 17, Issue:10 Topics: Adenosine Monophosphate; Alanine; Animals; Child, Preschool; COVID-19; DNA Copy Number Variations; DNA-Directed RNA Polymerases; DNA, Mitochondrial; Humans; Male; Mammals; Mitochondria; Nucleosides; Rats; RNA, Viral; SARS-CoV-2; Sequence Deletion	2022
Dual effects of NV-CoV-2 biomimetic polymer: An antiviral regimen against COVID-19. PloS one, 2022, Volume: 17, Issue:12 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Biomimetics; Body Weight; COVID-19; COVID-19 Drug Treatment; Humans; Rats; SARS-CoV-2	2022
Receptor-binding domain-based SARS-CoV-2 vaccine adjuvanted with cyclic di-adenosine monophosphate enhances humoral and cellular immunity in mice. Journal of medical virology, 2023, Volume: 95, Issue:2 Topics: Adenosine Monophosphate; Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Animals; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Mice; SARS-CoV-2; Spike Glycoprotein, Coronavirus	2023
Remdesivir saves lives. Were 3 years needed to learn that? The Lancet. Respiratory medicine, 2023, Volume: 11, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; SARS-CoV-2	2023
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients. Scientific reports, 2023, 03-18, Volume: 13, Issue:1 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Respiratory Insufficiency	2023
Remdesivir-induced conduction abnormalities: A molecular model-based explanation. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2023, Volume: 26 Topics: Adenosine; Adenosine Monophosphate; COVID-19; COVID-19 Drug Treatment; Humans	2023
Can changing the prodrug moiety in remdesivir be a life-saving strategy in COVID-19 infection? The Indian journal of medical research, 2023, Volume: 157, Issue:1 Topics: Adenosine Monophosphate; COVID-19; COVID-19 Drug Treatment; Humans; Prodrugs	2023
Remdesivir plus dexamethasone is associated to improvement in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status. Medicina clinica, 2023, 08-25, Volume: 161, Issue:4 Topics: Adenosine Monophosphate; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Humans; Oxygen; Vaccination	2023
Energetic Physical chemistry chemical physics : PCCP, 2023, May-17, Volume: 25, Issue:19 Topics: Adenosine Monophosphate; Adenosine Triphosphate; Antiviral Agents; Catalytic Domain; COVID-19; COVID-19 Drug Treatment; Humans; RNA, Viral; SARS-CoV-2	2023
Safety and Tolerability of Remdesivir in Infants and Children with COVID-19. Indian journal of pediatrics, 2023, Volume: 90, Issue:11 Topics: Adenosine Monophosphate; Child; COVID-19; COVID-19 Drug Treatment; Humans; Infant; SARS-CoV-2	2023
Assessing the gene expression of the adenosine 5'-monophosphate-activated protein kinase (AMPK) and its relation with the IL-6 and IL-10 plasma levels in COVID-19 patients. Molecular biology reports, 2023, Volume: 50, Issue:12 Topics: Adenosine; Adenosine Monophosphate; AMP-Activated Protein Kinases; COVID-19; Cytokines; Gene Expression; Humans; Inflammation; Interleukin-10; Interleukin-6; RNA, Messenger; SARS-CoV-2	2023
Drug treatment options for the 2019-new coronavirus (2019-nCoV). Bioscience trends, 2020, Mar-16, Volume: 14, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Discovery; Humans; Lopinavir; Neuraminidase; Nucleosides; Pneumonia, Viral; Ribonucleotides; Ritonavir; SARS-CoV-2	2020
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell research, 2020, Volume: 30, Issue:3 Topics: Adenosine Monophosphate; Alanine; Animals; Antimalarials; Antiviral Agents; Betacoronavirus; Biological Assay; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Drug Evaluation, Preclinical; Humans; Middle East Respiratory Syndrome Coronavirus; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Sincalide; Vero Cells	2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Lung; Macaca mulatta; Male; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Post-Exposure Prophylaxis; SARS-CoV-2; Viral Load; Virus Replication	2020
More than 80 clinical trials launch to test coronavirus treatments. Nature, 2020, Volume: 578, Issue:7795 Topics: Adenosine Monophosphate; Alanine; Animals; Anti-HIV Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dioxanes; Disease Models, Animal; Drug Combinations; Humans; Immunization, Passive; Lopinavir; Medicine, Chinese Traditional; Monosaccharides; Pandemics; Pneumonia, Viral; Registries; Ritonavir; SARS-CoV-2; Severe Acute Respiratory Syndrome; Stem Cell Transplantation; Steroids; Time Factors; Treatment Outcome; World Health Organization	2020
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life sciences, 2020, May-01, Volume: 248 Topics: Adenosine Monophosphate; Alanine; Alphacoronavirus; Amino Acid Sequence; Antiviral Agents; Betacoronavirus; Catalytic Domain; Computational Biology; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Guanosine Monophosphate; Guanosine Triphosphate; Humans; Molecular Docking Simulation; Pneumonia, Viral; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Ribavirin; RNA-Dependent RNA Polymerase; SARS-CoV-2; Sequence Alignment; Sequence Homology, Amino Acid; Sofosbuvir; Thermodynamics; Uridine Triphosphate; Viral Proteins	2020
Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature reviews. Drug discovery, 2020, Volume: 19, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hepatitis B; Hepatitis C; HIV Infections; Humans; Influenza, Human; Interferon-alpha; Middle East Respiratory Syndrome Coronavirus; Nucleosides; Pneumonia, Viral; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus	2020
Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2020, Volume: 15, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Breast Feeding; Coronavirus Infections; COVID-19; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Milk, Human; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. International journal of antimicrobial agents, 2020, Volume: 55, Issue:4 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Arguments in favour of remdesivir for treating SARS-CoV-2 infections. International journal of antimicrobial agents, 2020, Volume: 55, Issue:4 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; DNA-Directed RNA Polymerases; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug discoveries & therapeutics, 2020, Volume: 14, Issue:1 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Studies as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Humans; Indoles; Pandemics; Pneumonia, Viral; Pyrazines; Ribonucleotides; SARS-CoV-2; Virus Replication	2020
Advance of promising targets and agents against COVID-19 in China. Drug discovery today, 2020, Volume: 25, Issue:5 Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins	2020
Are there any Therapeutic Options Currently Available for Wuhan Coronavirus? Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2020, Volume: 19, Issue:2 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Chloroquine; Communicable Disease Control; Coronavirus Infections; COVID-19; Drug Discovery; Drug Repositioning; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Virus Internalization	2020
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. Pain physician, 2020, Volume: 23, Issue:2 Topics: Adenosine Monophosphate; Alanine; Analgesia; Antiviral Agents; Betacoronavirus; China; Compassionate Use Trials; Cord Blood Stem Cell Transplantation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Critical Illness; Cytokines; Humans; Hydroxychloroquine; Mesenchymal Stem Cell Transplantation; Pandemics; Pneumonia, Viral; SARS-CoV-2; Umbilical Cord; United States; Viral Vaccines	2020
Race to find COVID-19 treatments accelerates. Science (New York, N.Y.), 2020, 03-27, Volume: 367, Issue:6485 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Biomedical Research; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; World Health Organization	2020
A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 11-19, Volume: 71, Issue:16 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Community-Acquired Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Middle Aged; Respiratory Distress Syndrome; Risk Factors; Shock, Septic; Thorax; Tomography, X-Ray Computed; Treatment Outcome; United States	2020
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antimalarials; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus	2020
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral research, 2020, Volume: 178 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antimetabolites; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Emetine; Epithelial Cells; Homoharringtonine; Humans; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; SARS-CoV-2; Vero Cells; Virus Replication	2020
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Science translational medicine, 2020, 04-29, Volume: 12, Issue:541 Topics: Adenosine Monophosphate; Alanine; Animals; Antibiotic Prophylaxis; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus Infections; COVID-19; Cytidine; Disease Models, Animal; Drug Resistance, Viral; Humans; Hydroxylamines; Lung; Mice; Mice, Inbred C57BL; Middle East Respiratory Syndrome Coronavirus; Models, Molecular; Mutation; Pandemics; Pneumonia, Viral; Primary Cell Culture; Random Allocation; Respiratory System; Ribonucleosides; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Virus Replication	2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19. The New England journal of medicine, 2020, 06-11, Volume: 382, Issue:24 Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Alanine; Antiviral Agents; Betacoronavirus; Canada; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Europe; Female; Humans; Japan; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; United States; Young Adult	2020
Delayed Initiation of Remdesivir in a COVID-19-Positive Patient. Pharmacotherapy, 2020, Volume: 40, Issue:6 Topics: Adenosine Monophosphate; Adult; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Hydroxychloroquine; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Time Factors; Time-to-Treatment	2020
Coronavirus Disease (COVID-19) Pandemic: A Race Against Time. Current topics in medicinal chemistry, 2020, Volume: 20, Issue:16 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Hand Hygiene; Humans; International Cooperation; Masks; Pandemics; Patient Education as Topic; Pneumonia, Viral; Quarantine; SARS-CoV-2; Viral Vaccines	2020
Early impact of COVID-19 on transplant center practices and policies in the United States. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Critical Illness; Evidence-Based Medicine; Health Policy; Humans; Hydroxychloroquine; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Living Donors; Organ Transplantation; Pandemics; Pneumonia, Viral; Resource Allocation; SARS-CoV-2; Surveys and Questionnaires; Tissue Donors; Transplant Recipients; United States	2020
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. Antiviral research, 2020, Volume: 178 Topics: Adenosine Monophosphate; Alanine; Antimetabolites; Antiviral Agents; Betacoronavirus; Catalytic Domain; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Drug Resistance, Viral; Exoribonucleases; Humans; Models, Molecular; Mutation; Pandemics; Pneumonia, Viral; Protein Conformation; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Structure-Activity Relationship; Viral Nonstructural Proteins	2020
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus. Current medicinal chemistry, 2020, Volume: 27, Issue:27 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2	2020
COVID-2019: update on epidemiology, disease spread and management. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Apr-16, Volume: 90, Issue:1 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Basic Reproduction Number; Betacoronavirus; Clinical Laboratory Techniques; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Quarantine; Receptors, Virus; SARS-CoV-2	2020
The race against COVID-19. Nature nanotechnology, 2020, Volume: 15, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antibodies, Viral; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Humans; Hydroxychloroquine; Nucleic Acid Amplification Techniques; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines	2020
COVID-19 in a high-risk dual heart and kidney transplant recipient. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7 Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Cardiomyopathy, Dilated; Coronavirus Infections; COVID-19; Heart Transplantation; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Pandemics; Pneumonia, Viral; Radiography, Thoracic; Randomized Controlled Trials as Topic; Risk Factors; SARS-CoV-2; Treatment Outcome	2020
Remdesivir in covid-19. BMJ (Clinical research ed.), 2020, 04-22, Volume: 369 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Ribonucleotides; SARS-CoV-2	2020
Some drugs for COVID-19. The Medical letter on drugs and therapeutics, 2020, 04-06, Volume: 62, Issue:1595 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Neuraminidase; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2	2020
Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals. Drug discovery today, 2020, Volume: 25, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Aquatic Organisms; Biological Products; Chloroquine; Coronavirus Infections; COVID-19; Drug Compounding; Humans; Hydroxychloroquine; Models, Molecular; Pandemics; Pneumonia, Viral; Volatilization	2020
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020, Volume: 20, Issue:7 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Female; Hospitalization; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Intensive Care Units; Intubation; Male; Middle Aged; New York City; Organ Transplantation; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Steroids; Transplant Recipients; Treatment Outcome; United States	2020
Chloroquine hype is derailing the search for coronavirus treatments. Nature, 2020, Volume: 580, Issue:7805 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
The clinical manifestations and management of COVID-19-related liver injury. Journal of the Formosan Medical Association = Taiwan yi zhi, 2020, Volume: 119, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Liver; Liver Diseases; Liver Function Tests; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety. European heart journal. Cardiovascular pharmacotherapy, 2020, 07-01, Volume: 6, Issue:4 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway. Pharmacological research, 2020, Volume: 158 Topics: Adenosine Monophosphate; Alanine; Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Proliferation; Cells, Cultured; Chlorocebus aethiops; Complex Mixtures; Coronavirus Infections; COVID-19; Humans; Inflammation Mediators; NF-kappa B; Pandemics; Pneumonia, Viral; SARS-CoV-2; Signal Transduction; Virion	2020
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. The Journal of antimicrobial chemotherapy, 2020, 07-01, Volume: 75, Issue:7 Topics: Adenosine Monophosphate; Adenosine Triphosphate; Alanine; Betacoronavirus; Chromatography, High Pressure Liquid; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Sensitivity and Specificity; Tandem Mass Spectrometry	2020
The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:6 Topics: ADAM17 Protein; Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Benzylisoquinolines; Betacoronavirus; Biological Transport; Cathepsin L; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Endocytosis; Endosomes; Glycopeptides; Humans; Hydroxychloroquine; Intracellular Signaling Peptides and Proteins; Lysosomes; Membrane Lipids; Membrane Microdomains; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Oxysterols; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Triazoles; Virus Internalization	2020
Audio Interview: Studying Potential Covid-19 Therapies. The New England journal of medicine, 2020, 05-07, Volume: 382, Issue:19 Topics: Adenosine Monophosphate; Alanine; Anti-Infective Agents; Azithromycin; Betacoronavirus; Controlled Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2	2020
When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in Italy. ACS chemical biology, 2020, 06-19, Volume: 15, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Biomedical Research; Chemistry; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Italy; Laboratories; Pandemics; Phylogeny; Pneumonia, Viral; SARS-CoV-2	2020
Novel coronavirus 2019 (COVID-19): A case report and review of treatments. Medicine, 2020, Volume: 99, Issue:19 Topics: Adenosine Monophosphate; Aged; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Fatal Outcome; Female; Humans; Hydroxychloroquine; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2	2020
[Chloroquine as a possible treatment for COVID-19]. Nederlands tijdschrift voor geneeskunde, 2020, Mar-11, Volume: 164 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Lopinavir; Off-Label Use; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Treatment Outcome	2020
[The "Historic Study" SOLIDARITY-Research's Answer to the Sars-CoV-2 Pandemic]. NTM, 2020, Volume: 28, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Bioethical Issues; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Editorial Policies; Humans; Hydroxychloroquine; International Cooperation; Lopinavir; Pandemics; Pneumonia, Viral; Research Design; Ritonavir; SARS-CoV-2; World Health Organization	2020
In Vitro Data of Current Therapies for SARS-CoV-2. Current medicinal chemistry, 2020, Volume: 27, Issue:27 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles	2020
What Do We Know About Remdesivir Drug Interactions? Clinical and translational science, 2020, Volume: 13, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Compassionate Use Trials; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Drug Therapy, Combination; Excipients; Humans; Pandemics; Review Literature as Topic	2020
Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury. The New England journal of medicine, 2020, May-28, Volume: 382, Issue:22 Topics: Acute Kidney Injury; Adenosine Monophosphate; Aged; Alanine; Amides; Anti-Inflammatory Agents; Anticoagulants; Antiviral Agents; Betacoronavirus; Continuous Renal Replacement Therapy; Coronavirus Infections; COVID-19; Creatinine; Humans; Hypertension; Lung; Male; Obesity; Pandemics; Pneumonia, Viral; Pyrazines; Radiography, Thoracic; SARS-CoV-2	2020
Coronavirus drugs trials must get bigger and more collaborative. Nature, 2020, Volume: 581, Issue:7807 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Compassionate Use Trials; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020. Emerging infectious diseases, 2020, Volume: 26, Issue:8 Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Asthma; Azithromycin; Betacoronavirus; California; Clinical Laboratory Techniques; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Testing; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Intensive Care Units; Length of Stay; Male; Pandemics; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Tomography, X-Ray Computed	2020
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. JAMA, 2020, 06-16, Volume: 323, Issue:23 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Emergencies; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States	2020
Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City. The Journal of pediatrics, 2020, Volume: 223 Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Asthma; Betacoronavirus; Blood Urea Nitrogen; C-Reactive Protein; Child; Child, Preschool; Coronavirus Infections; COVID-19; Creatinine; Critical Illness; Dyspnea; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Natriuretic Peptide, Brain; New York City; Pandemics; Pediatric Obesity; Platelet Count; Pneumonia, Viral; Procalcitonin; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Sepsis; Shock, Septic; Tertiary Care Centers; Young Adult	2020
Dozens of coronavirus drugs are in development - what happens next? Nature, 2020, Volume: 581, Issue:7808 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Coronavirus Infections; COVID-19; Drug Development; Drug Industry; Humans; Hydroxychloroquine; Oseltamivir; Pandemics; Pneumonia, Viral	2020
Compassionate Use of Remdesivir in Covid-19. The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Compassionate Use of Remdesivir in Covid-19. The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Compassionate Use of Remdesivir in Covid-19. The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Compassionate Use of Remdesivir in Covid-19. The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Compassionate Use of Remdesivir in Covid-19. Reply. The New England journal of medicine, 2020, 06-18, Volume: 382, Issue:25 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Early experience with remdesivir in SARS-CoV-2 pneumonia. Infection, 2020, Volume: 48, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes	2020
Protect Pregnant and Lactating Women with COVID-19 Through Research, Not from Research. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2020, Volume: 15, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Breast Feeding; Coronavirus Infections; COVID-19; Drug Approval; Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactation; Milk, Human; Pandemics; Pneumonia, Viral; Pregnancy; Risk Assessment; SARS-CoV-2	2020
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Middle Aged; Pandemics; Pneumonia, Viral; Receptors, Interleukin-1; Respiratory Insufficiency; SARS-CoV-2	2020
[From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic]. Medicina intensiva, 2020, Volume: 44, Issue:8 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Decision-Making; Clinical Trials as Topic; Coronavirus Infections; Cost-Benefit Analysis; COVID-19; Drug Combinations; Empiricism; Humans; Hydroxychloroquine; Information Dissemination; Lopinavir; Pandemics; Pneumonia, Viral; Reproducibility of Results; Ritonavir; SARS-CoV-2; Viral Load	2020
Remdesivir for COVID-19: challenges of underpowered studies. Lancet (London, England), 2020, 05-16, Volume: 395, Issue:10236 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Double-Blind Method; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2	2020
Does lopinavir really inhibit SARS-CoV-2? Pharmacological research, 2020, Volume: 158 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Emetine; Homoharringtonine; Humans; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus	2020
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection. Medical hypotheses, 2020, Volume: 142 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deoxyribonucleosides; Deoxyribose; Drug Administration Schedule; Drug Synergism; Fluorouracil; Humans; Inflammation; Models, Theoretical; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Archives of medical research, 2020, Volume: 51, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; RNA, Viral; SARS-CoV-2	2020
Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit. The AAPS journal, 2020, 05-26, Volume: 22, Issue:4 Topics: Adenosine Monophosphate; Administration, Inhalation; Administration, Intravenous; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir - An Important First Step. The New England journal of medicine, 2020, 11-05, Volume: 383, Issue:19 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Audio Interview: New Data on Remdesivir in Covid-19. The New England journal of medicine, 2020, 05-28, Volume: 382, Issue:22 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Evaluation; Humans; Hydroxychloroquine; Infusions, Intravenous; Pandemics; Placebos; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Time Factors; Treatment Outcome; Viral Load	2020
Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective. The primary care companion for CNS disorders, 2020, 05-28, Volume: 22, Issue:3 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Interactions; Humans; Pandemics; Pneumonia, Viral; Psychotropic Drugs; SARS-CoV-2	2020
Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea. Journal of medical virology, 2021, Volume: 93, Issue:1 Topics: Adenosine Monophosphate; Adult; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Diarrhea; Female; Humans; Intestinal Mucosa; Intestine, Small; SARS-CoV-2; Vasculitis	2021
An update on novel COVID-19 pandemic: a battle between humans and virus. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:10 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; RNA, Viral; SARS-CoV-2; Survival Analysis	2020
Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019. JAMA pediatrics, 2020, 10-01, Volume: 174, Issue:10 Topics: Adenosine Monophosphate; Adolescent; Adult; Alanine; Antiviral Agents; Child; Child, Preschool; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Male; Models, Biological; Pandemics; Patient Simulation; Pneumonia, Viral; Therapies, Investigational; Young Adult	2020
Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials. BMJ open, 2020, 06-04, Volume: 10, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Infection Control; Meta-Analysis as Topic; Pandemics; Pneumonia, Viral; Research Design; SARS-CoV-2; Systematic Reviews as Topic; Treatment Outcome	2020
[Remdesivir til behandling af COVID-19-pneumoni]. Ugeskrift for laeger, 2020, 06-08, Volume: 182, Issue:24 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature, 2020, Volume: 585, Issue:7824 Topics: Adenosine Monophosphate; Alanine; Animals; Betacoronavirus; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Disease Models, Animal; Disease Progression; DNA Mutational Analysis; Drug Resistance, Viral; Female; Lung; Macaca mulatta; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Secondary Prevention; Time Factors; Viral Load; Virus Replication; Virus Shedding	2020
Revue medicale suisse, 2020, 06-10, Volume: 16, Issue:697 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Humans; Negative Results; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
COVID-19 in lung transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Cough; COVID-19; Cross Infection; Cystic Fibrosis; Dyspnea; Female; Fever; Gastrointestinal Diseases; Glucocorticoids; Graft Rejection; Humans; Idiopathic Pulmonary Fibrosis; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Lung; Lung Transplantation; Male; Methylprednisolone; Middle Aged; Pancreatitis, Acute Necrotizing; Pulmonary Disease, Chronic Obstructive; Pulse Therapy, Drug; SARS-CoV-2; Sepsis; Severity of Illness Index; Tomography, X-Ray Computed	2020
Flight of the COVID-19 patient: experience with a Wuhan evacuee: a case report. Journal of medical case reports, 2020, Jun-11, Volume: 14, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Blood Cell Count; California; China; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Transmission, Infectious; Female; Humans; Liver Function Tests; Middle Aged; Pandemics; Pneumonia, Viral; Quarantine; Radiography, Thoracic; SARS-CoV-2; Treatment Outcome	2020
The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection Le infezioni in medicina, 2020, 06-01, Volume: 28, Issue:suppl 1 Topics: Adenosine Monophosphate; Alanine; Anticoagulants; Antiviral Agents; Biomarkers; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Disease Management; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Embolism; Endothelium, Vascular; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Interferon beta-1b; Lopinavir; Macrophage Activation; Pandemics; Pneumonia, Viral; Pulmonary Fibrosis; Randomized Controlled Trials as Topic; Ritonavir; Thromboembolism; Thrombophilia; Thrombosis	2020
Uncertainty about the Efficacy of Remdesivir on COVID-19. Journal of Korean medical science, 2020, Jun-15, Volume: 35, Issue:23 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Pandemics; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Uncertainty; Virus Replication	2020
Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature, 2020, Volume: 582, Issue:7813 Topics: Adenosine Monophosphate; Alanine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Dexamethasone; Humans; Pandemics; Pneumonia, Viral; Preprints as Topic; Randomized Controlled Trials as Topic; Respiration, Artificial; Risk Assessment; Survival Rate	2020
A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance. Journal of Korean medical science, 2020, Jun-22, Volume: 35, Issue:24 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Primary Prevention; SARS-CoV-2	2020
[Remdesivir for patients with COVID-19]. Der Internist, 2020, Volume: 61, Issue:8 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient. Clinical chemistry and laboratory medicine, 2020, 08-27, Volume: 58, Issue:9 Topics: Adenosine; Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chromatography, Liquid; Coronavirus Infections; COVID-19; Drug Monitoring; Drug Stability; Female; Furans; Humans; Limit of Detection; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pyrroles; Reproducibility of Results; SARS-CoV-2; Tandem Mass Spectrometry; Triazines	2020
A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge. JAMA, 2020, 07-28, Volume: 324, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Health Care Rationing; Humans; Pandemics; Pneumonia, Viral; Resource Allocation; SARS-CoV-2; State Government	2020
Missed Opportunities on Emergency Remdesivir Use. JAMA, 2020, 07-28, Volume: 324, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Costs; Drugs, Investigational; Hemorrhagic Fever, Ebola; Humans; Length of Stay; National Institute of Allergy and Infectious Diseases (U.S.); Pandemics; Pneumonia, Viral; Registries; SARS-CoV-2; Treatment Outcome; United States	2020
Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease. The Journal of infection, 2020, Volume: 81, Issue:4 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Health Services Accessibility; Humans; London; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; State Medicine; United Kingdom	2020
Optimizing Medication Management During the COVID-19 Pandemic: It Takes a Village. Journal of gerontological nursing, 2020, Jul-01, Volume: 46, Issue:7 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Therapy; Humans; Hydroxychloroquine; Nurse-Patient Relations; Nursing Homes; Pandemics; Pneumonia, Viral; Prodrugs; SARS-CoV-2	2020
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. The Journal of antimicrobial chemotherapy, 2020, 10-01, Volume: 75, Issue:10 Topics: Adenosine Monophosphate; Adenosine Triphosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Female; Humans; Male; Pandemics; Pneumonia, Viral; Recovery of Function; SARS-CoV-2	2020
Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products. Interdisciplinary sciences, computational life sciences, 2020, Volume: 12, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Biological Products; Catalytic Domain; Computer Simulation; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Databases, Pharmaceutical; Drug Evaluation, Preclinical; Genome, Viral; Host Microbial Interactions; Humans; Ligands; Molecular Docking Simulation; Pandemics; Phylogeny; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Viral Nonstructural Proteins	2020
Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19). Obstetrics and gynecology, 2020, Volume: 136, Issue:5 Topics: Adenosine Monophosphate; Adult; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Interleukin-6; Lung; Oximetry; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Radiography, Thoracic; SARS-CoV-2; Treatment Outcome	2020
Case report study of the first five COVID-19 patients treated with remdesivir in France. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 98 Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; France; Hospitalization; Humans; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Load; Withholding Treatment	2020
A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19. Clinical transplantation, 2020, Volume: 34, Issue:11 Topics: Adenosine Monophosphate; Adult; Alanine; Algorithms; Antiviral Agents; Clinical Decision-Making; COVID-19; COVID-19 Testing; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Prospective Studies; Quality Improvement; SARS-CoV-2; Severity of Illness Index; Treatment Outcome	2020
Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020, Volume: 125, Issue:5 Topics: Adenosine Monophosphate; Adult; Alanine; Ampicillin; Angioedema; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes Mellitus, Type 2; Female; Humans; Hydroxychloroquine; Hyperlipidemias; Intubation, Intratracheal; Obesity; Pandemics; Pneumonia, Viral; Respiration, Artificial; Respiratory Insufficiency; SARS-CoV-2; Treatment Outcome	2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report. The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report. The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report. The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report. The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply. The New England journal of medicine, 2020, 09-03, Volume: 383, Issue:10 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection. British journal of haematology, 2020, Volume: 190, Issue:5 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Child, Preschool; Coronavirus Infections; COVID-19; Humans; Induction Chemotherapy; Male; Pandemics; Pneumonia, Viral; Precursor Cell Lymphoblastic Leukemia-Lymphoma; SARS-CoV-2	2020
COVID-19 Therapeutics: Making Sense of It All. AACN advanced critical care, 2020, 09-15, Volume: 31, Issue:3 Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Antiviral research, 2020, Volume: 181 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Antagonism; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells	2020
Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement. Annals of internal medicine, 2020, 07-21, Volume: 173, Issue:2 Topics: Adenosine Monophosphate; Adolescent; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2	2020
Using "old" medications to fight new COVID-19: Re-purposing with a purpose. Journal of molecular and cellular cardiology, 2020, Volume: 146 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Dexamethasone; Diabetes Mellitus; Drug Repositioning; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Obesity; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Potential Repurposed Therapeutics and New Vaccines against COVID-19 and Their Clinical Status. SLAS discovery : advancing life sciences R & D, 2020, Volume: 25, Issue:10 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Chloroquine; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cyclopropanes; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Isoindoles; Lactams; Lactams, Macrocyclic; Mice, Transgenic; Proline; Pyrazines; SARS-CoV-2; Small Molecule Libraries; Sulfonamides; Vaccines, Synthetic	2020
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer discovery, 2020, Volume: 10, Issue:10 Topics: Adenosine Monophosphate; Age Factors; Aged; Alanine; Betacoronavirus; Clinical Decision-Making; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Drug Utilization; Follow-Up Studies; Glucocorticoids; Healthcare Disparities; Hospital Mortality; Humans; Hydroxychloroquine; Male; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Severity of Illness Index; Sex Factors; Treatment Outcome; United States	2020
Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy. The Journal of infectious diseases, 2020, 09-01, Volume: 222, Issue:7 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Fever; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Time Factors; Treatment Outcome	2020
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature, 2020, Volume: 586, Issue:7827 Topics: Adenosine Monophosphate; Alanine; Alveolar Epithelial Cells; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Gene Expression Regulation; Humans; Hydrazones; Induced Pluripotent Stem Cells; Models, Biological; Morpholines; Pandemics; Pneumonia, Viral; Pyrimidines; Reproducibility of Results; SARS-CoV-2; Small Molecule Libraries; Triazines; Virus Internalization; Virus Replication	2020
Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking. Journal of nanoscience and nanotechnology, 2020, 12-01, Volume: 20, Issue:12 Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Drug Interactions; Humans; Hydrogen Bonding; Hydroxychloroquine; Ligands; Molecular Docking Simulation; Nanotechnology; Pandemics; Pneumonia, Viral; Protease Inhibitors; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Static Electricity; Viral Nonstructural Proteins	2020
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:12 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; Europe; Female; Humans; Incidence; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States	2020
Liver injury in remdesivir-treated COVID-19 patients. Hepatology international, 2020, Volume: 14, Issue:5 Topics: Adenosine Monophosphate; Administration, Intravenous; Adult; Aged; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Illness; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Italy; Liver Function Tests; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
[COVID-19: a cardiological point-of-view]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:15 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Arteritis; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Venous Thrombosis	2020
Remdesivir for severe covid-19: a clinical practice guideline. BMJ (Clinical research ed.), 2020, 07-30, Volume: 370 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Guideline Adherence; Humans; Length of Stay; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Time Factors; Treatment Outcome	2020
Communicating Science in the Time of a Pandemic. JAMA, 2020, 08-04, Volume: 324, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Communication; Coronavirus Infections; COVID-19; Dexamethasone; Glucocorticoids; Humans; Hydroxychloroquine; Journalism, Medical; Pandemics; Peer Review, Research; Pneumonia, Viral; SARS-CoV-2; Science	2020
Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice. Protein & cell, 2020, Volume: 11, Issue:10 Topics: Adaptation, Physiological; Adenosine Monophosphate; Administration, Intranasal; Alanine; Animals; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Female; Host Specificity; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mutation, Missense; Nasal Mucosa; Pandemics; Pneumonia, Viral; RNA, Viral; SARS-CoV-2; Turbinates; Vero Cells; Viral Load; Virus Replication	2020
BET 1: The role of remdesivir in COVID-19 infection. Emergency medicine journal : EMJ, 2020, Volume: 37, Issue:8 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Evidence-Based Practice; Female; Humans; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
The Enzyme-Free Release of Nucleotides from Phosphoramidates Depends Strongly on the Amino Acid. Angewandte Chemie (International ed. in English), 2020, 11-02, Volume: 59, Issue:45 Topics: Adenosine Monophosphate; Alanine; Amides; Amino Acids; Antiviral Agents; Catalytic Domain; COVID-19; COVID-19 Drug Treatment; Crystallography, X-Ray; Half-Life; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Molecular Dynamics Simulation; Nucleotides; Phosphoric Acids; Ribonuclease, Pancreatic; SARS-CoV-2	2020
Treatments for COVID-19: where are we now? British journal of community nursing, 2020, 08-02, Volume: 25, Issue:8 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Immunologic Factors; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Were it business opportunities or hidden risks: Observations on clinical trials and marketing authorizations of Gilead Science's remdesivir in China. Die Pharmazie, 2020, 08-01, Volume: 75, Issue:8 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; China; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Industry; Drugs, Generic; Economic Competition; Humans; Pandemics; Pneumonia, Viral	2020
Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019. American journal of obstetrics and gynecology, 2020, Volume: 223, Issue:5 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; Female; Humans; Pandemics; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome	2020
Experts Discuss COVID-19-Remdesivir, Vaccines, and More. JAMA, 2020, Aug-25, Volume: 324, Issue:8 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Contact Tracing; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Dexamethasone; Disease Transmission, Infectious; Humans; Masks; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines	2020
Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: a multistate approach. BMC medical research methodology, 2020, 08-11, Volume: 20, Issue:1 Topics: Adenosine Monophosphate; Alanine; Algorithms; Antiviral Agents; Betacoronavirus; Cohort Studies; Compassionate Use Trials; Coronavirus Infections; COVID-19; Critical Care; Humans; Intensive Care Units; Length of Stay; Models, Theoretical; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Survival Analysis; Survival Rate; Time Factors	2020
A Chemoenzymatic Synthesis of the ( Biochemistry, 2020, 08-25, Volume: 59, Issue:33 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Caulobacteraceae; Coronavirus Infections; COVID-19; Humans; Molecular Structure; Pandemics; Phosphoric Triester Hydrolases; Pneumonia, Viral; RNA-Dependent RNA Polymerase; SARS-CoV-2; Virus Replication	2020
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:12 Topics: Adenosine Monophosphate; Age Factors; Aged; Alanine; Antiviral Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Betacoronavirus; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Connective Tissue Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Immunosuppressive Agents; Logistic Models; Lopinavir; Lupus Erythematosus, Systemic; Male; Middle Aged; Obesity; Pandemics; Pneumonia, Viral; Polymyalgia Rheumatica; Prognosis; Rheumatic Diseases; Risk Factors; Ritonavir; SARS-CoV-2; Severity of Illness Index; Sex Factors; Sjogren's Syndrome; Spondylarthropathies	2020
Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19. JAMA internal medicine, 2020, 10-01, Volume: 180, Issue:10 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Orphan Drug Production; Pandemics; Pneumonia, Viral; SARS-CoV-2; United States; United States Food and Drug Administration	2020
Bilateral posterior cerebral artery territory infarction in a SARS-Cov-2 infected patient: discussion about an unusual case. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:9 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Fatal Outcome; Host-Pathogen Interactions; Humans; Infarction, Posterior Cerebral Artery; Male; Middle Aged; Pandemics; Pneumonia, Viral; Predictive Value of Tests; Risk Factors; SARS-CoV-2; Thrombolytic Therapy; Treatment Outcome	2020
A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2021, Volume: 126, Issue:1 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Asthma; Common Variable Immunodeficiency; COVID-19; COVID-19 Serotherapy; Fatal Outcome; Humans; IgG Deficiency; Immunization, Passive; Immunoglobulin G; Immunoglobulins, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Obesity, Morbid; SARS-CoV-2; Staphylococcal Infections	2021
Efficacy of Remdesivir in COVID-19. JAMA, 2020, 09-15, Volume: 324, Issue:11 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU. The Journal of antimicrobial chemotherapy, 2020, 11-01, Volume: 75, Issue:11 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Follow-Up Studies; Humans; Intensive Care Units; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Treatment Outcome	2020
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia. Cell reports. Medicine, 2020, 07-21, Volume: 1, Issue:4 Topics: Adenosine Monophosphate; Airway Remodeling; Alanine; Animals; Antiviral Agents; Bronchi; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Diltiazem; Drug Synergism; Humans; Immunity, Innate; Models, Biological; Nose; Respiratory Mucosa; SARS-CoV-2; Vero Cells	2020
Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center. American journal of obstetrics & gynecology MFM, 2020, Volume: 2, Issue:3 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Clinical Decision-Making; Compassionate Use Trials; COVID-19; COVID-19 Drug Treatment; Drug Monitoring; Female; Humans; Infant, Newborn; Liver Function Tests; Neonatal Screening; Perinatology; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; SARS-CoV-2; Treatment Outcome	2020
Allocating Remdesivir Under Scarcity: Social Justice or More Systemic Racism. The American journal of bioethics : AJOB, 2020, Volume: 20, Issue:9 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Healthcare Disparities; Humans; Pandemics; Pneumonia, Viral; Racism; SARS-CoV-2; Social Justice; United States	2020
Preferential use of dexamethasone for fetal lung maturation in severe coronavirus disease 2019. American journal of obstetrics & gynecology MFM, 2020, Volume: 2, Issue:4 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Compassionate Use Trials; COVID-19; Dexamethasone; Female; Fetal Organ Maturity; Glucocorticoids; Humans; Obesity; Oxygen Inhalation Therapy; Pregnancy; Respiratory Insufficiency; SARS-CoV-2; Severity of Illness Index; Treatment Outcome	2020
Antiviral treatment for COVID-19: the evidence supporting remdesivir. Clinical medicine (London, England), 2020, Volume: 20, Issue:6 Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2	2020
Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis. Therapeutic innovation & regulatory science, 2020, Volume: 54, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; China; Clinical Trials Data Monitoring Committees; Clinical Trials, Phase III as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Data Accuracy; Host Microbial Interactions; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; SARS-CoV-2; Time Factors; Treatment Outcome	2020
Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19. Antimicrobial agents and chemotherapy, 2020, 10-20, Volume: 64, Issue:11 Topics: Adenosine; Adenosine Monophosphate; Alanine; Antiviral Agents; beta-Cyclodextrins; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Furans; Humans; Intensive Care Units; Lung Transplantation; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Pyrroles; Renal Dialysis; SARS-CoV-2; Transplant Recipients; Triazines	2020
Catalytic Asymmetric Synthesis of the anti-COVID-19 Drug Remdesivir. Angewandte Chemie (International ed. in English), 2020, 11-16, Volume: 59, Issue:47 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Catalysis; COVID-19; COVID-19 Drug Treatment; Humans; Imidazoles; Kinetics; Molecular Conformation; SARS-CoV-2; Stereoisomerism	2020
It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV. The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antitubercular Agents; Antiviral Agents; Betacoronavirus; Coinfection; Comorbidity; Coronavirus Infections; COVID-19; Drug Interactions; HIV Infections; HIV-1; Humans; Mycobacterium tuberculosis; Pandemics; Pneumonia, Viral; Prevalence; Rifampin; SARS-CoV-2; Survival Analysis; Tuberculosis, Pulmonary; United States	2020
Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report. Medwave, 2020, Aug-19, Volume: 20, Issue:7 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir and COVID-19: What are the implications for Africa? South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2020, 05-07, Volume: 110, Issue:6 Topics: Adenosine Monophosphate; Africa; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Emergency Use Authorization for Remdesivir and Its Potential Implications. Therapeutic innovation & regulatory science, 2021, Volume: 55, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Humans; SARS-CoV-2	2021
Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2. Virology, 2020, Volume: 550 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Drug Administration Schedule; Humans; Inflammation; Macaca mulatta; Models, Statistical; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Load; Virus Replication	2020
Remdesivir, a remedy or a ripple in severe COVID-19? Expert opinion on investigational drugs, 2020, Volume: 29, Issue:11 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome	2020
Kidney Transplantation and COVID-19. Rhode Island medical journal (2013), 2020, 09-04, Volume: 103, Issue:8 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Pandemics; Pneumonia, Viral; SARS-CoV-2; Transplant Recipients	2020
Case of multisystem inflammatory syndrome in children presenting as fever and abdominal pain. BMJ case reports, 2020, Sep-08, Volume: 13, Issue:9 Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; C-Reactive Protein; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Diagnosis, Differential; Fever; Humans; Interleukin 1 Receptor Antagonist Protein; Intubation, Intratracheal; Male; Mucocutaneous Lymph Node Syndrome; Myocarditis; Nasopharynx; Natriuretic Peptide, Brain; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Tachycardia; Treatment Outcome	2020
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease. Blood advances, 2020, 09-22, Volume: 4, Issue:18 Topics: Adenosine Monophosphate; Alanine; Antibodies, Neutralizing; Antiviral Agents; Coronavirus Infections; COVID-19; Down Syndrome; Female; Heart Diseases; Humans; Immunization, Passive; Infant; Pandemics; Pneumonia, Viral; Respiratory Insufficiency	2020
Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. Journal of the Pediatric Infectious Diseases Society, 2021, Feb-13, Volume: 10, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Child; COVID-19; COVID-19 Drug Treatment; Evidence-Based Medicine; Humans; Immunocompromised Host; Risk Factors; Severity of Illness Index; Systemic Inflammatory Response Syndrome	2021
COVID-19: Rescue by transcriptional inhibition. Science advances, 2020, Volume: 6, Issue:27 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytidine; Humans; Hydroxylamines; Pandemics; Pneumonia, Viral; Ribonucleosides; RNA-Dependent RNA Polymerase; SARS-CoV-2; Transcription, Genetic	2020
Pulmonary administration of remdesivir in the treatment of COVID-19. The AAPS journal, 2020, 09-17, Volume: 22, Issue:6 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Severe COVID-19 Infections-Knowledge Gained and Remaining Questions. JAMA internal medicine, 2021, 01-01, Volume: 181, Issue:1 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Critical Care; Critical Care Outcomes; Extracorporeal Membrane Oxygenation; Hospital Mortality; Humans; Patient Positioning; Prone Position; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index	2021
Successfully treated severe COVID-19 and invasive aspergillosis in early hematopoietic cell transplantation setting. Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:2 Topics: Adenosine Monophosphate; Alanine; Amphotericin B; Coinfection; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung; Male; Methylprednisolone; Myeloablative Agonists; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Transplantation Conditioning; Treatment Outcome; Young Adult	2021
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovascular research, 2020, 12-01, Volume: 116, Issue:14 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Apoptosis; Caco-2 Cells; Cathepsins; COVID-19; COVID-19 Drug Treatment; Heart Diseases; Host-Pathogen Interactions; Humans; Myocytes, Cardiac; Reactive Oxygen Species; SARS-CoV-2; Signal Transduction	2020
Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues. Biomolecules, 2020, 09-21, Volume: 10, Issue:9 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Viral; Antigen-Antibody Reactions; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Eflornithine; Humans; Hydrophobic and Hydrophilic Interactions; Ivermectin; L-Lactate Dehydrogenase; Models, Molecular; Molecular Docking Simulation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proline; Protein Binding; Protein Conformation; Protein Interaction Mapping; Receptors, Glycine; Saposins; SARS-CoV-2; Sofosbuvir; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship	2020
SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response. Cell stem cell, 2020, 12-03, Volume: 27, Issue:6 Topics: Adenosine Monophosphate; Alanine; Alveolar Epithelial Cells; Animals; Antiviral Agents; Cells, Cultured; COVID-19; Drug Development; Enzyme Inhibitors; Humans; Inflammation; Models, Biological; Pluripotent Stem Cells; RNA-Seq; SARS-CoV-2; Serine Endopeptidases; Virus Replication	2020
Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13). International journal of biological macromolecules, 2020, Nov-15, Volume: 163 Topics: Adenosine Monophosphate; Amino Acid Sequence; Betacoronavirus; Binding Sites; Computer Simulation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; Enzyme Inhibitors; Folic Acid; Genome, Viral; Glucosides; Humans; Methyltransferases; Molecular Docking Simulation; Mutation; Pandemics; Pneumonia, Viral; RNA Helicases; SARS-CoV-2; Stilbenes; Vidarabine; Viral Nonstructural Proteins	2020
Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 10-05, Volume: 73, Issue:7 Topics: Adenosine Monophosphate; Aged; Alanine; B-Lymphocytes; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Female; Humans; Immunization, Passive; Mutation; RNA-Dependent RNA Polymerase; SARS-CoV-2	2021
Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity". Antimicrobial agents and chemotherapy, 2020, 11-17, Volume: 64, Issue:12 Topics: Adenosine; Adenosine Monophosphate; Alanine; beta-Cyclodextrins; COVID-19; Furans; Humans; Lung Transplantation; Neuroglia; Pandemics; Pyrroles; Renal Dialysis; SARS-CoV-2; Transplant Recipients; Triazines	2020
Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity. Antimicrobial agents and chemotherapy, 2020, 11-17, Volume: 64, Issue:12 Topics: Adenosine; Adenosine Monophosphate; Alanine; beta-Cyclodextrins; COVID-19; Furans; Humans; Lung; Pandemics; Pyrroles; Renal Dialysis; SARS-CoV-2; Transplant Recipients; Triazines	2020
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant. The Journal of allergy and clinical immunology, 2021, Volume: 147, Issue:2 Topics: Adenosine Monophosphate; Adolescent; Alanine; Antibodies, Viral; Antiviral Agents; B-Lymphocytes; COVID-19; Hospitalization; Humans; Interleukin-6; Male; NF-kappa B p52 Subunit; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index	2021
Compassionate Drug Use - Time Arising for a New Law in Bulgaria in the Era of COVID-19. Folia medica, 2020, Sep-30, Volume: 62, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Bulgaria; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drugs, Investigational; Health Policy; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir and COVID-19. Lancet (London, England), 2020, 10-03, Volume: 396, Issue:10256 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir and COVID-19. Lancet (London, England), 2020, 10-03, Volume: 396, Issue:10256 Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir and COVID-19. Lancet (London, England), 2020, 10-03, Volume: 396, Issue:10256 Topics: Adenosine Monophosphate; Adult; Alanine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Remdesivir and COVID-19 - Authors' reply. Lancet (London, England), 2020, 10-03, Volume: 396, Issue:10256 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Ribonucleotides; SARS-CoV-2	2020
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report. Modern rheumatology case reports, 2021, Volume: 5, Issue:1 Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Autoantibodies; Bronchoscopy; Child; COVID-19; COVID-19 Nucleic Acid Testing; Cyclophosphamide; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung; Lung Diseases, Interstitial; Lymphohistiocytosis, Hemophagocytic; Mediastinal Emphysema; Methylprednisolone; Piperidines; Pneumonia, Pneumocystis; Pneumothorax; Pyrimidines; Respiratory Insufficiency; Shock, Septic; Subcutaneous Emphysema; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination	2021
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir. Scientific reports, 2020, 10-06, Volume: 10, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Drug Discovery; Drug Repositioning; Exonucleases; Hepacivirus; Hepatitis C; Humans; Pandemics; Pneumonia, Viral; Prodrugs; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Sofosbuvir; Viral Nonstructural Proteins; Virus Replication	2020
Audio Interview: Covid-19 and the President. The New England journal of medicine, 2020, 10-08, Volume: 383, Issue:15 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Federal Government; Glucocorticoids; Government Employees; HIV Protease Inhibitors; Humans; Hypoxia; Immunization, Passive; Lopinavir; Oxygen Inhalation Therapy; Pandemics; Patient Acuity; Pneumonia, Viral; Risk Assessment; SARS-CoV-2; United States; Virus Replication	2020
Severe COVID-19 initially presenting as mesenteric adenopathy. Pediatric radiology, 2021, Volume: 51, Issue:1 Topics: Abdominal Pain; Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; COVID-19; COVID-19 Testing; Diagnosis, Differential; Humans; Lymphadenopathy; Male; Peritoneal Diseases; Polymerase Chain Reaction; Positive-Pressure Respiration; Tomography, X-Ray Computed; Treatment Outcome	2021
Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice. Acta pharmacologica Sinica, 2021, Volume: 42, Issue:7 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Kidney; Liver; Lung; Male; Mice; Nucleosides; Nucleotides; Polyphosphates; SARS-CoV-2; Tissue Distribution	2021
Management and outcomes of patients hospitalized with severe COVID-19 at a tertiary care center in midwestern United States. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Oct-08, Volume: 90, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Critical Care; Glucocorticoids; Hospitalization; Humans; Immunization, Passive; Midwestern United States; Pandemics; Pneumonia, Viral; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers; Tertiary Healthcare	2020
Cyanoamidine Cyclization Approach to Remdesivir's Nucleobase. Organic letters, 2020, 11-06, Volume: 22, Issue:21 Topics: Adenosine Monophosphate; Alanine; Amidines; Antiviral Agents; Chemistry Techniques, Synthetic; Coronavirus Infections; COVID-19; Cyclization; Pandemics; Pneumonia, Viral	2020
Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient. The Journal of infectious diseases, 2021, 01-04, Volume: 223, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antibodies, Viral; COVID-19; Hospitalization; Humans; Immunity, Humoral; Immunocompromised Host; Lymphoma, Mantle-Cell; Male; Middle Aged; Primary Immunodeficiency Diseases; SARS-CoV-2; Seroconversion; Virus Replication	2021
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes. Antiviral research, 2020, Volume: 184 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antimalarials; Antiviral Agents; Chlorocebus aethiops; Chloroquine; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Flow Cytometry; Heart Diseases; Humans; Hydroxychloroquine; Microscopy, Fluorescence; Myocytes, Cardiac; Pluripotent Stem Cells; Pyrazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vero Cells; Viral Plaque Assay	2020
Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response. Science advances, 2020, Volume: 6, Issue:47 Topics: Adenosine Monophosphate; Adoptive Transfer; Alanine; Antibodies, Viral; Antiviral Agents; Broadly Neutralizing Antibodies; Cell- and Tissue-Based Therapy; COVID-19; COVID-19 Drug Treatment; Humans; Hydrazines; Killer Cells, Natural; Models, Theoretical; SARS-CoV-2; Time Factors; Treatment Outcome; Triazoles; Viral Load; Virus Shedding	2020
Exploring RdRp-remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV. SAR and QSAR in environmental research, 2020, Volume: 31, Issue:11 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Molecular Docking Simulation; Pandemics; Pneumonia, Viral; Quantitative Structure-Activity Relationship; RNA-Dependent RNA Polymerase; SARS-CoV-2; Viral Proteins	2020
Phytochemicals from Selective Plants Have Promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations. BioMed research international, 2020, Volume: 2020 Topics: Adenosine Monophosphate; Alanine; Antimetabolites; Antiviral Agents; China; COVID-19; COVID-19 Drug Treatment; Dioxolanes; Fluoroquinolones; Humans; Methyltransferases; Molecular Docking Simulation; Nelfinavir; Phytochemicals; Piperazines; Protein Conformation; RNA Helicases; SARS-CoV-2; Topoisomerase II Inhibitors; Viral Nonstructural Proteins	2020
Sustained Response After Remdesivir and Convalescent Plasma Therapy in a B-Cell-Depleted Patient With Protracted Coronavirus Disease 2019 (COVID-19). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 12-06, Volume: 73, Issue:11 Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Immunization, Passive; SARS-CoV-2	2021
Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience. The Journal of the American Osteopathic Association, 2020, 12-01, Volume: 120, Issue:12 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; Critical Care; Female; Hospital Mortality; Hospitalization; Hospitals, Community; Humans; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Treatment Outcome	2020
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies. Acta pharmaceutica (Zagreb, Croatia), 2021, Jun-01, Volume: 71, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Crystallography, X-Ray; Drug Discovery; Drug Repositioning; Humans; Models, Chemical; Molecular Docking Simulation; Molecular Structure; Pandemics; Pneumonia, Viral; Protease Inhibitors; Structure-Activity Relationship	2021
Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study. Journal of medical Internet research, 2020, 11-20, Volume: 22, Issue:11 Topics: Adenosine Monophosphate; Alanine; Azithromycin; Chloroquine; Communication; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Federal Government; Fraud; Humans; Hydroxychloroquine; Internet; Language; Mass Media; Pandemics; Pneumonia, Viral; Public Health; United States	2020
Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection? Autophagy, 2020, Volume: 16, Issue:12 Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal; Antimetabolites; Antiviral Agents; Autophagy; Betacoronavirus; COVID-19; Dexamethasone; Disease Outbreaks; Drug Development; Humans; Mice; Pandemics; SARS-CoV-2; Signal Transduction; Virus Internalization	2020
Scientists criticize use of unproven COVID drugs in India. Nature, 2020, Volume: 587, Issue:7833 Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; Drugs, Investigational; Humans; Hydroxychloroquine; India; Patient Safety; Placebos; Pyrazines; Reproducibility of Results; SARS-CoV-2; Time Factors; United States; Virus Shedding	2020
The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access. JAMA, 2020, Dec-01, Volume: 324, Issue:21 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Humans; Pandemics; United States	2020
Why do COVID death rates seem to be falling? Nature, 2020, Volume: 587, Issue:7833 Topics: Adenosine Monophosphate; Age Distribution; Age Factors; Aged; Aged, 80 and over; Alanine; Antibodies, Monoclonal, Humanized; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Dexamethasone; Humans; Immunization, Passive; Intensive Care Units; Oxygen; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Time Factors; Ventilators, Mechanical	2020
Safe and effective medication utilization in pediatric patients requiring rehabilitation services during the Coronavirus pandemic of 2019. Journal of pediatric rehabilitation medicine, 2020, Volume: 13, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Drug Discovery; Humans; Hydroxychloroquine; Off-Label Use; Pandemics; Pediatrics; Public-Private Sector Partnerships; Rehabilitation; Research Support as Topic; United States	2020
Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment. The protein journal, 2020, Volume: 39, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Binding Sites; Coronavirus Papain-Like Proteases; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Protein Conformation; SARS-CoV-2; Viral Nonstructural Proteins	2020
Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids. Cellular and molecular gastroenterology and hepatology, 2021, Volume: 11, Issue:4 Topics: Adenosine Monophosphate; Alanine; Caco-2 Cells; COVID-19; COVID-19 Drug Treatment; Human Embryonic Stem Cells; Humans; Intestinal Mucosa; Organoids; SARS-CoV-2; Virus Replication	2021
SARS-CoV-2 Triggering Severe Acute Respiratory Distress Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in a 3-Year-Old Child With Down Syndrome. Journal of the Pediatric Infectious Diseases Society, 2021, Apr-30, Volume: 10, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Child, Preschool; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Critical Care; Down Syndrome; Genetic Predisposition to Disease; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Lymphohistiocytosis, Hemophagocytic; Male; Prednisolone; SARS-CoV-2; Systemic Inflammatory Response Syndrome	2021
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome. BMC pulmonary medicine, 2020, Nov-16, Volume: 20, Issue:1 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Humans; Hydroxychloroquine; Inflammation; Intensive Care Units; Interleukin-10; Interleukin-6; Interleukin-8; Italy; Leukocytes; Leukocytes, Mononuclear; Lopinavir; Lung; Lymphocytes; Macrophages, Alveolar; Male; Microscopy, Electron, Transmission; Middle Aged; Neutrophils; Pandemics; Pneumonia, Viral; Prognosis; Prospective Studies; Respiration, Artificial; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Survival Rate; Virion	2020
Hydration-Induced Disorder Lowers the Energy Barriers for Methyl Rotation in Drug Molecules. The journal of physical chemistry letters, 2020, Dec-03, Volume: 11, Issue:23 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Crystallography, X-Ray; Dexamethasone; Hydroxychloroquine; Methylation; Models, Molecular; Water	2020
A Patient with Fever and Dyspnea. The New England journal of medicine, 2020, Nov-05, Volume: 383, Issue:19 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Combined Modality Therapy; COVID-19; Dexamethasone; Diagnosis, Differential; Dyspnea; Female; Fever; Humans; Leukocyte Count; Lung; Middle Aged; Myalgia; Nasopharynx; Oxygen; Radiography, Thoracic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2	2020
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today. The New England journal of medicine, 2020, 11-05, Volume: 383, Issue:19 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; COVID-19 Vaccines; Dexamethasone; Disease Transmission, Infectious; Drug Development; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Treatment Outcome; Viral Vaccines	2020
Covid-19-Associated Myopathy Caused by Type I Interferonopathy. The New England journal of medicine, 2020, 12-10, Volume: 383, Issue:24 Topics: Adenosine Monophosphate; Adult; Alanine; COVID-19; Humans; Interferon Type I; Male; Methylprednisolone; Muscle, Skeletal; Muscular Diseases; Myxovirus Resistance Proteins; Prednisone	2020
A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2. Antiviral research, 2021, Volume: 185 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Chromosomes, Artificial, Bacterial; COVID-19; COVID-19 Drug Treatment; HEK293 Cells; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Replicon; RNA-Binding Proteins; SARS-CoV-2; Sofosbuvir; Vero Cells; Virus Replication	2021
Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19. Journal of pediatric hematology/oncology, 2022, 01-01, Volume: 44, Issue:1 Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disease Management; Female; Hospitalization; Humans; Immunocompromised Host; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; SARS-CoV-2	2022
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis. The Journal of antimicrobial chemotherapy, 2021, 02-11, Volume: 76, Issue:3 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Renal Dialysis	2021
Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers. Journal of global health, 2020, Volume: 10, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; Congenital Abnormalities; COVID-19; COVID-19 Drug Treatment; Female; Global Health; Humans; Hydroxychloroquine; Infant, Newborn; Infant, Newborn, Diseases; Neural Tube Defects; Physicians; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2	2020
[Nursing Experience Caring for a COVID-19 Patient With Hearing Loss]. Hu li za zhi The journal of nursing, 2020, Volume: 67, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Communication; Coronavirus Infections; COVID-19; Hearing Loss; Humans; Male; Pandemics; Patient-Centered Care; Pneumonia, Viral; SARS-CoV-2; Social Isolation; Taiwan; Treatment Outcome	2020
Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC-MS/MS. Journal of pharmaceutical and biomedical analysis, 2021, Feb-05, Volume: 194 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Humans; Liver; Male; Mice; Prodrugs; Tandem Mass Spectrometry	2021
A survey of US hospitals' criteria for the allocation of remdesivir to treat COVID-19. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2021, 01-22, Volume: 78, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Health Personnel; Humans; Patient Care Team; Pharmacists; Pharmacy Service, Hospital; Resource Allocation; Surveys and Questionnaires; United States	2021
Molecular Descriptors of Some Chemicals that Prevent COVID-19. Current organic synthesis, 2021, Volume: 18, Issue:8 Topics: Adenosine Monophosphate; Alanine; Biflavonoids; Catechin; COVID-19; Humans; Hydroxychloroquine; Quantitative Structure-Activity Relationship; SARS-CoV-2	2021
A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humans. CPT: pharmacometrics & systems pharmacology, 2021, Volume: 10, Issue:2 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cells, Cultured; COVID-19; COVID-19 Drug Treatment; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Animal; Respiratory Mucosa; Species Specificity	2021
Gender differences in treatment of Coronavirus Disease-2019. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Dec-03, Volume: 90, Issue:4 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Amides; Antimalarials; Antiviral Agents; Cardiovascular Diseases; Chloroquine; Clinical Trials as Topic; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Diabetes Complications; Female; Humans; Hypertension; Immunity; Immunization, Passive; Immunoglobulins; Lopinavir; Male; Middle Aged; Mortality; Pandemics; Pyrazines; Ritonavir; SARS-CoV-2; Sex Characteristics	2020
Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia in a Newborn Treated With Remdesivir and Coronavirus Disease 2019 Convalescent Plasma. Journal of the Pediatric Infectious Diseases Society, 2021, May-28, Volume: 10, Issue:5 Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; COVID-19; COVID-19 Serotherapy; Female; Humans; Immunization, Passive; Infant, Newborn; Infectious Disease Transmission, Vertical; Pneumonia, Viral; SARS-CoV-2	2021
Are academia-pharma partnerships essential for novel drug discovery in the time of the COVID-19 pandemic? Expert opinion on drug discovery, 2021, Volume: 16, Issue:5 Topics: Academic Medical Centers; Adenosine Monophosphate; Alanine; Antiviral Agents; Bias; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Drug Discovery; Drug Industry; Humans; Public-Private Sector Partnerships; Research; Research Support as Topic; SARS-CoV-2; Universities	2021
Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection. Protein & cell, 2021, Volume: 12, Issue:9 Topics: Adenosine Monophosphate; Alanine; Alveolar Epithelial Cells; Antibodies, Neutralizing; COVID-19; COVID-19 Drug Treatment; Down-Regulation; Drug Discovery; Human Embryonic Stem Cells; Humans; Immunity; Lipid Metabolism; Lung; RNA, Viral; SARS-CoV-2; Virus Replication	2021
Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series. Respiration; international review of thoracic diseases, 2020, Volume: 99, Issue:12 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Aged; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; APACHE; Azithromycin; COVID-19; COVID-19 Drug Treatment; Doxycycline; Enzyme Inhibitors; Extracorporeal Membrane Oxygenation; Female; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Intensive Care Units; Length of Stay; Lopinavir; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Time Factors; Young Adult	2020
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report. Nature communications, 2020, 12-14, Volume: 11, Issue:1 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; COVID-19; Fever; Humans; Immunity, Humoral; Lymphocyte Count; Male; SARS-CoV-2; Treatment Outcome	2020
[The medicinal treatment of COVID-19: a brief update]. Nederlands tijdschrift voor geneeskunde, 2020, 11-12, Volume: 164 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Netherlands; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome	2020
On the molecular structure of Remdesivir for the treatment of Covid-19. Computer methods in biomechanics and biomedical engineering, 2021, Volume: 24, Issue:9 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Humans; Models, Molecular; Molecular Structure; SARS-CoV-2; Vero Cells	2021
Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 104 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Humans; Immunocompromised Host; SARS-CoV-2; Virus Replication	2021
Extracorporeal Membrane Oxygenation for COVID-19-Associated Multisystem Inflammatory Syndrome in a 5-year-old. The American surgeon, 2022, Volume: 88, Issue:2 Topics: Adenosine Monophosphate; Adrenergic alpha-Agonists; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Child, Preschool; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Epinephrine; Extracorporeal Membrane Oxygenation; Female; Humans; Hypotension; Immunization, Passive; Immunoglobulins, Intravenous; Interleukin 1 Receptor Antagonist Protein; Methylprednisolone; Norepinephrine; Shock, Cardiogenic; Systemic Inflammatory Response Syndrome	2022
Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing. European journal of clinical pharmacology, 2021, Volume: 77, Issue:6 Topics: Adenosine Monophosphate; Airway Management; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disease Progression; Humans; Hypoxia; Mortality; Patient Selection; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiratory Insufficiency; SARS-CoV-2; Time-to-Treatment; Treatment Outcome	2021
COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper. Cardiology in the young, 2021, Volume: 31, Issue:3 Topics: Adenosine Monophosphate; Alanine; Anti-Arrhythmia Agents; Anticoagulants; Antiviral Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Surgical Procedures; Cardiology; COVID-19; COVID-19 Drug Treatment; Heart Defects, Congenital; Heart Transplantation; Humans; Immunologic Factors; Infectious Disease Transmission, Vertical; Long QT Syndrome; Myocarditis; Myocardium; Pediatrics; Risk Assessment; SARS-CoV-2; Societies, Medical; Systemic Inflammatory Response Syndrome; Tachycardia, Ventricular	2021
[Clinical progression of the first wave of novel coronavirus infection in Ostrava]. Klinicka mikrobiologie a infekcni lekarstvi, 2020, Volume: 26, Issue:3 Topics: Adenosine Monophosphate; Aged; Alanine; Amides; COVID-19; Czech Republic; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Pyrazines; Respiration, Artificial	2020
Research shows racial disparity, mortality data for patients with cancer and COVID-19. Cancer, 2021, 02-01, Volume: 127, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Black or African American; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Healthcare Disparities; Humans; Hydroxychloroquine; Mortality; Neoplasms; Race Factors; United Kingdom; United States	2021
Remdesivir and mortality reduction in COVID-19 patients: a systematized subgroup analysis of clinical trials. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2021, 01-13, Volume: 45, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic	2021
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system. Antiviral research, 2021, Volume: 187 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Autophagy; Benzimidazoles; Bronchi; Cell Line; Coronavirus 229E, Human; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Epithelial Cells; Humans; Interferon Type I; Lung; Membrane Proteins; SARS-CoV-2; Virus Replication	2021
ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response. Cell stem cell, 2021, 02-04, Volume: 28, Issue:2 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Apolipoproteins E; Astrocytes; Brain; Cell Differentiation; Chlorocebus aethiops; COVID-19; Humans; Induced Pluripotent Stem Cells; Nerve Degeneration; Neurites; Neurons; Organoids; Protein Isoforms; SARS-CoV-2; Synapses; Tropism; Vero Cells	2021
Deep vein thrombosis with pulmonary thromboembolism in a case of severe COVID-19 pneumonia. BMJ case reports, 2021, Jan-15, Volume: 14, Issue:1 Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Anticoagulants; Antiparasitic Agents; Antiviral Agents; Computed Tomography Angiography; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 2; Doxycycline; Femoral Vein; Fibrin Fibrinogen Degradation Products; Glucocorticoids; Heparin, Low-Molecular-Weight; Humans; Ivermectin; Male; Methylprednisolone; Middle Aged; Oxygen Inhalation Therapy; Popliteal Vein; Pulmonary Embolism; SARS-CoV-2; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Venous Thrombosis	2021
A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report. European journal of hospital pharmacy : science and practice, 2021, Volume: 28, Issue:5 Topics: Adenosine Monophosphate; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Alanine; Antiviral Agents; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Incidence; Inpatients; Male; Middle Aged; Monitoring, Physiologic; Pharmacovigilance; Portugal; Prospective Studies	2021
Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:6 Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Azithromycin; Ceftriaxone; Coinfection; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Dexamethasone; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pneumococcal Infections; SARS-CoV-2; Streptococcus pneumoniae	2021
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses mBio, 2021, 01-19, Volume: 12, Issue:1 Topics: Adenosine Monophosphate; Alanine; Animals; Antimetabolites; Antiviral Agents; Azo Compounds; Chlorocebus aethiops; Coronavirus NL63, Human; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Isoquinolines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinazolinones; SARS-CoV-2; Vero Cells; Virus Replication	2021
Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial. The Journal of infectious diseases, 2021, 04-23, Volume: 223, Issue:8 Topics: Adenosine Monophosphate; Adult; Alanine; Antibodies, Viral; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokines; Female; Humans; Immunity; Male; SARS-CoV-2	2021
Allergen fragrance molecules: a potential relief for COVID-19. BMC complementary medicine and therapies, 2021, Jan-21, Volume: 21, Issue:1 Topics: Adenosine Monophosphate; Alanine; Allergens; Benzopyrans; Benzyl Compounds; Cinnamates; Coronavirus 3C Proteases; Coronavirus Nucleocapsid Proteins; COVID-19; COVID-19 Drug Treatment; Diterpenes; Drug Evaluation, Preclinical; Humans; Ligands; Molecular Docking Simulation; Odorants; Perfume; Phosphoproteins; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Transcription Factors	2021
Available drugs and supplements for rapid deployment for treatment of COVID-19. Journal of molecular cell biology, 2021, 07-06, Volume: 13, Issue:3 Topics: Adenosine Monophosphate; Alanine; Animals; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Repositioning; Flavonoids; Humans; Mice; Nitro Compounds; Pharmaceutical Preparations; SARS-CoV-2; Small Molecule Libraries; Teicoplanin; Thiazoles	2021
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science (New York, N.Y.), 2021, 02-26, Volume: 371, Issue:6532 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Coronavirus Nucleocapsid Proteins; COVID-19; COVID-19 Drug Treatment; Depsipeptides; Drug Evaluation, Preclinical; Female; HEK293 Cells; Humans; Lung; Mice, Inbred C57BL; Mutation; Peptide Elongation Factor 1; Peptides, Cyclic; Phosphoproteins; RNA, Viral; SARS-CoV-2; Virus Replication	2021
Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant. The New England journal of medicine, 2021, Jan-14, Volume: 384, Issue:2 Topics: Adenosine Monophosphate; Africa; Age Factors; Alanine; Antibodies, Neutralizing; Azabicyclo Compounds; Communicable Disease Control; COVID-19; COVID-19 Testing; COVID-19 Vaccines; Dexamethasone; Disease Transmission, Infectious; Humans; Immunization Programs; Mutation; Patient Acuity; Quinazolines; Risk Factors; SARS-CoV-2; Sequence Analysis, RNA; South Africa; Virulence	2021
A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation. Scientific reports, 2021, 01-26, Volume: 11, Issue:1 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Chlorocebus aethiops; CHO Cells; COVID-19; Cricetulus; Drug Design; Drug Evaluation, Preclinical; Electroporation; Genome, Viral; HEK293 Cells; Humans; Inhibitory Concentration 50; Kinetics; Open Reading Frames; Polymerase Chain Reaction; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Untranslated Regions; Vero Cells; Virion; Virus Replication	2021
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium. PLoS pathogens, 2021, Volume: 17, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Epithelium; Humans; Interferons; Interleukin-6; Lung; SARS-CoV-2; Viral Tropism; Virus Replication	2021
In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality. Annals of internal medicine, 2021, Volume: 174, Issue:2 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Intention to Treat Analysis; Interferon beta-1a; Kaplan-Meier Estimate; Length of Stay; Lopinavir; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Respiration, Artificial; Treatment Failure; World Health Organization	2021
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Emerging microbes & infections, 2021, Volume: 10, Issue:1 Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Viral; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Macrophages; Male; Mesocricetus; Methylprednisolone; Respiratory System; RNA, Viral; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Viral Load; Virus Replication	2021
Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment. International journal of pharmaceutics, 2021, Mar-15, Volume: 597 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Delayed-Action Preparations; Drug Evaluation, Preclinical; Humans; Injections, Subcutaneous; Prodrugs; SARS-CoV-2	2021
Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 104 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Bayes Theorem; COVID-19; COVID-19 Drug Treatment; Humans; Probability; Respiration, Artificial; SARS-CoV-2	2021
SARS-CoV-2 evolution during treatment of chronic infection. Nature, 2021, Volume: 592, Issue:7853 Topics: Adenosine Monophosphate; Aged; Alanine; Antibodies, Neutralizing; Antibodies, Viral; Chronic Disease; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Evolution, Molecular; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Immune Evasion; Immune Tolerance; Immunization, Passive; Immunosuppression Therapy; Male; Mutagenesis; Mutant Proteins; Mutation; Phylogeny; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Viral Load; Virus Shedding	2021
A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma. Journal of clinical immunology, 2021, Volume: 41, Issue:5 Topics: Adenosine Monophosphate; Adult; Agammaglobulinemia; Alanine; COVID-19; COVID-19 Serotherapy; Genetic Diseases, X-Linked; Humans; Immunization, Passive; Male	2021
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum Journal of pharmaceutical and biomedical analysis, 2021, Mar-20, Volume: 196 Topics: Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Chloroquine; Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Furans; Humans; Hydroxychloroquine; Isotopes; Lopinavir; Pandemics; Pyrazines; Pyrroles; Ritonavir; SARS-CoV-2; Tandem Mass Spectrometry; Triazines	2021
Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir. Antiviral research, 2021, Volume: 188 Topics: Adenosine Monophosphate; Alanine; Amino Acid Substitution; Animals; COVID-19; COVID-19 Drug Treatment; Drug Resistance, Viral; Evolution, Molecular; Genetic Variation; Humans; Mink; Models, Molecular; Protein Conformation; RNA, Viral; SARS-CoV-2; Sequence Analysis, DNA; Structure-Activity Relationship; Viral Nonstructural Proteins; Virus Replication; Whole Genome Sequencing	2021
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Critical care medicine, 2021, 03-01, Volume: 49, Issue:3 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Anticoagulants; COVID-19; COVID-19 Serotherapy; Critical Care; Dexamethasone; Disease Management; Evidence-Based Medicine; Hemodynamics; Humans; Hydroxychloroquine; Immunization, Passive; Intensive Care Units; Patient Positioning; Practice Guidelines as Topic; Ventilation	2021
Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2. International journal of molecular sciences, 2021, Feb-04, Volume: 22, Issue:4 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Deoxycytidine; Drug Therapy, Combination; Gemcitabine; Humans; Inhibitory Concentration 50; SARS-CoV-2; Vero Cells; Virus Replication	2021
Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture. Viruses, 2021, 02-09, Volume: 13, Issue:2 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cell Culture Techniques; Cell Line; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Defensins; Guanidines; Humans; Peptidomimetics; Pyrimidines; SARS-CoV-2; Vero Cells; Virus Internalization; Virus Replication	2021
Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19). Journal of medical virology, 2021, Volume: 93, Issue:5 Topics: Adenosine Monophosphate; Aged; Alanine; Bradycardia; COVID-19; COVID-19 Drug Treatment; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; SARS-CoV-2; Treatment Outcome	2021
Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region. Pathogens and global health, 2021, Volume: 115, Issue:4 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Aged; Alanine; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Colchicine; COVID-19; Drug Therapy, Combination; Female; Greece; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult	2021
A shorter symptom onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: A real-world analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 106 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Hospital Mortality; Humans; Male; Middle Aged; Odds Ratio; Retrospective Studies; Treatment Outcome	2021
COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels. The Journal of pharmacology and experimental therapeutics, 2021, Volume: 377, Issue:2 Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; ERG1 Potassium Channel; HEK293 Cells; Humans; Hydroxychloroquine; Potassium Channel Blockers	2021
Real-life use of remdesivir in hospitalized patients with COVID-19. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021, Volume: 34, Issue:2 Topics: Adenosine Monophosphate; Aged; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Female; Hospital Mortality; Humans; Inpatients; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Spain; Treatment Outcome	2021
Dermatological manifestations during COVID-19 infection: a case series and discussion on the problem of differential diagnosis. Acta bio-medica : Atenei Parmensis, 2021, 02-09, Volume: 92, Issue:1 Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; SARS-CoV-2; Skin Diseases	2021
[Scientific research in times of pandemics.] Recenti progressi in medicina, 2021, Volume: 112, Issue:3 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Vaccines; Disease Outbreaks; Drug Approval; European Union; Humans; Influenza, Human; Information Dissemination; Informed Consent; Oseltamivir; Pandemics; Peer Review, Research; Periodicals as Topic; Politics; Publishing; Research; Risk; SARS-CoV-2; Time Factors; United States	2021
1'-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication. Physical chemistry chemical physics : PCCP, 2021, Mar-14, Volume: 23, Issue:10 Topics: Adenosine Monophosphate; Alanine; Catalytic Domain; COVID-19; COVID-19 Drug Treatment; Cyanides; Humans; Molecular Dynamics Simulation; Nucleotides; Ribose; RNA-Dependent RNA Polymerase; SARS-CoV-2; Static Electricity; Virus Replication	2021
Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors. European journal of cancer (Oxford, England : 1990), 2021, Volume: 148 Topics: Adenosine Monophosphate; Aged; Alanine; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; COVID-19 Serotherapy; Dexamethasone; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Immunization, Passive; Immunotherapy; Latent Infection; Lopinavir; Lung Neoplasms; Male; Molecular Targeted Therapy; Neoplasms; Proportional Hazards Models; Risk Factors; Ritonavir; SARS-CoV-2; Spain; Time Factors; Virus Shedding	2021
Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study. Journal of Korean medical science, 2021, Mar-22, Volume: 36, Issue:11 Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Humans; Male; Middle Aged; Real-Time Polymerase Chain Reaction; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Viral Load	2021
Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19. JAMA network open, 2021, 03-01, Volume: 4, Issue:3 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Baltimore; Case-Control Studies; Comparative Effectiveness Research; COVID-19; COVID-19 Drug Treatment; District of Columbia; Female; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Treatment Outcome	2021
A young man presenting with encephalopathy and seizures secondary to SARS-CoV-2. BMJ case reports, 2021, Mar-24, Volume: 14, Issue:3 Topics: Adenosine Monophosphate; Adult; Alanine; Anticonvulsants; Antiviral Agents; Brain Diseases; Confusion; COVID-19; COVID-19 Serotherapy; Humans; Immunization, Passive; Magnetic Resonance Imaging; Male; Polymerase Chain Reaction; Radiography; SARS-CoV-2; Seizures; Treatment Outcome	2021
Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex. Cell biochemistry and biophysics, 2021, Volume: 79, Issue:2 Topics: Adenosine Monophosphate; Adenosine Triphosphate; Alanine; Antiviral Agents; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Dynamics Simulation; SARS-CoV-2; Thermodynamics; Viral Nonstructural Proteins	2021
COVID-19 and Heart Transplant: A Case Series and Review of the Literature. Transplantation proceedings, 2021, Volume: 53, Issue:4 Topics: Adenosine Monophosphate; Aged; Alanine; Comorbidity; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Glucocorticoids; Graft Rejection; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; SARS-CoV-2; Withholding Treatment	2021
COVID-19, a tale of two peaks: patients' characteristics, treatments, and clinical outcomes. Internal and emergency medicine, 2021, Volume: 16, Issue:6 Topics: Adenosine Monophosphate; Adult; Age Distribution; Aged; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Disease Progression; Female; Hospitalization; Humans; Immunization, Passive; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Sex Distribution	2021
Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report. Current problems in cancer, 2021, Volume: 45, Issue:6 Topics: Adenosine Monophosphate; Adult; Alanine; Amides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Brentuximab Vedotin; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Male; Pregnenediones; Pyrazines; Time Factors; Vinblastine	2021
The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study. Frontiers in immunology, 2021, Volume: 12 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Bacteremia; Biomarkers; C-Reactive Protein; Cohort Studies; Comorbidity; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Female; Humans; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Respiratory Distress Syndrome; Severity of Illness Index; Staphylococcal Infections	2021
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2021, 04-06, Volume: 193, Issue:14 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Chemical and Drug Induced Liver Injury; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Hypersensitivity; Humans; SARS-CoV-2; Treatment Outcome	2021
Use of Remdesivir in Myasthenia gravis and COVID-19. Pharmacotherapy, 2021, Volume: 41, Issue:6 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Inflammatory Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Fatal Outcome; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Treatment Outcome	2021
Neonates With SARS-CoV-2 Infection and Pulmonary Disease Safely Treated With Remdesivir. The Pediatric infectious disease journal, 2021, 05-01, Volume: 40, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Infant; Male; SARS-CoV-2; United Kingdom	2021
The race for antiviral drugs to beat COVID - and the next pandemic. Nature, 2021, Volume: 592, Issue:7854 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Birds; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytidine; Drug Development; Drug Industry; Europe; Humans; Hydroxylamines; Indoles; Influenza, Human; Leucine; Orthomyxoviridae; Pandemics; Pyrrolidinones; Severe Acute Respiratory Syndrome; Strategic Stockpile; United States	2021
Funders, now is the time to invest big in COVID drugs. Nature, 2021, Volume: 592, Issue:7854 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Development; Humans; Investments; Pandemics; Strategic Stockpile	2021
Economic evaluation of remdesivir for the treatment of severe COVID-19 patients in China under different scenarios. British journal of clinical pharmacology, 2021, Volume: 87, Issue:11 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; China; Cost-Benefit Analysis; COVID-19; COVID-19 Drug Treatment; Humans; Quality of Life	2021
Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19: A case report. International journal of laboratory hematology, 2021, Volume: 43, Issue:5 Topics: Adenosine Monophosphate; Alanine; Allografts; Antiviral Agents; Bone Marrow; Chromosomes, Human, Pair 8; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Hematopoietic Stem Cell Transplantation; Humans; Laboratories; Leukemia, Myeloid, Acute; Lymphocytes; Male; Middle Aged; Neoplastic Stem Cells; Plasma Cells; Recurrence; Salvage Therapy; SARS-CoV-2; Trisomy	2021
Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir. Clinical pharmacology and therapeutics, 2022, Volume: 111, Issue:3 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Clinical Trials, Phase III as Topic; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Double-Blind Method; Drug Approval; Humans; Japan; Pyrazines	2022
Compassionate Use of Remdesivir in Children With Severe COVID-19. Pediatrics, 2021, Volume: 147, Issue:5 Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Child; Child, Preschool; Compassionate Use Trials; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Hospitalization; Humans; Infant; Male; Oxygen Inhalation Therapy; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Treatment Outcome	2021
Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex. Proceedings of the National Academy of Sciences of the United States of America, 2021, 05-11, Volume: 118, Issue:19 Topics: Adenosine Monophosphate; Antiviral Agents; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Cryoelectron Microscopy; DNA Helicases; Genome, Viral; Humans; Molecular Dynamics Simulation; RNA Helicases; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Viral Nonstructural Proteins; Virus Replication	2021
A 10-Year-old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir. Journal of pediatric hematology/oncology, 2022, 03-01, Volume: 44, Issue:2 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Child; COVID-19; COVID-19 Drug Treatment; Female; Humans; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; SARS-CoV-2	2022
Successful Management of COVID-19 Infection in 2 Early Post-Liver Transplant Recipients. Transplantation proceedings, 2021, Volume: 53, Issue:4 Topics: Adenosine Monophosphate; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Female; Humans; Hydroxychloroquine; Immunization, Passive; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Methylprednisolone; Middle Aged; SARS-CoV-2	2021
A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. Antiviral research, 2021, Volume: 190 Topics: A549 Cells; Adenosine Monophosphate; Alanine; Antiviral Agents; Cell Survival; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Exoribonucleases; HEK293 Cells; High-Throughput Screening Assays; Humans; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Viral Nonstructural Proteins	2021
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Cell reports, 2021, 05-04, Volume: 35, Issue:5 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Alveolar Epithelial Cells; Child, Preschool; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Epithelial Cells; Epithelium; Female; Fibroblasts; Humans; Lung; Male; Middle Aged; Models, Biological; Primary Cell Culture; Respiratory Mucosa; SARS-CoV-2; Virus Replication	2021
Treatment patterns in US patients hospitalized with COVID-19 and pulmonary involvement. Journal of medical virology, 2021, Volume: 93, Issue:9 Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Black People; Bronchodilator Agents; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Female; Hospitalization; Humans; Hydroxychloroquine; Lung; Male; Middle Aged; Pneumonia; Retrospective Studies; SARS-CoV-2; United States; White People	2021
Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19. Journal of medical virology, 2021, Volume: 93, Issue:9 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Aspirin; Blood Platelets; Coronary Artery Disease; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus; Disseminated Intravascular Coagulation; Drug Combinations; Female; Hospital Mortality; Humans; Hypertension; Iran; Lopinavir; Lung; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Respiration, Artificial; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Treatment Outcome	2021
Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-2. Viruses, 2021, 04-02, Volume: 13, Issue:4 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Chlorocebus aethiops; Coronavirus Nucleocapsid Proteins; COVID-19; Deep Learning; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Machine Learning; Phosphoproteins; SARS-CoV-2; Vero Cells; Viral Load	2021
Remdesivir Use in COVID-19 Patients: Cutaneous Adverse Effect or Disease Manifestation? Journal of drugs in dermatology : JDD, 2021, May-01, Volume: 20, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Diagnosis, Differential; Drug Eruptions; Humans	2021
Clinical Outcomes of COVID-19 Patients Treated with Convalescent Plasma or Remdesivir Alone and in Combination at a Community Hospital in California's Central Valley. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2021, Volume: 24 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; California; Combined Modality Therapy; COVID-19; COVID-19 Serotherapy; Female; Hospitals, Community; Humans; Immunization, Passive; Length of Stay; Male; Middle Aged; Retrospective Studies; Treatment Outcome	2021
A toddler diagnosed with severe postinfectious bronchiolitis obliterans and COVID-19 infection. Pediatric pulmonology, 2021, Volume: 56, Issue:7 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Bronchiolitis Obliterans; Child; Child, Preschool; COVID-19; Humans; Pandemics; Retrospective Studies; SARS-CoV-2	2021
Predictors of mortality in patients with severe COVID-19 pneumonia - a retrospective study. Advances in respiratory medicine, 2021, Volume: 89, Issue:2 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; COVID-19; Critical Illness; Female; Hospital Mortality; Hospitalization; Humans; India; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome	2021
Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine: Potential Inhibitor of SARS-CoV2. Bioorganic chemistry, 2021, Volume: 112 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Binding Sites; COVID-19; Crystallography, X-Ray; Density Functional Theory; Half-Life; Humans; Molecular Conformation; Molecular Docking Simulation; Piperidines; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Viral Matrix Proteins	2021
Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome. JMIR public health and surveillance, 2021, 05-19, Volume: 7, Issue:5 Topics: Adenosine Monophosphate; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Cytokine Release Syndrome; Drug Therapy, Combination; Humans; Immunization, Passive; Male; SARS-CoV-2	2021
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic. JAMA network open, 2021, 05-03, Volume: 4, Issue:5 Topics: Adenosine Monophosphate; Adult; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticoagulants; Antiviral Agents; Azithromycin; California; Colchicine; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Drug Utilization Review; Female; Hospitalization; Humans; Hydrocortisone; Hydroxychloroquine; Male; Pandemics; SARS-CoV-2	2021
Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2021, Volume: 24 Topics: Adenosine; Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cell Line; COVID-19; COVID-19 Drug Treatment; Dogs; Dose-Response Relationship, Drug; Drug Approval; Furans; Humans; Kidney; Kidney Tubules, Proximal; Madin Darby Canine Kidney Cells; Organic Anion Transporters; Pyrroles; Triazines	2021
Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned. Viruses, 2021, 05-22, Volume: 13, Issue:6 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; SARS-CoV-2; Treatment Outcome; Virus Replication	2021
Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany-An Ethical Analysis. International journal of environmental research and public health, 2021, May-26, Volume: 18, Issue:11 Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Ethical Analysis; Germany; Humans; Hydroxychloroquine; Immunization, Passive; Pandemics; SARS-CoV-2	2021
Evaluation of the AMP SARS-CoV-2 rapid antigen test in a hospital setting. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 108 Topics: Adenosine Monophosphate; COVID-19; Hospitals; Humans; Real-Time Polymerase Chain Reaction; Retrospective Studies; SARS-CoV-2; Sensitivity and Specificity	2021
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models. Virus research, 2021, Volume: 302 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cell Culture Techniques; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Folic Acid Antagonists; Humans; Methotrexate; RNA, Viral; SARS-CoV-2; Vero Cells; Virus Replication	2021
Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19. British journal of haematology, 2021, Volume: 194, Issue:3 Topics: Adenosine Monophosphate; Adolescent; Alanine; Antimalarials; Antineoplastic Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disease Management; Humans; Hydroxychloroquine; Hydroxyurea; Leukemia, Myeloid, Acute; Male; SARS-CoV-2; Young Adult	2021
Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2021, Volume: 24 Topics: Adenosine; Adenosine Monophosphate; Alanine; Antiviral Agents; Computer Simulation; COVID-19; COVID-19 Drug Treatment; Databases, Chemical; Drug Interactions; Furans; Humans; Prodrugs; Pyrroles; Risk Assessment; Risk Factors; SARS-CoV-2; Triazines	2021
Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study. Clinical interventions in aging, 2021, Volume: 16 Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Aging; Alanine; Antiviral Agents; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Female; Glomerular Filtration Rate; Humans; Male; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome	2021
COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system. PloS one, 2021, Volume: 16, Issue:6 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Delivery of Health Care; Drug Therapy, Combination; Humans; Hydroxychloroquine; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Treatment Outcome; United States	2021
Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective. Pharmacological reports : PR, 2021, Volume: 73, Issue:6 Topics: Adenosine; Adenosine Monophosphate; Alanine; Antiviral Agents; Binding Sites; Computer Simulation; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Drug Design; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; SARS-CoV-2	2021
COVID-19 Second Wave in India - Wait or Act? The American journal of medicine, 2021, Volume: 134, Issue:11 Topics: Adenosine Monophosphate; Administration, Intravenous; Alanine; Ambulatory Care; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Critical Pathways; Female; Humans; India; Male; Middle Aged; Risk Adjustment; SARS-CoV-2; Severity of Illness Index; Triage	2021
Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study. Circulation. Arrhythmia and electrophysiology, 2021, Volume: 14, Issue:7 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Bradycardia; COVID-19; COVID-19 Drug Treatment; Female; Heart Rate; Hospitalization; Humans; Incidence; Italy; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors	2021
Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments. Viruses, 2021, 06-14, Volume: 13, Issue:6 Topics: Adaptive Immunity; Adenosine Monophosphate; Alanine; Antibodies, Viral; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Host-Pathogen Interactions; Humans; Immunity, Innate; Immunization, Passive; Models, Theoretical; Virus Internalization	2021
Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type. Biomolecules, 2021, 06-22, Volume: 11, Issue:7 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Binding Sites; Catalytic Domain; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Dynamics Simulation; Point Mutation; SARS-CoV-2	2021
Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:9 Topics: Adenosine Monophosphate; Alanine; B-Lymphocytes; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Administration Schedule; Humans; Immunization, Passive; Immunocompromised Host; Immunosuppressive Agents; Italy; Lymphoma, Non-Hodgkin; Lymphopenia; Male; Middle Aged; Pneumonia, Viral; Rituximab; SARS-CoV-2; Treatment Outcome	2021
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir. Frontiers in immunology, 2021, Volume: 12 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antibodies, Viral; Antiviral Agents; Becaplermin; Brain-Derived Neurotrophic Factor; Case-Control Studies; COVID-19; COVID-19 Drug Treatment; Cytokines; Female; Hospitalization; Humans; Immunoglobulin G; Male; Membrane Proteins; Middle Aged; Prospective Studies; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Treatment Outcome	2021
Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19. JAMA network open, 2021, 07-01, Volume: 4, Issue:7 Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Hospital Mortality; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Patient Discharge; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; United States; Veterans; Veterans Health Services	2021
Clinical course and serial chest ultra-low-dose CT findings in a patient with COVID-19 treated with remdesivir. Minerva medica, 2021, Volume: 112, Issue:4 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Female; Humans; Middle Aged; Radiation Dosage; Thorax; Tomography, X-Ray Computed; Treatment Outcome	2021
Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings. PloS one, 2021, Volume: 16, Issue:7 Topics: Adenosine Monophosphate; Alanine; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Europe; Humans; SARS-CoV-2; Treatment Outcome; United States	2021
Post-COVID-19 Hyperglycemia: A Concern in Selection of Therapeutic Regimens. Iranian journal of medical sciences, 2021, Volume: 46, Issue:4 Topics: Adenosine Monophosphate; Blood Glucose; COVID-19; COVID-19 Drug Treatment; Humans; Hyperglycemia	2021
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir. The Journal of general virology, 2021, Volume: 102, Issue:7 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cells, Cultured; Chymases; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Humans; Molecular Docking Simulation; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolines; SARS-CoV-2	2021
Trends in COVID-19 cases and clinical management in Veterans Health Administration medical facilities: A national cohort study. PloS one, 2021, Volume: 16, Issue:7 Topics: Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Comorbidity; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Female; Hospital Mortality; Hospitalization; Humans; Longitudinal Studies; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; United States; Veterans Health	2021
Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data. Expert opinion on drug safety, 2021, Volume: 20, Issue:12 Topics: Acute Kidney Injury; Adenosine Monophosphate; Adverse Drug Reaction Reporting Systems; Alanine; Antiviral Agents; Bradycardia; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Liver Function Tests; Male; Middle Aged; SARS-CoV-2; United States; United States Food and Drug Administration	2021
Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection. Life science alliance, 2021, Volume: 4, Issue:10 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Lung; Macaca mulatta; Models, Theoretical; Nose; Pharynx; SARS-CoV-2; Time Factors; Viral Load; Virus Replication; Virus Shedding	2021
Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study. Annals of internal medicine, 2021, Volume: 174, Issue:10 Topics: Adenosine Monophosphate; Adolescent; Adrenal Cortex Hormones; Adult; Age Distribution; Aged; Alanine; Antiviral Agents; COVID-19; Critical Care; Cross-Sectional Studies; Female; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Pandemics; Respiration, Artificial; SARS-CoV-2; United States; Vasoconstrictor Agents; Young Adult	2021
Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy. IUBMB life, 2022, Volume: 74, Issue:1 Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Caspase 9; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Cytopathogenic Effect, Viral; Endoplasmic Reticulum Stress; Humans; MAP Kinase Signaling System; Models, Biological; Nelfinavir; NF-kappa B; SARS-CoV-2; Unfolded Protein Response; Vero Cells	2022
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study. Annals of internal medicine, 2021, Volume: 174, Issue:10 Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Alanine; Anti-Inflammatory Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Practice Patterns, Physicians'; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; United States; Young Adult	2021
Elevated inflammatory markers are associated with poor outcomes in COVID-19 patients treated with remdesivir. Journal of medical virology, 2022, Volume: 94, Issue:1 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Biomarkers; C-Reactive Protein; COVID-19; COVID-19 Drug Treatment; Female; Fibrin Fibrinogen Degradation Products; Humans; Inflammation; L-Lactate Dehydrogenase; Length of Stay; Male; Middle Aged; Prognosis; Retrospective Studies; SARS-CoV-2	2022
Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19. Respiratory investigation, 2021, Volume: 59, Issue:6 Topics: Adenosine Monophosphate; Aged; Alanine; Azetidines; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Purines; Pyrazoles; Respiration, Artificial; SARS-CoV-2; Sulfonamides; Treatment Outcome	2021
Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients. Journal of medical virology, 2022, Volume: 94, Issue:1 Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Child; Child, Preschool; COVID-19; COVID-19 Drug Treatment; Drug Resistance, Viral; Evolution, Molecular; Female; Haplotypes; Humans; Infant; Lung; Male; Phylogeny; RNA, Viral; SARS-CoV-2; Viral Load; Virus Replication	2022
Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients Turkish journal of medical sciences, 2021, 12-13, Volume: 51, Issue:6 Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Amides; Antiviral Agents; Clinical Protocols; COVID-19; COVID-19 Nucleic Acid Testing; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Oseltamivir; Pandemics; Pyrazines; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult	2021
Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:11 Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Child; Child, Preschool; COVID-19; Developing Countries; Female; Humans; Infant; Male; Neoplasms; Prospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome	2021
Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: Bioinformatic studies. Archiv der Pharmazie, 2021, Volume: 354, Issue:11 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Binding Sites; Boswellia; Computational Biology; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Nucleoproteins; Polyproteins; Prodrugs; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship; Triterpenes; Viral Proteins	2021
Oxygen Sparing Effect of Bacteriotherapy in COVID-19. Nutrients, 2021, Aug-23, Volume: 13, Issue:8 Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; Azithromycin; Blood Gas Analysis; Cell Line; COVID-19; Female; Heparin; Humans; Hypoxia; Italy; Lung; Male; Middle Aged; Oxygen; Probiotics; Prospective Studies	2021
Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery. International journal of molecular sciences, 2021, Aug-18, Volume: 22, Issue:16 Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; B-Lymphocytes; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Immunization, Passive; Immunocompromised Host; Rituximab; SARS-CoV-2; T-Lymphocytes; Vero Cells	2021